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1. Executive Summary 
 
SpaceWorks Enterprises, Inc. (SEI) has conducted an evaluation of an advanced habitat system designed to transport 
crews between the Earth and Mars. This new and innovative habitat concept is capable of placing crew members in 
inactive, torpor states during transit phases of a deep space mission. This substantially reduces the mass and size of 
the habitat, which ultimately leads to significant reductions in the overall architecture size.  
 
Our approach for achieving this is based on extending the current and evolving medical practice of Therapeutic 
Hypothermia (TH) – a proven and effective treatment for various traumatic injuries. TH is a medical treatment that 
lowers a patient's body temperature by just 5 to 10 degrees Fahrenheit causing human metabolic rate to decrease 
significantly and the body to enter an unconscious state. This method avoids the intractable challenges often associated 
with cell metabolic cessation through cryogenic freezing and other highly speculative approaches. 
 
The initial results obtained from the research and analysis conducted in the Phase I effort warranted further study of 
this concept and technology. The specific objectives of the continued work include: 
 
1. Addressing critical medical aspects and risks for inducing torpor via Therapeutic Hypothermia and the 
approach for providing nutrition and hydration for the crew during torpor 
2. Focusing on mitigation aspects and technology potential for solving key human spaceflight challenges 
3. Addressing critical engineering aspects of the design that may impact the initial performance and cost results 
obtained in Phase I  
4. Examining the broader extensibility and enabling capabilities of this concept through applicability to 
additional exploration missions beyond Mars 
5. Establishing a technology development roadmap, addressing both medical and engineering aspects, that 
indicate a logical and scientifically achievable path forward for maturation of this technology 
 
For this effort, four (4) key task areas were identified. These were structured and developed based on prior work to 
address key challenges/issues and to achieve the research objectives. Each element was designed to further explore 
and advance our knowledge of the concept. As shown in Figure 1, the focus areas and study task activities are: 
(i) Medical Assessments and Evaluations 
(ii) Mars Mission Habitat Design 
(iii) Extensibility Beyond Mars 
(iv) Technology Roadmap Development 
 
 
 
 
Figure 1. Study Organization and Key Research Areas 
 
In addition to the experienced team of engineers from SpaceWorks, a diverse medical team that consists of expert 
practitioners and respected industry leaders in the fields of animal hibernation, therapeutic hypothermia, and advanced 
medicine were assembled. These experts supported further studies on the medical viability for this concept, 
identification of key risk and mitigation options, and assisted in creation of the technology roadmap.  
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The results of this effort provide NASA with the knowledge and information needed to understand the medical aspects, 
the engineering trades, and overall viability of this concept. This could potentially set NASA and the industry on a 
completely new path towards enabling exploration and make the prospects of humanity extending itself into deep 
space truly a reality. 
 
This concept is multi-faceted and trans-disciplinary in nature. To fully realize its potential, it will require engineers 
from every discipline, hardware technicians, medical specialists in every aspect of human physiology, psychologists, 
psychiatrists, and human factors experts. For mission planners and designers, the effort will outline multiple options 
and paths forward to understand the best way to capitalize on the technology and maximize the benefits. It is expected 
that this broad look at the concept applicability will serve to foster further studies and innovation amongst the industry.  
 
The ultimate goal of the team is to advance the concept from what is likely viewed as still very speculative based on 
the Phase I study to a viable option enabling human exploration at the conclusion of the Phase II effort (albeit with 
much work still to do). This study will likely encourage further investigations amongst the medical community that 
NASA can continue to leverage and use to the benefit of spaceflight. Similarly, NASA’s interest and support in this 
field will likely help to maintain current research investments by NIH and DoD, potentially leading to spinoffs in the 
medical community in the form of new medical treatments, equipment, and applications.  
 
To this end, SpaceWorks has compiled a developmental roadmap for this technology. As shown in Figure 1, research 
efforts for both the medical and engineering aspects are summarized and phased in time, including potential off-ramps 
as contingency for some key approaches.  
 
 
Figure 2. Space Torpor Development Roadmap 
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2. Introduction and Rationale 
 
2.1. Introduction 
 
Technology development for in-space habitats is often focused on improving the power generation system efficiency, 
lightweight structures, and environmental control and life support systems (ECLSS). Assuming these advanced 
technologies, estimates for Mars in-space habitats still range from 25 to 50 t for crew sizes between 4 and 6 [1,2]. 
With these habitat masses, advanced propulsion (SEP, NTR, etc.) and cryogenic transfer stages become mandatory 
architecture elements just to make the end-to-end system remotely feasible. We need affordable, game-changing 
technologies if we are to truly contemplate the prospects of humans pioneering to Mars and beyond. 
 
SpaceWorks proposes the development of an advanced habitat system for transporting crews between the Earth and 
deep space destinations. This new and innovative habitat design is capable of cycling the crew through inactive, non-
cryonic torpor sleep states for the duration of the in-space mission segments. While this idea of “suspended animation” 
for interstellar human exploration has often been shown in the realm of science fiction as the solution for long-duration 
spaceflight, recent medical advancements in Therapeutic Hypothermia (TH) have demonstrated our ability to induce 
deep sleep states (i.e. torpor) with significantly reduced metabolic rates for humans over extended periods of time 
with moderate reductions in core body temperature [4]. With currently foreseeable stasis periods of up to two weeks, 
this new approach to spaceflight can offer numerous benefits to the crew and mission [5]. Cycling the crew in and out 
of the torpor state further reduces the burden on fully autonomous systems, ensures crew cognitive abilities are 
maintained, and enables use by NASA on early Mars missions. Over time, it is reasonable to assume this capability 
can be further extended to periods of months to offer additional benefits. 
 
The torpor habitat primarily consists of sleep chambers, or pods, that crewmembers would enter for stasis shortly after 
departure from Earth or after leaving their destination for Earth-return. The current approach envisions these pods 
using a combination of passive cooling systems, minimal dosage suppressive drugs, and an adenosine A1AR agonist 
pharmaceutical, to initiate and sustain the torpor state. As a result of this process, crew metabolic rates are subsequently 
and significantly reduced relative to standard basal metabolic rate (BMR), minimizing the oxygen demand and nutrient 
requirements. The body’s core temperature need only be reduced to 89o to 93oF to enable this process. In stasis, body 
hydration and nutritional needs are then provided enterally via all-liquid solutions. 
 
The baseline crew operations approach is referred to as a “sentry protocol”. This protocol puts each crew member in 
a rotation sequence of being active for a brief period of a few days followed by a 10-14 days of an inactive, torpor 
phase. This approach is considered very reasonable based on current medical capabilities and emerging practices. At 
any time during transit, scheduling permits there to be at least one alert and active crew member on the mission with 
one other crew member either undergoing a cooling phase to enter torpor –or- a warming cycle to awaken. This 
schedule is repeated throughout the duration of the transit phase and has only minimal negative impact on the potential 
size of the habitat and mass savings that could be achieved compared to a full duration stasis period for the entire crew 
(e.g. 6 months of torpor). 
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Figure 3. Torpor Inducing Habitat Concept Overview 
 
With the mass savings achieved with torpor inducing transfer habitats compared to current industry habitat designs, a 
host of new options are available to enhance mission capability. This includes ability to expand launch windows, 
reduce trip times, reduce program costs (e.g. less hardware and complexity), and/or improve crew safety (e.g. thicker 
radiation shielding, greater redundancy). This can all be done with almost no detrimental impact to the scientific value 
or goals of the mission. This technology also uniquely offers a more sustainable approach to exploration, not merely 
from a cost perspective but also for system scalability. As humanity will ultimately desire and need to send ever 
increasing crew sizes into space, this technology is capable of supporting the demanding performance requirements 
for those missions. 
 
2.2. Rationale 
 
Enabling the human exploration of Mars is arguably one of the most challenging problems whose achievement would 
represent one of the greatest feats in human history. The challenges are extremely diverse and range from engineering, 
to affordability, sustainability, and human factors. Committing to such an endeavor will surely test our commitment 
and resolve to be a space faring species. However, success can ensure our long-term survival as a species against such 
threats as planetary-scale extinction events and ecological crisis. 
 
The engineering analysis results under the 2013 Phase I study indicated the potential for substantial habitat mass 
reductions as well as significant architecture improvements [5]. In the cumulative experiences of the authors, no other 
single technology has been found to have such a significant impact on a system element and across a Mars exploration 
architecture as those achieved through the torpor concept. Based on the potential of this concept, further evaluation 
was certainly warranted. The innovative adaptation of TH to spaceflight is an opportunity to realize a game changing 
technology. 
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A brief description of a few key exploration challenges that torpor can address will be provided next. The objective 
here is to emphasize the multifaceted nature (and magnitude) of this problem and not necessarily provide an exhaustive 
list of every challenge and solution. 
 
Engineering- 
In order to safely send and return a crew from deep space, a massive system-of-systems architecture is required that 
will contain dozens of system elements, each with dozens of systems and subsystems within each of these. Ensuring 
that each architecture element is able to interface with the rest of the system is a massive coordination problem. 
Additionally, it is critical that each hardware piece (e.g. component, subsystem, etc.) meets the required mass, power, 
and volume budgets to make sure the combined system will work. Mass growth in one area can significantly increase 
the size of other elements due to the coupled nature of the systems. 
 
Space Environment- 
Traveling in space away from the protective atmosphere and magnetic field of the Earth exposes astronauts to both 
Solar Particle Events (SPE) and Galactic Cosmic Radiation (GCR). Left unprotected, this radiation exposure can 
damage the central nervous system, skin, and body organs as well as ultimately increase an astronaut’s risk of cancer 
in the long term. SPEs originate from the sun and occur intermittently. It is generally possible to receive notification 
of the event in advance and place the crew in small shielded compartment. GCR consists of a continuous, 
omnidirectional stream of very high-energy particles that originated from outside our solar system. For space travel, 
it is currently mass-prohibitive to provide adequate shielding against GCR, so alternative approaches and technologies 
must be used. 
 
Mission Duration- 
Round-trip Mars missions tend to be on the order of 2.5-3 years, with the biggest variation being in how long the 
surface stay/residence time is for the crew. All hardware systems and machines will need to be redundant and able to 
operate for the duration of the mission as only minimal spare parts and repairs will be possible. While additive 
manufacturing capabilities will surely offer some solutions for sparing, it is not a panacea. In addition to the need for 
highly robust systems, both the required levels of redundancy and spare parts increase the total system mass. 
 
Affordability and Sustainability- 
A good first-order indicator of exploration mission costs, assuming similar technology levels, is the system’s Initial 
Mass in Low Earth Orbit (IMLEO). The IMLEO for the crew stage of a typical Mars mission is often 300-500 tonnes 
(on par with the ISS), compared to ~120 tonnes for the Apollo-era lunar missions. Any approaches that can reduce the 
IMLEO are likely to have significant costs savings associated with them, assuming the technology development costs 
required to achieve the savings are not substantial. 
 
Not only is IMLEO an indicator of the amount of mission hardware needed, but it indicates the Earth-to-orbit (ETO) 
payload lift capability needed to place all these elements and propellants into orbit. Even with a vehicle like NASA’s 
SLS, a Mars-class mission could require half a dozen or more launches in just a few months’ time for a single mission. 
Given that the current SLS launch manifest envisions 1-launch per year, this will put major demands on the operations 
infrastructure.  
 
The affordability and more importantly, sustainability, of the architecture approach must be factored into the solution. 
If we are to accomplish more than a “flags and footprints” mission with lasting consequences we need to consider 
technologically innovative solutions that will have a long-term impact on the program. 
 
Human Factors- 
The introduction of the human crew to the architecture, compared to robotic exploration, has major consequences to 
the mission design. Time becomes of the essence as the human body is not naturally adapted and designed for survival 
in the space environment. 
 
On the medical side, there are challenges with simply providing treatment (e.g. open surgery) and having the necessary 
equipment and expertise on hand. To date, there has never been surgery conducted in space. Communications with 
the crew can also take anywhere from 4 to 24 minutes, depending on the position of the planets. In an emergency 
situation, almost any delay puts the crew in a position of having to make decisions with minimal or no input from 
remote support staff such as program managers, engineers, and medical teams.  
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Physiologically, the human body experiences a number of detrimental effects in space. Due to the microgravity 
environment, significant bone demineralization and muscle atrophy occurs over time. These can seriously impact the 
performance and health of the astronauts. Additionally, the extended exposure to high-levels of radiation can have 
near-term as well as permanent, long term mortality rate impacts. Other complications such as increased intracranial 
pressure (ICP), spinal elongation, and altered immune systems are also compounded with mission duration. 
 
Psychologically, the 2+ year mission duration is difficult both socially and emotionally for the crew members. At 
typical crew sizes of only 4-8 members, interpersonal conflicts are likely to amplify as the mission progresses. Data 
recorded by astronauts on the International Space Station (ISS) for missions of only 1-year in duration have shown a 
significant increase in recorded conflicts during the latter half of the mission. Results from the 2010-2011 Russian-
ESA-Chinese Mars500 experiment with a 6-member “crew” held in isolation for 520-days also indicated interrupted 
sleeping patterns, depression, lethargy, and even willful isolationism.  
 
 
2.3. Technology 
 
The torpor state is achieved by inducing a mild hypothermic state, a practice known as Therapeutic Hypothermia 
(TH). TH is a medical treatment that lowers a patient's body temperature in order to help reduce the risk of ischemic 
injury to tissue following a period of insufficient blood flow. Since 2003 TH has become a staple of Critical Care for 
newborn infants suffering from fetal hypoxia and for adults suffering from head trauma, neurological injuries, stroke 
and cardiac arrest. Benefits of hypothermic therapy have been well proven, and it is relatively inexpensive to 
implement and use. Standard protocols exist in most major medical centers throughout the world [6]. 
 
Large medical teams are generally required to provide care and treatment for the types of traumatic injuries that 
necessitate the use of TH in hospitals today. However, a single medical professional can perform the application and 
monitoring of the TH treatment component, as is currently demonstrated by Emergency Medical Technicians (EMTs) 
and first responders [7]. Thus, it is not unreasonable to assume that over the next decade or two, a healthy Mars-bound 
crew in torpor could be monitored by a single active crew member assisted by advanced robotic/AI systems and/or 
self-induce the process via automation. 
 
While TH is a proven treatment for traumatic injuries, it has not been applied in non-critical care settings due to a 
current lack of medical need or purpose. The opportunity exists to use TH in this capacity to enable and enhance our 
human spaceflight capability. With this concept, we have the potential to simultaneously solve multiple exploration 
challenges. 
 
This concept is inherently multifaceted and introduces a number of wide-ranging questions that span medicine, 
physiology, psychology, and aerospace design. To summarize a few medical facts on what is currently known: 
 
• Therapeutic Hypothermia (TH) is an emerging and evolving procedure that the medical community is 
still identifying its multiple benefits and applications  
 
• Human patients that have experienced traumatic injuries regularly undergo TH for periods of 24-48 hours 
(established treatment protocol). A recent Chinese study has indicated at least one patient successfully 
underwent TH for up to 14-days, although very little about their current condition(s) is known [4].  
 
• A Percutaneous Endoscopic Gastrostomy (PEG) is a tube inserted through a small incision in the abdomen 
and into the stomach and is intended for long-term enteral nutrition (with a median use of 6 months, but 
with well documented extended use for over 4 years) [8]. 
 
• Conversations conducted with multiple medical practitioners, researchers, and experts have confirmed 
the medical plausibility of this concept and approach 
 
As with any new concept or technology, there are potential risks or complications involved due to the lack of data 
and/or knowledge. This study effort has attempted to identify and mitigate any known or likely medical risks and 
challenges through revisions to the intial torpor approach that was postulated during the Phase I effort.   
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3. Background 
 
3.1. Hibernation  
 
Hibernation is a physiologic state that occurs in warm-blooded animals and is characterized by inactivity, reduced 
body temperature, slowed breathing and heart rate, and a decreased metabolic rate. Most often associated with low 
ambient temperatures and winter months, the primary function of hibernation is to allow an animal to conserve energy 
when resources are scarce. To enter this state, an animal decreases its metabolic rate, which in turn decreases its overall 
body temperature and other physiologic functions [2]. Hibernation can last from several days to several months 
depending on the species, the reason for hibernation, the ambient temperature, and the time of year. 
 
The term hibernation can technically be subdivided into two distinct processes, obligate hibernation and facultative 
hibernation. While the mechanisms that initiate each type of hibernation are similar, the end result is markedly 
different [9]. Obligate hibernation is the process of spontaneous and annual hibernation that occurs regardless of the 
ambient temperature or an animal’s access to food. This is the state most traditionally identified as "hibernation", 
where the animal’s body temperature, heart rate, respiration rate, and metabolic activity level slows drastically. 
Facultative hibernation (also known as Torpor), on the other hand, only occurs when an animal is stressed by some 
environmental factor (i.e. extreme cold or food deprivation). A torpor state can last days to weeks, or even be episodic 
occurring at regular intervals in a 24-hour period (known as "daily torpor") [10]. There are dozens of warm-blooded 
species that are known to hibernate or undergo torpor, including four species of primates. 
 
 
The actual step by step process that prepares an animal for hibernation and initiates its associated metabolic reduction 
is not currently known. This is likely due to the fact that hibernation is a complex physiological process regulated by 
multiple organ systems. At this time, the most accepted theory of hibernation induction is by a chemical called a 
“Hibernation Inducing Trigger” (HIT for short), which when released by the animal initiates the hibernation process. 
There is some research to support this theory. Early hibernation research in 1990s hinted at the ability to induce torpor 
in animals through the injection of blood taken from hibernating animals. While this research has not been duplicated, 
there is clinical evidence of substances in hibernator’s blood that can lend protection to organs for possible transplant 
[11]. The leading candidates for the HIT chemical are either a selective delta opioid receptor agonist or an adenosine 
receptor agonist [12,13]. 
 
 
3.2. Therapeutic Hypothermia (TH) 
 
Therapeutic hypothermia (TH), or the recently termed targeted temperature management (TTM), is a medical 
treatment that lowers and maintains a specific core body temperature in critically injured people in an effort to improve 
health outcomes. While the concept of hypothermia in medical applications has been theorized since the Greek 
physician Hippocrates, in-depth scientific research into its effectiveness and utilization started in the 1950s [14]. From 
this time, through the 1980s, multiple studies indicated the ability of mild hypothermia to assist in reducing blood loss 
during surgery, as well as its ability to act as a general neuroprotectant from incidents that resulted in reduced blood 
flow to the brain [15]. These animal studies were supported by two large human studies (conducted in Europe and 
Australia), that were published in the February 2002 issue of the New England Journal of Medicine demonstrating the 
positive effects of mild hypothermia utilized following cardiac arrest [16,17]. Since these landmark study findings 
hundreds of additional studies have been performed, resulting in the routine employment of TH/TTM in every major 
medical center throughout the world for multiple medical applications, including [18]: 
 
1) Cardiac Arrest: Both the American Heart Association (2010) and the International Liaison Committee 
on Resuscitation (ILCOR) (2013) established guidelines supporting the use of TH (or TTM) as a 
treatment following resuscitation from cardiac arrest [19,20].  
2) Neonatal Encephalopathy: In 2014 the American College of Obstetricians and Gynecologists (ACOG) 
and American Academy of Pediatrics (AAP) Task Force on Neonatal Encephalopathy recommended the 
routine use of TTM and established consensus-based guidelines for cases of suspected neonatal 
encephalopathy. In publishing their recommendations, they sited twelve studies showing the beneficial 
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effects of decreasing body temperature as a protective treatment during episodes of decreased fetal 
oxygen [21]. 
3) Increased Intracranial Pressure (Intracranial Hypertension): Studies support the use of TH as a safe and 
effective treatment option for refractory Intracranial Hypertension [22]. 
4) Ischemic Stroke: Multiple studies have shown the viability of TH as a protective treatment for the 
resuscitation of patients suffering from ischemic stroke [22,23].   
5) Traumatic Brain or Spinal Cord Injury: A 2009 review of multiple TH studies supports the use of 
therapeutic hypothermia as a neuroprotectant during both traumatic brain and spinal cord injuries, 
although consensus on the optimal temperature and time of cooling has yet to be determined [24]. 
 
Current TH/TTMprotocols call for whole body or selective head cooling to 32–34 degrees Celsius, beginning within 
six hours of injury and continued for up to 72 hours [25]. A duration of 72 hours had been established as the maximum 
treatment period as no clinical benefit has been established at this time for continuing treatment beyond this period in 
large clinical trials [18]. However, several studies have been conducted that have noted a benefit of hypothermia when 
utilized for longer durations. Three independent studies were conducted in China between 2000 and 2009 [26 - 28]. 
In these studies patients were treated with mild hypothermia (31 to 34 degrees Celsius) ranging from a total of 2 to 14 
days. These studies showed that compared with short-term mild hypothermia, long-term mild hypothermia 
significantly improved the outcome of severe traumatic brain injured (TBI) patients with cerebral contusion and 
intracranial hypertension without significant complications. Their data also suggested 5 days of cooling was more 
efficacious than 2 days of cooling when mild hypothermia was used to control refractory intracranial hypertension in 
patients with severe TBI [27]. In another joint study conducted in Europe, patients were grouped according to 
hypothermia initiation (early: days 1–2 and late: days 4–5 after admission) and hypothermia duration (short: 4–8 days 
and long: 9–15 days) [29]. This study noted a significant benefit of both hypothermia initiation and duration on the 
outcomes of patients with traumatic brain injury and increased intracranial pressure. Studies such as these listed above 
support the need for further research on the maximum duration and benefit of TH in the future.  
 
 
3.3. Hypothermia  
 
3.3.1. Method of Action 
 
There are several ways that the cooling associated with TH results in therapeutic benefit. These range from decreases 
in cellular metabolic activity, the prevention of cellular death (apoptosis), the stabilization of cellular structures under 
stress, and protection from oxidative stress. At this time it is uncertain whether any of these effects are the primary 
factor behind TH’s clinical benefits or if it is derived from all of the above noted physiological changes working in 
concert.   
 
Early researchers theorized hypothermia’s effectiveness as a neuroprotectant was due to the lower cellular metabolic 
rate that resulted from decreasing body temperature. Research shows that cellular metabolism slows by 5–7% for 
every one degree Celsius drop in body temperature [30]. This data supports the hypothesis that hypothermia prevents 
cellular damage by simply decreasing a cell’s need for oxygen [31]. As a result, early studies primarily focused on the 
use of extreme hypothermia treatments in an attempt to directly correlate protective effects to the extent of temperature 
decline [32]. However, recent research suggests that there is equal benefit during cardiac arrest when cooling was 
performed at a near-normal temperature of 36 degrees Celsius compared to 33 degrees [33].  
 
When addressing Neonatal Encephalopathy, the primary source of brain cell injury appears to be due to programmed 
apoptosis (automated cell death) caused by low oxygen supply. To be more specific, cell death is not directly caused 
by decreased oxygen levels, but is initiated indirectly by activating a cascade of intracellular events. The primary use 
of oxygen by cells is to create ATP. Cells use ATP to perform numerous functions, but its primary use is to fuel the 
import and export of ions to regulate intracellular ion levels. Thus, oxygen deprivation itself does not precipitate cell 
death, but the loss of intracellular homeostasis triggers the cell to initiate its own death as the cell cannot make the 
ATP it needs to regulate ion concentrations [31]. 
 
Research further shows that even a small drop in temperature encourages cell membrane stability during periods of 
oxygen deprivation. As a result, a decrease in cellular temperature makes the cell membrane less permeable, which in 
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turn blocks the influx of unwanted ions during periods of low oxygen supply. By making the cell membrane more 
impermeable, hypothermia helps prevent the above noted apoptosis that is initiated by oxygen deprivation. This 
protective strengthening of cellular membranes is noted even with minimal decreases in body temperature [31]. 
 
TH may also prevent cellular damage by reducing reperfusion injury. Reperfusion injury is damage that is caused by 
the oxidative stress that occurs when the blood supply is restored to tissue after a period of ischemia. The primary 
mechanism of reperfusion injury is a series of inflammatory immune responses that affect cells that have been deprived 
of oxygen. In humans, the primary effect of these inflammatory responses is a marked increase in intracranial pressure 
and the introduction of free radicals, both of which lead to the injury and death of otherwise healthy tissue. Research 
shows that hypothermia is effective at reducing intracranial pressure, and therefore able to minimize this harmful 
effect [23]. The oxidation that results during tissue reperfusion also increases free radical production. During normal 
aerobic/anaerobic cellular activity, oxygen in the body is split into single atoms with unpaired electrons. As electrons 
like to be in pairs, these atoms, called free radicals, scavenge the body to seek out other electrons to pair with. This 
pairing causes damage to cellular structures, proteins and even DNA. Hypothermia has been shown to directly reduce 
free radical production, indicating another mechanism of action for hypothermia's therapeutic effect [34,35]. 
 
3.3.2. Methods of Cooling 
 
There are a number of methods to induce hypothermia, with study data showing that there is no one method that is 
safer or more effective than the other [19,36]. No matter which method is employed, the same basic steps are 
performed. Core body temperature is measured (either directly via the esophagus, bladder, rectum, tunneled catheter, 
or wirelessly via an ingestible capsule) to monitor cooling rates and steady state cooling levels [19]. Prior to initiating 
TH, pharmacological agents (commonly used medications include buspirone, meperidine, dexmedetomidine, fentanyl, 
and propofol) are administered to both suppress the shivering response and help the patient tolerate the cooling process 
[37]. Patients are cooled at a rate of 1.5 to 2 degrees Celsius per hour and maintained at a target temperature of 32 to 
36 degrees Celsius for 24 to 72 hours. In current hospital settings the rewarming process occurs slowly (at a rate of 
0.5 degrees Celsius per hour) to avoid spikes in blood pressure and electrolyte shifts in the blood that are not well 
tolerated in critically ill patients [36].   
 
Cooling catheters are closed loop intravenous lines that are inserted into the femoral or subclavian vein. Cooled saline 
solution is then circulated through the closed loop portion (commonly composed of either a metal coated tube or 
balloon) which uses convection cooling to lower the temperature of a patient’s blood. While the most invasive of the 
cooling techniques, multiple studies show that this method is both safe and effective, and allows for the tightest level 
of control over steady state temperature as well as cooling and rewarming rates [38,39]. However, unlike other non-
invasive methods of cooling, the insertion of cooling catheters must be performed by a physician familiar with the 
procedure.  
 
Nasopharyngeal evaporative cooling is a method of initiating TH that utilizes a cannula, placed into the patient’s nasal 
or oral cavity, to deliver a cooling gas.  This gas usually consists of either dehumidified air plus nitric oxide gas or an 
inert perfluorocarbon coolant mixed with oxygen [40]. These gases pass directly underneath the brain and base of the 
skull, causing evaporative cooling of the blood passing through the cooling area, reducing core body temperature. 
This method is currently employed by emergency responders to easily and rapidly reduce a person's temperature while 
targeting the brain as the first area of cooling. Research has shown that this method of cooling is both simple to employ 
and results in very high cooling rates (average of 2.6 degrees Celsius) [41,42]. 
 
Cooling blankets also employ convection cooling, but with this method cold water is circulated through a blanket or 
torso vest and pelvic girdle. To use this method, approximately 70% of a person’s surface area should be exposed to 
the cooling surface. This method is the most commonly employed and the best studied means of controlling body 
temperature for TH. However, this method does possess several undesirable qualities. Cooling blankets are susceptible 
to leaking, which may represent an electrical hazard. In addition, The Food and Drug Administration has reported 
several cases of external cooling blankets causing significant burns to the skin. Other problems with this form of 
cooling include temperature overshoot (in up to 20% incidence) and increased induction time versus other methods 
[43]. 
 
The final clinic method for initiating TH (used primarily in infants suffering from Neonatal Encephalopathy and adults 
with head trauma) is through non-invasive head cooling systems [40]. There are a number of cooling caps and helmets 
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currently available, all designed to target cooling of the brain while maintaining core temperature at near normal 
levels. These devices are typically constructed from a synthetic material such as neoprene, silicone, or polyurethane 
and filled with a cooling agent (such as ice or gel) that is cooled and pumped through the cooling cap. Heat from the 
head is transferred by conduction through the helmet wall and then removed by the circulating coolant. Theses systems 
have the benefit of being able to be tightly maintained at a constant temperature and have the facility for easy 
temperature adjustment [40]. 
 
There has been some recent initial research into other methods of hypothermia induction. In 2005, researchers were 
able to induce a suspended animation-like hypothermia state in mice through the inhalation of low dose hydrogen 
sulfide [44]. However, two 2008 studies failed to reproduce the effect in pigs or sheep, concluding that the effects 
seen in mice were not present in larger mammals [44]. The Future Technology Advisory Panel, under the European 
Space Agency’s Directorate of Technical and Quality Management, has investigated other methods of hibernation 
induction, including both pharmacological and direct manipulation of the hypothalamus (research data pending). In 
addition, since 2010 numerous researchers, including Dr. Kelly Drew from the University of Alaska Fairbanks, have 
been conducting experiments with A1 adenosine receptor agonists to initiate hibernation in arctic ground squirrels and 
other members of the rodent family [13,45,46]. Updates on this research will be explored in later sections of this 
report. 
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4. Medical Approach 
 
4.1. Overview 
 
SpaceWorks proposed to leverage the well-studied application of therapeutic hypothermia (TH) to place long-duration 
spaceflight crews in an inactive, low-metabolic torpor state. Torpor would be initiated during the mission transit phases 
(e.g. after leaving Low Earth Orbit or a Lunar pre-stage orbit through arrival at Mars, and vice versa). This approach 
could simultaneously solve a myriad of medical and engineering challenges associated with human spaceflight, which 
would potentially make this capability the key enabling technology that will ultimately permit human exploration to 
Mars and beyond.  
 
Current research supports the safe and effective use of TH for up to 15 days [26-29]. While the potential exists for 
even longer torpor durations, current study proven limits allow for the capability to place the crew in rotating and 
repeating torpor cycles lasting 14 days, referred to as a sentinel protocol. For a four-member crew, three crew members 
would be placed in a torpor state with the assistance of the fourth crew member. Through the duration of the 14-day 
cycle, alternating crew members would be woken approx. every 14 days with the assistance of the current sentinel 
crew member, and then assisted in the initiation of their own two-week torpor phase after a 2-3 day period of non-
torpor activity. 
 
The ultimate result of the sentinel protocol is that it allows for one member of the mission crew to be fully awake and 
active at all times, which provides multiple mission benefits. First, it allows for preventative and corrective 
maintenance of equipment and daily communication with mission control during the outbound and return phases of 
the mission. Second, it provides an onboard assistant to the medical team to assist with the monitoring and wakening 
of the other crew members thereby minimizing some of the dependency on automation systems. Finally, it allows for 
the capability of immediate corrective action during equipment malfunction or during a habitat or medical emergency.  
The main systems necessary to initiate, maintain, and recover from torpor are discussed in detail next.   
 
 
4.2. Method of Induction 
 
The baseline approach is to use the combination of an adenosine receptor agonist and cooling via convection with the 
ambient air. An alternative to this approach involves an active cooling system combined with sedatives. Details for 
both the baseline and alternative approach will be provided next. 
 
Baseline Method of Induction  
 
As discussed in the hibernation review above, the most accepted theory of hibernation induction in nature is through 
a chemical called a “Hibernating Inducing Trigger” (HIT for short), which when released by an animal initiates the 
hibernation process. One of the leading candidates for this agent is an adenosine receptor agonist [12,13]. Since 2010 
numerous researchers, including Dr. Kelly Drew (a SpaceWorks hibernation consultant), have been conducting 
experiments with A1 adenosine receptor (A1AR) agonists to initiate hibernation in arctic ground squirrels and other 
members of the rodent family [13,45,46]. The synthetic adenosine receptor agonist used by Dr. Kelly Drew, N6-
Cyclohexyl Adenosine (called CHA), is a pharmacological agent that has shown the ability to spontaneously initiate 
a torpor state with the associated decrease in metabolic rate in rats [54]. In addition, through the use of bolus and then 
continuous drip administration of CHA, Dr. Drew has been able to keep Arctic Ground squirrels and rats in a torpor 
state for over 24 hours [55]. 
 
In 2017, Dr. Kelly Drew, in conjunction with Dr. Matthew Kumar, Mayo Clinic (a member of the SpaceWorks Torpor 
Medical Team) performed an independently funded but collaborative research effort utilizing N6-Cyclohexyl 
Adenosine for torpor induction on a large animal model [56]. The results of this experiment are shown in Figure 4. 
After administering the CHA bolus, core body temperature of the test subjects remained steady state between 30-32 
degrees C, without the assistance of evaporative gas, IV fluid, or conductive cooling. The presence of CHA in the 
blood stream resulted in lowering the animal’s core body temperature to 32 degrees Celsius. In addition, the subjects 
in this experiment exhibited no shivering response while body cooling occurred. Third, this compound appeared to be 
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non-sedating. As demonstrated through oxygen consumption in Figure 5, twice during the process the animals started 
to wake. Two CHA boluses were given with only very short-term effect, resulting in the eventual need for a small 
dose of propofol to be administered to cause the subject to return to sleep.  
 
 
 
Figure 4. Administration of CHA A1AR Agonist in Swine [Kelly,Kumar] 
 
Figure 5. Oxygen Consumption in Swine During Administration of CHA [Kelly,Kumar] 
 
Dr. Drew’s research team has also been conducting experiments on another chemical compound, 8 – Sulphophenyl 
Theophylline (called 8-SPT). 8-SPT acts as A1AR Adenosine Receptor Antagonist, which means that it is a counter 
to the CHA discussed above. This medication has been used by her research team to counteract episodes of bradycardia 
(or a lowered heart rate), and hypotension (or low blood pressure) which can accompany induced hypothermia in rat 
studies [57]. This agent was also studied during the experimental trial conducted by Dr. Drew and Dr. Kumar, the 
results of which are shown in Figure 6. 
 
As visualized on this chart, there is a significant effect on both heart rate and blood pressure of the test subjects when 
CHA is initially administered. However, a single dose of 8-SPT (time denoted as ‘S’) restored cardiovascular levels 
to normal without countering the CHA cooling process. This is because 8-SPT does not cross the blood-brain barrier, 
meaning it does not affect the brain or the hypothalamus, which is the thermoregulatory center for the body. As a 
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result, a combination of CHA and 8-SPT could be used to set the core body temperature to torpor target levels while 
maintaining the cardiovascular system at a level that is within safe physiologic ranges. 
 
 
Figure 6. Administration of 8-SPT Adenosine Antagonist in Swine [Kelly, Kumar] 
 
Most hospital TH protocols recommend a cooling rate of 1.5 to 2 degrees Celsius per hour until a target temperature 
of 32 to 34 degrees Celsius is achieved. As this is a well-established and studied cooling rate, the envisioned 
SpaceWorks Torpor protocol would utilize the same guidelines. Core body temperature would then be maintained at 
the target level (or oscillated between 32 to 34 degrees Celsius depending upon final crew availability requirements). 
In current hospital settings, rewarming occurs at a much slower rate (0.5 degrees Celsius per hour) to avoid spikes in 
blood pressure and electrolyte shifts in the blood that are not well tolerated in critically ill patients [36]. However, 
previous research has shown that much more rapid rates of warming (up to 1.5 degrees Celsius per hour) are possible 
without an associated increase in adverse risks [52]. Again, as 0.5 degrees Celsius is the well-established rewarming 
rate, the SpaceWorks Torpor protocol would utilize the same guidelines for normal torpor cycles. However, by 
employing the higher 1.5 degree Celsius rewarming rate crewmembers could be recalled from the torpor state rapidly 
and be available to provide assistance to the sentinel crew member during emergency situations.  
 
While this is still early with limited research results available, initial experimental results are very encouraging. Further 
development and testing of these compounds could lead to a torpor induction protocol that does not require any active 
cooling, eliminates the need for pharmacological sedation to suppress shiver responses, and would counter any 
potential cardiovascular side effects associated with hypothermia and torpor induction. This would further reduce both 
the medical complexity and the equipment requirements for torpor utilization.  
 
Ambient air cooling would be utilized during induction as needed to establish and/or maintain the target temperature 
profile for the torpor crew. Decreasing the ambient temperature of the habitat by simply radiating out more energy 
and increasing body surface area exposure, permits cooling to be achieved through direct convection from the skin to 
the surrounding air. Alternately, cooling could be limited to glabrous skin surfaces (namely the hands and feet), which 
account for 80% of human ambient heat loss [53]. This method would be similar to the cooling blanket and vest 
devices currently used by hospitals for targeted temperature management, which continues to be the most commonly 
employed and the most well studied means of controlling body temperature. This cooling method would alleviate 
potential complications associated with an active cooling system approach, decreasing overall system weight and 
volume requirements (as well as crew interfaces/contacts). 
 
Alternate Method of Induction 
 
If core body ambient air cooling and/or the A1AR agonist approach does not prove to be effective (or safe), the current 
alternative approach is to utilize a nasopharyngeal evaporative cooling technique combined with sedation for torpor 
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induction. This method of initiating TH utilizes a cannula that is placed into the crew member’s nasal cavity to provide 
very precise temperature control during the cooling, warming, and maintenance phases. A gas is delivered directly 
underneath the brain and base of the skull, causing evaporative cooling of the blood passing through the cooling area 
resulting in a reduction in core body temperature. SpaceWorks favors dehumidified air plus nitric oxide gas for the 
cooling agent as it is easily recycled and does not require the added containment or collection systems that would be 
associated with the alternative perfluorocarbon coolant. Application of this cooling method would require a small, 
non-erosive cannula attached to an oxygen delivery system. This gas would be stored at the required cooling 
temperature or passed through a cooling system upon delivery. Feedback from core temperature monitoring would 
then allow for the adjustment of gas flow rate and temperature, maximizing thermoregulation. As this system only 
consists of the nasal canula, oxygen lines, and oxygen storage, maintenance and repair of the equipment would require 
little time and be simple enough for any active crew member to perform. Research has shown that this method of 
cooling is both simple to employ and can support very high cooling rates (average of 2.6 degrees Celsius) [41,42]. 
This method is also currently employed by emergency responders in the field to easily and rapidly reduce a person's 
temperature in a timely period prior to arrival at a hospital facility, and thus can be modified for utilization in the space 
environment with minor system alterations. 
 
Crew members undergoing torpor first require the administration of a pharmacological agent to suppress the shivering 
response and help them tolerate the cooling process until core body temperature is reduced past the “shivering 
threshold” (approximately 35 °C or 95 °F) [47]. While there are multiple medications available for use (including 
magnesium sulfate, midazolam, fentanyl, remifentanil, and Propofol), our research team prefers dexmedetomidine 
[37,47]. Dexmedetomidine is an α2-adrenergic receptor agonist that has multiple uses including reducing anxiety, 
patient sedation, and pain management [48]. Dexmedetomidine is notable for its ability to provide sedation without 
risk of respiratory depression and neurocognitive dysfunction (unlike the other commonly used sedatives noted above) 
and can also provide cooperative and/or semi-arousable sedation [49,51]. The long-term use and effects of 
dexmedetomidine has not been characterized to date. 
 
 
4.3. Intravenous (IV) Access 
 
Whether utilizing torpor or not, safe and stable long-term IV access may be essential for both crew monitoring and 
healthcare during prolonged missions. First, long-term intravenous access allows for the simple collection and 
processing of laboratory testing to evaluate system electrolytes, basic body chemistry, red and white blood cell levels, 
and the presence and identification of any systemic body infection. Second, intravenous access allows for the 
administering of both IV fluids (the first and most common treatment during serious illness and trauma related injuries) 
and higher potency and more efficient medications. Finally, nutritional support can be provided through an IV to crew 
members that are in any state that does not allow for normal oral intake. While temporary IV placement can be useful, 
these access sites can be hard to place in a high stress environment and are only viable for a short period of time (a 
maximum of 72 hours) [58]. Presented below are the two of the most common forms of prolonged intravenous access: 
Peripherally Inserted Central Catheters, and port catheters. 
 
A peripherally inserted central catheter (PICC or PIC line), is a form of intravenous access currently utilized in the 
hospital setting for chemotherapy regimens, extended antibiotic therapy, or total parenteral nutrition (TPN). PIC 
lines are inserted through the skin (percutaneously) at a peripheral site (usually the arm), then guided to the superior 
vena cava. PICCs can remain in place for extended periods of time, from seven days to up to 12 months in current 
studies [59]. PIC lines should be used regularly or undergo periodic flushing with normal saline and "locking" with 
Heparin or a normal saline solution when not in use. While these lines allow for higher volumes of fluids and 
nutrients to pass through them, they have a higher risk of failure and local infection or blood clot formation [60]. 
 
SpaceWorks proposes the use of an alternate form of long-term IV access, port catheters (shown Figure 7). Port 
catheters are small medical appliances that are surgically installed beneath the skin, usually in the upper chest just 
below the clavicle or collar bone. A catheter then connects the port to an underlying vein. Sitting directly under the 
skin, the port provides direct venous access via a septum through which medications and IV fluids can be administered 
and blood samples can be drawn. In medical settings, ports are commonly used to treat hematology and oncology 
patients, and are intended for long-term, outpatient use [61]. Once in place, these devices require no special 
maintenance or care, and usually do not limit any physical activities, including weightlifting and swimming.  Ports 
can remain in place as long as required; however if used infrequently they it may be necessary to access the port, flush 
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it with saline, and inject a saline or heparin lock similar to PIC line maintenance between uses [62]. Port access sites 
have lower fluid flow rates then PIC lines, but significantly reduced risk of failure, blood clot formation, and local 
infection [60]. 
  
Figure 7. Port-A-Cath® Device for Central Vein Access (Credit: PM Solutions) 
 
4.4. Nutritional Approach 
 
There are two approaches for providing nutritional support during torpor cycles: Total Parenteral Nutrition (TPN), 
and enteral feeding via temporary nasogastric(NG)/orogastric(OG) feeding line or Percutaneous Endoscopic 
Gastrostomy (PEG) tube. Both of these methods rely on prepared solutions consisting of water and all the necessary 
nutrients, microelements and electrolytes necessary for healthy physiologic function. Both preparations contain 
approximately the same nutritional value (0.5 to 2 kcal/ml), so food stores for either method would occupy the same 
amount of habitat space [63]. Both preparations also have the same storage capabilities (2 years extended shelf life for 
unopened containers stored at room temperature) [63]. However, the actual method of nutritional delivery and the 
necessary support equipment involved with each nutritional method are markedly different.   
 
Total parenteral nutrition (TPN) is the process of feeding of a person intravenously, bypassing the normal digestive 
system. In the medical setting, TPN is provided when the gastrointestinal tract is nonfunctional because of an 
interruption in its continuity, or due to impaired absorptive capacity. While TPN is typically a short-term therapy, 
there are approximately 40,000 people using long-term TPN at home in the United States each year [64]. Multiple 
delivery systems exist, including portable systems that allow for mobility and even the continuation of normal 
exercise. Solutions for TPN may be customized to individual personal requirements, or standardized solutions may be 
used. The use of standardized parenteral nutrition solutions is actually preferred as it is more cost effective and 
provides better control of serum electrolytes [65]. While the schedule of TPN administration is highly dependent on 
the medical condition of each patient, most receive TPN treatments three to five days a week. Possible complications 
associated with TPN include: infection or blood clot due to prolonged IV access, Fatty liver, Cholecystitis, and gut 
atrophy [66,67]. However, recent changes to TPN composition have helped to minimize or even potential eliminate 
some of these risks [68]. 
 
Enteral feeding involves a liquid based nutrient system similar to infant or geriatric supplements that are delivered via 
a temporary nasogastric (NG)/orogastric(OG) feeding line or permanent Percutaneous Endoscopic Gastrostomy 
(PEG) tube. Nasogastric and orogastric intubation systems are commonly used devises that are easy to place and 
maintain (with a 2013 study confirming the ability of people to safely insert and remove tubes themselves), although 
they are general used for short-term feeding indications [69,70]. NG tubes can have complications, although these are 
primarily limited to accidental removal of the tube and nasal irritation [69]. A Percutaneous Endoscopic Gastrostomy 
(PEG) is a tube inserted through a small incision in the abdomen and into the stomach. It is intended for long-term 
enteral nutrition (with a median use of 6 months, but with well documented extended use for over 4 years) [71]. 
Insertion of the tube is a simple surgical procedure that does not require general anesthesia; although mild sedation is 
typically needed. As the PEG is intended for long-term use, it requires minimal maintenance and care, and can be 
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adjusted or even replaced at home with little training [72]. Complications of a PEG are rare after insertion, primarily 
consisting of cellulitis (infection of the skin) around the gastrostomy site, ulcer formation at either the site of the button 
or on the opposite wall of the stomach ("kissing ulcer"), or "Buried bumper syndrome" [73]. PEG administration of 
enteral feeds is the most commonly used method of nutritional support for patients in the home setting [69]. 
 
SpaceWorks supports the use of enteral feeding via NG/OG tube or PEG tube during torpor cycles, with a PEG tube 
as the baseline approach. First, it is now well documented that enteral feeding is the preferable nutritional route in 
long-term nutritional supplementation as it is less prone to complications and more closely maintains normal 
physiologic function [74,79]. Second, as previously noted, the initial placement of NG/OG or PEG tubes and the 
subsequent maintenance and replacement of enteral feeding equipment is significantly easier than parenteral (TPN 
based systems), requiring only minimal training. Third, the transition from normal oral nutritional intake to enteral 
feeding is a simple and seamless process, while the transition from IV to oral nutrition requires a systematic, step by 
step approach [80]. Utilizing an enteral feeding system could allow the active (sentinel) crew members to resume 
normal meals and hydration between torpor cycles, as well as during prolonged surface or orbital crew missions.    
 
Figure 8. PEG Tube for Delivery of Liquid Nutrition and Hydration Fluids (Credit: Cancer Research UK) 
 
The total caloric needs for crewmembers in Torpor will be approximately 25-35 kcal/kg/day, with a protein component 
of 1.2 – 2.0 gm/kg/day. No more than 20% of the calories will come from lipid emulsions, with fish oil fat emulsion 
like Omegaven® instead of egg-based formulas utilized as they help prevent/reverse liver disease and cholestasis [68]. 
Micronutrients will be adjusted as needed based on the type of solution utilized. 
 
 
4.5. Waste Management 
 
Whether enteral or parenteral nutrition is utilized, crew members undergoing torpor will require some method of urine 
collection. The most common indwelling bladder catheter is the Foley catheter, a flexible tube which a clinician passes 
through the urethra and into the bladder to drain urine. The catheter is secured in place with a balloon that is inflated 
with sterile water once inside the bladder. While most catheters are intended for short-term use (1-7 days), newer 
catheters created from PTFE, hydrogel or a silicon elastomer make catheters suitable for 28 days to three months 
indwelling duration [81]. As with enteral feeding tubes, Foley catheters are easy to insert, remove and maintain, with 
even children easily able to master the process with simple training [82]. Complications associated with prolonged 
catheter use include equipment failure and malfunction, irritation to the urethra, and bladder infection. However, the 
implementation of multifaceted intervention plans (i.e. sterile insertion, prophylactic antibiotics, and advanced 
materials) has reduced the risk of infection by 3-fold [83]. 
 
While the use of enteral feeding has significant advantages to Total Parenteral Feeding (TPN), it does introduce the 
need for fecal waste management during torpor cycles. There are multiple fecal collectors available, the newest of 
which are external collection systems that consist of a self-adhering skin barrier and attached pouch. These fecal 
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collectors are a closed system and the pouch is entirely external and non-invasive, meaning patients using fecal 
collectors do not encounter the same risks to the internal anal sphincter and rectal mucosa that can accompany internal 
devices that pass through the anal sphincter and dwell in the rectum [84]. Fecal collectors are also classified as Class 
I medical devices (considered as presenting minimal potential for harm) [85]. In addition, with training a well-
positioned and adhered fecal collector can provide up to 30 days of extended wear [86]. Possible complications 
associated with use include skin irritation caused by the adhesives on skin, leakage, and blockage [87]. Overall, fecal 
collectors are a user-friendly, cost-effective, efficient tool to contain solid waste for extended periods of time. 
 
 
4.6. Monitoring and Evaluation 
 
The evaluation of crew vital signs can continue to be adequately performed using current NASA approved monitoring 
systems. Systems like LifeGuard® and BioHarness® have been created and utilized to monitor the health of astronauts 
to ensure their safety during space flight and extravehicular activities and to monitor their physiology during exercise 
routines. NASA intends to further develop this technology to support medical emergency contingencies during long 
duration missions and address a number of the Bioastronautics Critical Path Roadmap risk areas [88]. These systems 
consist of button sensors that stick to the skin to take EKG and breathing rates. The device also uses an arm cuff to 
measure blood pressure and a sensor clipped or wrapped on an index finger to measure oxygen levels in the blood and 
pulse rate. These systems can also measure astronaut movements in three dimensions [89]. They are intended for long 
term use, have already been validated with research and on station testing, and would adequately provide all of the 
necessary vital signs monitoring required during torpor cycles. For core body temperature monitoring for torpor 
temperature regulation, SpaceWorks recommends the current medical practice of utilizing indwelling catheter bladder 
temperature monitors as they are easy to incorporate into Foley catheter systems and provide the most reliable 
temperature readings [90]. New wireless, indwelling temperature monitoring devices may also be viable option in the 
long term. 
 
As discussed above, safe and stable long-term IV access will be essential for both crew monitoring and healthcare by 
providing access for the simple collection and processing of laboratory testing to evaluate system electrolytes, basic 
body chemistry, red and white blood cell levels, presence and identification of any systemic body infection, etc. 
SpaceWorks advocates the use of a port catheter system as they are unobtrusive to normal activity, easy to maintain 
and access, and have very low risk of failure or complication. Use of this port would allow awake crew members, with 
little training, to obtain periodic blood samples on torpor personnel [91]. However, newer systems are being tested 
that provide automated measurement of blood parameters for bedside monitoring of patient blood chemistry. These 
are programmable systems that can automatically draw blood samples at a suitable time frequency (or at predetermined 
times), and can automatically analyze the drawn blood samples and immediately measure and display blood 
parameters such as glucose levels, hematocrit levels, hemoglobin blood oxygen saturation, blood gases, lactate or 
other blood chemistry parameters [92]. By directly accessing the installed port catheter system, blood chemistry 
evaluation could then be accomplished remotely by observing medical personnel. 
 
Direct visual examination of both torpor and sentinel crew members is another key component to evaluating and 
maintaining overall astronaut health. While basic evaluations can easily be performed by the sentinel crew member, 
SpaceWorks recommends a combination of remotely controlled and crew member-controlled video systems. This 
would allow both the crew and mission control medical team to perform scheduled visual examination of IV or port 
sites, areas touched by skin adhesives, and body pressure points as they often provide early indications of infection, 
equipment failure, or skin break down [93,94]. Visual inspection of crew support systems and habitats would also 
allow for recommendations and guidance during repair and preventative maintenance. Face to face communications 
between mission control and with active crew members could also provide insight on current fatigue and stress levels. 
Finally, the ability to observe the crew would allow for the direct assistance of terrestrial based medical providers 
during routine and emergency medical situations. While the effectiveness of direct communication would be reduced 
as distance increased the time delay of video and audio signals, regularly scheduled video recordings transmitted to 
mission control health teams would still provide an effective method of daily crew evaluation. 
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4.7. Potential Medical Challenges 
 
With any new medical approach, pharmaceuticals, and/or adaptation, there will be potential areas of risk with 
challenges to address. This is particularly true in the space environment, given the additional uncertainties and limited 
human medical data available. A brief discussion of the key risk areas will be presented next. 
 
Infection- 
Infection is the most common complication associated with medical procedures. The Centers for Disease Control and 
Prevention estimates that 10% of patients per year become infected, with the most frequent type being urinary tract 
infections (36%), followed by surgical site infections (20%), and pneumonia (11%) [95]. In at least one study, the 
utilization of TH was shown to increase the overall risk of pneumonia [96].  
 
However, the risk of infection associated with torpor is overall very low. Hospital infection rates are significantly 
impacted by the poor health of patients in the hospital setting. A study of patients utilizing central venous catheters 
for home based TPN showed an infection rate of only 1.47 per 1000 catheter days (or roughly 1 infection every 3 
years) [97]. Infection rates with both OG/NG and PEG enteral feeding tubes and port catheter systems (the preferred 
SpaceWorks method of nutrition and IV access) are even lower, and are almost exclusively limited to the time period 
immediately after insertion when crew members would still be on Earth [98]. As discussed above, both the advent of 
new Foley catheter materials and advancements in the practices of catheter insertion and care have decreased the risk 
of urinary tract infections 3-fold (4.2 infections per 1000 catheter days) [83].  In addition, the use of low dose 
prophylactic antibiotics has been clinically proven to decrease the risk of catheter related bladder infections by another 
50% [99]. Finally, recent studies show that the rates of pneumonia associated with TH treatment are equal to rates 
associated with intubated patients not undergoing torpor, indicating that the act of intubation and not hypothermia is 
the likely cause of pneumonia [100]. As the SpaceWorks torpor protocol does not require intubation this would 
significantly reduce the risk of lung-based infections. 
 
Blood Clot Formation- 
Blood clot formation, or thrombosis, is a medical complication that occurs when the human clotting cascade is 
activated resulting in the formation of a collection of platelets and other blood products in a superficial or deep vein. 
There are multiple risk factors for thrombosis, but two are associated with conditions experienced during TH; 
indwelling catheters and inactivity. In a recent study of 23,000 patients with PICC placement, there was a 4% overall 
incidence of vein thrombosis [101]. In the largest study available, the blood clot risk associated with the SpaceWorks 
preferred port catheter access was 1.8%, but this was a study conducted on patients undergoing port placement for 
cancer treatment, a known risk factor for blood clot formation [102]. Adjusting for those odds ratio numbers, the actual 
risk of blood clot formation with the port catheter IV system is closer to 0.6%. In addition, as discussed above, the use 
of intermittent heparin flushes has been proven to significantly reduce the risk of catheter blockage and blood clot 
formation [60].   
 
Another significant factor in the prevention of blood clot formation is the direct affect TH itself has on the clotting 
cascade. Thrombin is an enzyme in the body that acts to convert fibrinogen to fibrin, a key component to binding 
platelets together to form blood clots. It also acts as a catalyst to many other coagulation-related reactions in initiating 
the clotting cascade. Numerous studies have noted that patients undergoing TH were at higher risk for bleeding, but 
not at increased risk for severe bleeding or complications from bleeding [103]. Recent studies indicate the cause, 
namely that dropping a human’s core temperature impairs thrombin generation [104]. As a result, healthy humans 
undergoing torpor would be less likely to generate an indwelling catheter or immobility induced blood clot due the 
decrease in clotting cascade activity achieved simply through the process of being cooled.  
 
Electrolyte Imbalances- 
Hypothermia can induce a process called "cold diuresis". This condition is thought to be caused by the constriction of 
peripheral blood vessels redirecting blood flow from the extremities to the body core [105]. The kidneys then sense 
this shift and increase urine production to excrete the perceived extra fluid in an attempt to stabilize core blood pressure 
[106]. This can lead to electrolyte abnormalities, specifically hypokalemia, hypomagnesaemia, and 
hypophosphatemia, as well as hypovolemia [107]. However, these changes are noted primarily during the cooling and 
rewarming phases and are easily mitigated by limiting cooling and heating rates [108]. In addition, the ability to 
directly measure and correct minor electrolyte abnormalities through a permanent port catheter and automated 
monitoring system would significantly counter this effect on a healthy, torpor induced crew. 
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Skin Pressure Ulceration- 
Pressure ulcers (aka bedsores) are localized damage to the skin or underlying tissue that occur as a result of the constant 
pressure experienced by bedridden or mobility impaired patients. The most common sites for pressure ulcers are in 
the skin overlying the lower spine and the heels or the hips, but other sites such as the ankles, elbows, shoulders, or 
even the back of the head can be affected. Pressure ulcers occur due to a constant pressure being applied to the soft 
tissue, resulting in partial or complete obstructed blood flow. Outside of impaired immobility there are multiple other 
risk factors for developing pressure ulcers, including but not limited to: protein-calorie malnutrition, skin 
contamination, diseases that reduce blood flow or sensation in the skin, and age [109].  
 
In a microgravity environment there would be little to no direct contact of astronaut pressure points to bedding to 
cause the compression force needed to make pressure ulcer formation a concern. However, if the torpor habitat was 
designed to utilize artificial gravity to potentially mitigate other complications of prolonged space travel (i.e. muscle 
atrophy and bone density loss), then preventative measures would be needed. The most important care for a person at 
risk for pressure ulcers is continuous movement and redistribution of pressure [110]. While this is generally 
accomplished by low cost alternatives (nurses or other hospital staff manually moving patients), more advanced 
technology does exist, such as single- or multi-compartment pressure ulcer prevention padding controlled by tactile 
sensory and temperature based sensors [111,113].  
 
Interestingly, hypothermia may also be an effective preventative treatment for pressure ulcer formation. Previous 
animal studies have revealed that local skin cooling reduced the severity of ulceration in spinal cord injury patients. 
In addition, cooling is widely used in plastic surgery and organ transplants for tissue preservation. A human study 
from 2010 showed that, in patients at high risk for developing pressure ulcers, skin cooling to 25 C resulted in both 
decreased incidence and severity of pressure ulcer formation. These authors concluded that both metabolic and 
myogenic responses contributed to this protective effect. As a result, prolonged hypothermia may provide a protective 
benefit to skin degradation caused by prolonged immobility and pressure. 
 
Medical Support Equipment Failures- 
Equipment failure and repair are significant concerns for a prolonged space mission where both technical support and 
storage of spares is severely limited. Concerning torpor induction and maintenance equipment, continuing to employ 
NASA’s philosophy of simple, user friendly and universally compatible electronics and materials should be 
maintained. Luckily, most of the equipment that would be utilized for torpor induction and cycling is already 
manufactured with ease of use, field operability and integrated redundancy and durability in mind. However, little to 
none of the equipment that SpaceWorks proposes incorporating into the torpor protocol has been tested in the 
microgravity environment, so this type of equipment verification would need to be included in any proposal that plans 
to fully test the functionality of torpor for space applications.   
 
No matter which form of hypothermia induction is utilized for torpor, each employs the premise of physically or 
pharmacologically lowering core body temperature below normal physiologic levels. In addition, active interventions 
(most likely in the form of medications) may be required to counteract the human body’s natural response to try and 
increase body temperature to normal levels. Because of this, failure of hypothermic inducing equipment would result 
in the loss of the artificial drive to decrease core temperature. In response, the crewmembers would begin to naturally 
increase core body temperature to normal levels and out of the torpor state. Therefore, the proposed SpaceWorks 
Torpor induction method would fail to “normal”, meaning that crew members would not be excessively cooled, or 
“locked” into a hypothermic state that could not be reversed if there was an equipment failure. 
 
PICC line complications that involve intervention or removal tend to occur during the period immediately following 
insertion, and therefore would likely be identified and corrected before departing Earth. There are still some 
complications, including dislodgement, infection or clogging that would warrant removal during space missions. The 
use of the port catheter system has a significantly reduced risk of failure, blood clot formation, and local infection 
[60]. However, in the rare instance that a port catheter failed it could be removed by another crew member with 
minimal medical training and equipment. Removal of long-term IV access would result in the need for cyclic short-
term peripheral IV placement or discontinuing torpor for the remainder of the mission. 
 
Enteral feeding with a permanent PEG tube would require the use of a simple solution dispensary pump. If a rare long-
term complication did occur, such as ulcer formation at either the site of the PEG or on the opposite wall of the 
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stomach, then the tube would need to be removed, allowing the site to heal and close. At this point, torpor and enteral 
feeding could be continued using an NG/OG tube. 
 
Concerning waste disposal, Foley catheters for urine collection are easy to insert, remove and maintain with simple 
training [82]. As these are collection and drain systems with no electronic and mechanical components, they have no 
true mechanical failure concerns other than anchor bulb leakage or tube degradation. Fecal collectors are also non-
mechanical, closed loop systems. Possible complications associated with their use include skin irritation caused by 
skin adhesives, leakage, and blockage [87]. As with Foley catheters, fecal collectors are user-friendly, cost-effective, 
efficient tools which are easy for crew members to maintain and replace if needed. 
 
Vital signs evaluation can continue to be adequately performed using current NASA approved monitoring systems. 
As these systems are currently in use all the necessary maintenance, repair and back-up protocols already exist [89]. 
Concerning core body temperature monitoring for torpor temperature regulation, current medical practice is to utilize 
an indwelling catheter bladder temperature monitor as they are easily incorporated into the Foley catheter system. If 
the core temperature sensor was to fail, the whole Foley system could simple be removed and replaced. 
 
Medication Storage and Shelf-life- 
The effects of microgravity and radiation exposure on the overall safety and effectiveness of medications during 
missions is a key concern to the NASA Human Research Program (HRP), so much so that it is included in 1 of their 
33 identified key risks for prolonged space flight. Torpor specific medications and provisions, just like those currently 
used in space, will need to be adequately tested in a microgravity environment to verify their stability for multi-year 
missions. However, terrestrial based testing provides encouraging data towards the long-term stability of the proposed 
torpor medications and compounds. As discussed before, both TPN and enteral based nutrition formulas have a store 
capability of two years as currently constituted (for unopened containers stored at room temperature) [63]. Intravenous 
solutions and electrolyte supplements have an FDA approved shelf life of two to five years [114 - 116]. Most 
antibiotics maintain 90% of their effectiveness up to 66 months after they are manufactured, which would mean that 
they would be viable for the duration of any of the prolonged missions NASA currently has planned [117]. Heparin 
(used for long-term IV flushing) has a shelf life of 36 months (unopened bottles stored at room temperature) [118]. If 
N6-Cyclohexyl Adenosine (CHA) and 8 – Sulphophenyl Theophylline (8-SPT) were utilized for chemical torpor 
induction, shelf life effectiveness would need to be conducted. However, these chemicals are stored in powder form, 
and then reconstituted with injectable saline for use. Per Dr. Kelly Drew, the likely shelf-life of CHA and 8-SPT would 
be similar to other powder-based medications (2 to 5 years).  Her team currently uses a shelf life of thirty days in the 
reconstituted, active form. 
 
Cognitive Impairment- 
The effect of hypothermia on the short-term and long-term cognitive function of crew members is a critical question 
to address before torpor can be utilized for space applications. Unfortunately, little to no study data exists on the 
cognitive effects of TH. This is because TH is currently performed on infants or critically injured or ill patients, 
situations that do not allow for obtaining pre-hypothermia controls or permit the differentiation of any adverse 
cognitive effects to hypothermia itself or to the medical condition that resulted in the application of TH. Key questions 
to address include: 
 
1) How long does it take for a crew member to fully recover from a torpor cycle after the warming 
process? 
2) What affect does torpor have on circadian rhythms and sleep quality? 
3) Does prolonged torpor affect long-term or short-term memory? 
4) If negative effects are noted, will they resolve or be compounded by repeat torpor cycles?  
 
Concerning circadian rhythms and sleep quality, it is important to understand that hibernation and sleep are very 
different. Hibernation is a physiologic state. It results in a reduction of basal metabolic processes and basal core 
temperature in an attempt to slow an animal’s utilization of energy stores, allowing them to survive during periods of 
extreme cold temperatures or food shortages. There are physiological changes during sleep that are similar to 
hibernation (reduced heart and breathing rate, slightly lower basal temperature and metabolic rate), but these changes 
are very slight compared to extremes we see during hibernation [119]. Sleep is primarily a mental state, characterized 
by changes in brain activity. However, studies show that the brain waves of hibernating animals more closely resemble 
waking brain wave patterns [120]. It is also known that during long periods of hibernation many animals (including 
bears, hamsters and dwarf lemurs) exit their hibernation state to allow for short periods of sleep. This is important, 
Advancing Torpor Inducing Transfer Habitats for Human Stasis to Mars  
NIAC Phase II Final Report 
SpaceWorks Enterprises, Inc. (SEI) 
21 
because many animals that are awaked from hibernation exhibit some signs of sleep deprivation and often need to 
sleep to recover [121]. Sleep, on the other hand, is much easier to reverse. Animals go from deep sleep to fully awake 
within a matter of seconds if the right stimulus is supplied. 
 
Studies of animal brainwave activity during hibernation show that they continuously cycle through states of electro-
physiologically defined wakefulness and non-rapid-eye-movement (NREM) sleep [122]. Unlike REM sleep, NREM 
sleep is associated with little or no eye movement or dreaming. They are the result of two different brain generators, 
which explains the differences seen in REM and NREM mental activity [123]. The mental activity that takes place 
during NREM sleep is more thought-like in appearance, whereas REM sleep is more hallucinatory [123]. Even though 
we spend the majority of our time in NREM sleep, REM sleep is believed to be essential for restfulness [119]. This is 
why hibernating animals, even though they cycle through NREM sleep, often need days or even weeks of normal 
sleep to completely recover from long hibernation periods. 
 
Humans in altered states of consciousness (i.e. comatose or “vegetate states”) can also provide some insight into the 
mind of an astronaut undergoing torpor. Consciousness still remains a mysterious phenomenon. Scientists still don't 
know exactly how brain activity gives rise to consciousness, but they have been able to find some similarities between 
a conscious brain and an unconscious one. It now appears that comatose patients may be aware of their surroundings 
even though they can't visibly communicate with others. Like hibernating animals, their brains cycle through states of 
wakefulness and non-rapid-eye-movement (NREM) sleep [124]. Some comatose patients show brain wave patterns 
and levels of awareness similar and to that of fully awake, healthy individuals. For example, although the patients did 
not perform any physical movements in response to commands, brain imaging showed that when comatose patients 
were told to imagine doing a physical activity the area of the brain responsible for controlling that movement was 
activated. Similar responses have been observed in asking a comatose patient to picture an image in their head or upon 
the mentioning of the name of a loved one. And like hibernating animals, humans often need a period of normal sleep 
to completely recover after awaking from a comatose state. 
 
Given this data, an astronaut in a state of torpor would most likely cycle through episodes of mental wakefulness 
(without awareness), and non-REM sleep. They would receive the physiologic advantages of hibernation (decreased 
need for food and water, potentially decreases in bone density loss and muscle mass reductions), while the only mental 
deficits they would experience would be those similar to sleep deprivation. A short period of sleep recovery could 
potentially be all that is needed to transition from sleeping passenger to active explorer.   
 
Response to Injury/Emergent Situations- 
With all but one crew member in torpor during the outbound and return stages of a long duration mission, concern 
exists regarding the ability to provide adequate and appropriate assistance to that individual during an injury or 
emergent situation. As discussed in detail above, most hospital TH protocols recommend a maintained, fixed target 
temperature of 32 to 34 degrees Celsius. As this is a well-established and thoroughly studied process, the SpaceWorks 
torpor protocol would utilize the same guidelines. However, core body temperature could be oscillated between 32 to 
34 degrees Celsius and still provide significant metabolic reductions and protective benefit. In addition, while current 
hospital settings recommend rewarming rates of 0.5 degrees Celsius per hour, previous research has shown that much 
more rapid rates of warming (up to 1.5 degrees Celsius per hour) are possible without an associated increase in adverse 
risks [52]. Again, as 0.5 degrees Celsius is the well-established rewarming rate, the SpaceWorks torpor protocol would 
utilize the same guidelines for normal torpor cycles. However, by employing both an oscillating core temperature and 
the higher 1.5-degree Celsius rewarming rate crewmembers could be recovered from torpor much more rapidly and 
be available to aid the sentinel crew member during emergency situations at an accelerated rate.  
  
Fortunately, the likelihood of an emergency situation arising during a mission appears to be low. The NASA Human 
Research Program has performed an extensive summary on the risk of injury and illness on both astronauts and those 
personnel who work in astronaut analog fields [125]. This report addressed the incidence of behavior and psychiatric 
conditions, the risk of inability to adequately treat an ill or injured crew member and provided a detailed list of all 
historical astronaut fatalities and injuries during space flight to date. 
 
Concerning the occurrence of behavioral and psychiatric conditions, the incidence rate onboard shuttle missions was 
one per every 2.86 person-year, with the most commonly reported symptoms being anxiety and annoyance [126]. The 
incidence rates of these conditions on the Russian Mir station from 1995 -1998 was 0.77 per person year [127].  
Anxiety symptoms during space flight occurred once every 1.2 years, and signs and symptoms of depression occurred 
once every 7.2 years [128]. To date, no behavioral emergencies have occurred before or during any U.S. space flight 
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mission. In examining Antarctica crews, the overall incidence rate for depression that required pharmacological 
intervention was 2.03% (or one case of depression every 1.1 years) [129]. For submariners, the incidence of psychiatric 
disorders that were severe enough to result in either the loss of a workday or the need to be medically evacuated ranged 
between 0.44 and 2.8 per person-year [130]. It should be noted that sleep disruption, monotony and boredom are the 
most frequent complaints of individuals in an integrated collaboration environment such as space flight, with the 
combination of monotonous work with requirements for high degrees of alertness and penalties for errors seen as 
especially stressful [131,132]. 
 
In-flight illness incidence rates are summarized in Table 1 through Table 3 [133]. It should be noted that a majority 
of these conditions are not true medical emergencies and could be adequately treated by taking medications carried 
on board. Astronauts routinely take medication during missions for non-emergency conditions (motion sickness, 
headache, sleeplessness, and back pain). More important is the potential for medical emergencies during space flight. 
Among these conditions, only arrhythmias, renal colic, and infections have been noted. The documented arrhythmias 
were mostly mild abnormalities, such as occasional premature atrial contractions (PACs) and premature ventricular 
contractions (PVCs), which were present in 30% of astronauts at some point during periods of strenuous activity. 
There is one noted case of ventricular bigeminy, as well as one case of ventricular ectopy that was reported on Skylab 
and a 14-beat run of ventricular tachycardia experienced by one Russian astronaut onboard MIR [134]. Other medical 
emergencies that have been observed in space include cases of urological and dental emergencies [135,136]. Of 
concern are noted episodes of renal colic and arrhythmia that have required that crew members be brought back to 
Earth for evaluation [137]. 
 
Table 1. In-flight Medical Events for U.S. Astronauts During Space Shuttle Program (STS-1 to STS-89) 
Medical Event or System by ICD9* Category Number of Events % of Total 
Space adaptation syndrome 788 42.2 
Nervous system and sense organs 318 17.0 
Digestive system 163 8.7 
Skin and subcutaneous tissue 151 8.1 
Injuries or trauma 141 7.6 
Musculoskeletal system and connective tissue 132 7.1 
Respiratory system 83 4.4 
Behavioral signs and symptoms 34 1.8 
Infectious diseases 26 1.4 
Genitourinary system 23 1.2 
Circulatory system 6 0.3 
Endocrine, nutritional, metabolic, and immunity disorders 2 0.1 
*International Classification of Diseases, 9th Ed. 
 
Table 2. Medical Events Among Astronauts on MIR (3/1995 – 6/1998) 
Event Number of Events % of Total 
Musculoskeletal 7 25 
Skin 6 21 
Nasal Congestion, irritation 4 14 
Bruise 2 7 
Eyes 2 7 
Gastrointestinal 2 7 
Psychiatric 2 7 
Hemorrhoids 1 4 
Headaches 1 4 
Sleep disorders 1 4 
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Risk of injury due to equipment failure or malfunction is also a concern during prolonged space missions, especially 
in the setting of torpor where only one crew member would be active for a majority of the habitat transit time. Of all 
non-fatal spaceflight accidents reported, only one involved the loss of consciousness of a crew member, and there 
were no incidents that involved any major injury. In addition, all but one of the injuries occurred during a high-risk 
event (EVA mission, corrective maintenance, payload release, etc). By having astronauts avoid these types of activities 
while serving as the sentinel crew member would ensure that one or more of the crew would be available to aid during 
an accident or medical emergency. 
 
Table 3. Medical Events and Recurrences Among Astronauts of All Nationalities on Mir (3/1995-6/1998) 
Event Number of Events % of Total 
Superficial injury 43 24 
Arrhythmia 32 18 
Musculoskeletal 29 16 
Headache 17 9 
Fatigue 17 9 
Sleeplessness 13 7 
Contact dermatitis 5 3 
Surface burn 5 3 
Conjunctivitis 4 2 
Acute respiratory infection 3 2 
Asthenia 3 2 
Ocular foreign body 3 2 
Globe contusion 2 1 
Dental 2 1 
Constipation 1 1 
 
  
Advancing Torpor Inducing Transfer Habitats for Human Stasis to Mars  
NIAC Phase II Final Report 
SpaceWorks Enterprises, Inc. (SEI) 
24 
4.8. Proposed Induction Protocol 
 
The current SpaceWorks proposal for torpor induction and maintenance is outlined below in Figure 9, and is divided 
into five stages: Pre-Flight, Preparation, Initiation, Maintenance, and Reversal. The current protocol utilizes adenosine 
receptor agonist compounds with minimal sedation combined with ambient air cooling (vs active cooling). Long-term 
IV access would be provided through a preplaced Port catheter. Nutrition would be provided through enteral feeding 
via a preplaced PEG tube during torpor cycles, with an option for normal oral hydration and nutrition while active. 
Waste collection during torpor would be accomplished through Foley catheter and fecal waste collection systems. 
 
 
Figure 9. Overview of Key Torpor Induction Steps 
 
A description of the activities associated with and required for each stage of the process are provided next. 
 
4.8.1. Stage 1: Pre-Flight 
 
Beginning approximately six (6) months before the crew mission is launched: 
 
4.8.1.1. Training 
Training on catheterization of the bladder, application and removal of fecal collection systems and competency in 
venous access, including access and maintenance of Porta Cath® will be mastered. Crew members will also become 
familiar with the inspection, maintenance, and use of the PEG tube and alternate NG/OG tubes. 
 
Basic interpretation of altered vital signs including level of consciousness, heart rate, blood pressure, respiratory rate, 
urine output, and end-tidal carbon dioxide output must be learned to assist with medical staff evaluation of torpor 
induced crew members. Finally, the crew must familiarize themselves with the operation and maintenance of basic 
life support monitoring systems (e.g. EKG, pulse oximeter, automatic blood pressure device, and end-tidal carbon 
dioxide capnography) as well as torpor specific systems (e.g. gas delivery, nutritional support). 
 
4.8.1.2. Exposure to Torpor Cycles 
Crew members will undergo short duration (24-48 hour) cycles of torpor. This will allow the crew to experience and 
prepare for the physical and psychological effects associated with the torpor initiation and waking process. Crew 
members can also assist the medical team in torpor initiation and recovery steps, increasing their knowledge and 
application of induction protocols to allow them to assist with mission torpor cycles. Finally, exposing each 
crewmember to short torpor cycles will help identify which members of the crew best tolerate the temperature and 
pharmacological aspects of torpor. 
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4.8.1.3. Establish Permanent IV and Nutritional Access 
Approximately 12 weeks prior to the flight, a central venous catheter, 9 Fr single lumen silicone catheter with Titanium 
portal (Porta Cath®) will be inserted in the left subclavian vein for right handed subjects and in the right subclavian 
vein for left handed subjects. 
 
A Percutaneous Endoscopic Gastrostomy (PEG) tube will also be surgical placed via a combined laparoscopic and 
endoscopic approach. This will allow adequate time for surgical recovery and to identify postsurgical complications. 
Procedures on the safe access, discontinuation, flushing, and maintenance of these portals must be practiced and 
mastered. 
 
4.8.2. Stage 2: Crew Preparation 
 
Beginning approximately one (1) week before torpor induction (likely post-Earth departure): 
 
4.8.2.1. Skin Preparation 
Crew members will apply Mupirocin 2% ointment to each nostril twice a day for 7 days prior to induction of torpor. 
Three days prior to induction, the skin will be cleaned with chlorhexidine gluconate (CHG) alcohol wipes, twice a 
day, paying attention to axillae, groin, and rectal regions. Most nosocomial infections in prolonged bedridden patients 
are from the patients’ own endogenous flora found in the skin, mucus membrane, respiratory tract, and gastrointestinal 
tract. Reducing the surface bacterial flora appears to mitigate the risk of local and post-site skin infection [138,139]. 
Once torpor cycling has been initiated, this procedure will be repeated daily during any active, non-torpor periods for 
the crew members until the last torpor cycle. 
 
4.8.2.2. Bowel Preparation 
With enteral feeding through PEG or NG/OG tube: Two days prior to torpor crew members will start a clear liquid 
diet. Twelve hours prior to torpor astronauts should take two bisacodyl tablets (common stool softener). They will 
continue to consume oral liquids until two hours prior to the induction of torpor. As bowel movements, passage of 
flatus, and defecation are decreased under moderate sedation and hypothermia, this will transition waste to a more 
mobile form that is more conducive to the proposed waste collection systems.  
 
4.8.2.3. Perform Systems Test on Torpor Induction Systems 
One day prior to torpor induction the crew, in conjunction with mission control support teams, shall perform 
operational tests on all torpor-based electronics and mechanical equipment systems. 
 
4.8.2.4. Test Access to Port-a-Cath and PEG Tube: 
Prior to induction of torpor, the crew shall access the Porta Cath and initiate maintenance infusion of Lactated Ringers 
40 ml/hr. The PEG tube line will be flushed with 100-200 ml of sterile water or saline to ensure patency.  
 
4.8.3. Stage 3: Initiation  
 
4.8.3.1. Torpor Habitat 
Crew members will maximize skin exposure to facilitate heat transfer from the body. If glabrous skin surface cooling 
is utilized, then hand and feet heat-exchange garments will be donned. If heat exchange through ambient cooling is 
utilized, then crew torpor habitat cooling will be commenced at this time and cabin temperature reduced to <10 degrees 
Celsius. 
 
4.8.3.2. Place Foley Catheter, Fecal Collection system, and OG/NG Tube 
At this time fecal collection system placement is required if enteral feeding is selected, and OG/NG tube placement 
would be required if a PEG tube is not utilized. Urination continues whether TPN or enteral feeding is utilized. Foley 
collection systems therefore must be placed as the drainage of the bladder is necessary to maintain renal function and 
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measure the adequacy of tissue perfusion. The bladder temperature obtained through Foley catheter will also provide 
a measure of core body temperature. 
 
4.8.3.3. Apply Monitors 
Crew will apply the following monitors: Bispectral Index (BISTM) monitor, non-invasive blood pressure, EKG, pulse 
oximeter, and end-tidal CO2 monitor. Core body temperature will be recorded from bladder temperature measured 
through Foley catheter. 
 
4.8.3.4. Induce Moderate Sedation 
Moderate sedation will be induced and maintained for the duration of the torpor using a balanced anesthetic technique. 
A combination of intravenous medication will be used to achieve hypnosis, analgesia, and depression of the nervous 
system to suppress the shivering response and help the crew tolerate the cooling process until core body temperature 
is reduced past the “shivering threshold” (approximately 35 °C/ 95 °F) [47]. 
 
Dexmedetomidine is the current preferred sedation medication as discussed above [37,47]. The objective is to provide 
analgesia, amnesia, and abolish spontaneous movements. At the same time the crewmembers should be able to 
maintain a patent airway, adequate minute ventilation, and satisfactory hemodynamic parameters. The level of 
sedation should be such that the crew will not respond to verbal commands but should respond to noxious stimuli. 
The need for sedation would be reduced and may potentially be avoided with CHA torpor induction as CHA not only 
resets thermogenesis threshold but also suppresses the shivering response. 
 
4.8.3.5. Induction of Hypothermia 
Ambient cooling of the torpor habitat would be continued, resulting in hypothermia through direct conduction and 
convection from the skin to the surrounding air. Alternately, cooling could be limited to glabrous skin surfaces (namely 
the hands and feet). Core temperature would be regulated by either further cooling the ambient environment, or 
through active warming by convection air or through a heating pad or blanket (commonly used in operating rooms to 
prevent hypothermia during surgical cases) [49].  
 
Adenosine Receptor Agonist: CHA and 8-SPT torpor induction would be initiated through IV infusion through the 
Port-a-Cath per research study verified weight-based calculations. Current estimates are 4.2 mg bolus with a 0.1 
mg/kg/h maintenance infusion rate for CHA, with 8-SPT administered per research study verified weight-based 
calculations as needed to maintain normal blood pressure. 
 
4.8.4. Stage 4: Torpor Maintenance 
 
4.8.4.1. Evaluation of Vital Signs and Blood chemistry 
Continuous vital signs evaluation would be performed using current NASA approved monitoring systems. The 
collection and processing of laboratory testing to evaluate system electrolytes, basic body chemistry, red and white 
blood cell levels, and the presence and identification of any systemic body infection can be conducted by 
programmable automated systems or by sentinel crew member [92]. Laboratory testing, including urinalysis from 
Foley catheter samples, would be conducted at scheduled intervals and as per crew member vital signs or physical 
symptoms dictate. 
 
4.8.4.2. Nutrition 
Enteral feeding via temporary NG/OG feeding line or PEG tube would be initiated through gravity drainage or lower 
pressure pump assistance. Prepared solutions consisting of water and all the necessary nutrients, microelements and 
electrolytes necessary for healthy physiologic function would be administered in a single feeding of 2 kcal/ml nutrient 
solution. 
 
4.8.4.3. Infection Control 
To minimize the risk of infections, broad spectrum antibiotics (Ciprofloxacin at ~400 mg every 12 hours) will be 
started and continued for the duration of hypothermic torpor. Broad spectrum antibiotic ointment should be instilled 
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in both eyes, with lids closed. The inside of the mouth and gum lines should be periodically swiped with chlorhexidine 
gel swabs. Porta Cath access should also be inspected and cleaned with Betadine swabs. Both urethral orifice and 
catheter surfaces should be inspected for signs of infection or biofilm formation. If necessary, the Foley catheter should 
be replaced with a sterile new catheter.  
 
4.8.4.4. Thrombosis Prevention 
Systemic intravenous anticoagulation will be started and continued for the duration of the hypothermic torpor. Periodic 
Heparin line flushes with Lepirudin or Rivaroxaban (once daily through enteral feeding tube) are the preferred 
medications for preventing blood clot formation. Mechanical pulsatile compression devices will also be utilized as 
well as automated pressure point modification systems. 
 
4.8.4.5. Monitoring and Periodic Care 
Each crew member in torpor should be monitored daily for signs of infection, development of deep venous thrombosis, 
or formation of pressure ulcers. Exams should be performed in a systematic fashion from head to toe, looking for 
injury or infection of any kind. Routine care such as changing the position of crewmembers, dental care, monitoring 
and cleaning of IV and nutritional access sites, Foley catheter and fecal collection system inspection and replacement, 
and auscultation of heart and lungs will also be performed. Many of these activities can occur via automated systems 
with robotic manipulators. Periodic crew member inspections will be video recorded and sent to mission control based 
medical teams for further review and care recommendations. 
 
4.8.5. Stage 5: Torpor Reversal 
 
4.8.5.1. Rewarming 
The ambient temperature in the hibernation pod will be increased, allowing passive rewarming to occur until core 
temperature has reached 36°C, at which point the infusion of CHA will be stopped.  
 
4.8.5.2. Wakening 
Once the core body temperature has reached 36°C, the infusion of sedatives will be stopped (if utilized) and the 
crewmember will be allowed to gradually wake up. 
 
4.8.5.3. Discontinue Monitoring, Antibiotics and Anticoagulation 
Monitoring should be maintained until all physiological functions have returned to normal levels. If necessary, serum 
chemistry, including glucose, acid-base, and electrolytes should be check prior to discontinuing the EKG. Once torpor 
has been reversed antibiotics can be stopped. Anticoagulation should be stopped after the crewmember has resumed 
spontaneous and voluntary movements in the limbs. 
 
4.8.5.4. Resume Normal Diet (if available) 
Crewmembers may start on an oral liquid diet and then advance gradually to a normal solid diet. Once oral nutrient 
intake is adequate the temporary NG/OG tube can be removed (it utilized). 
 
4.8.5.5. Resume Normal Activity 
Crewmembers will gradually increase physical and mental activities. Minor muscle weakness, joint stiffness, and 
clouding of consciousness may need to be reversed through increased physical and mental activities immediately after 
wakening. Structured exercises to increase muscle strength and tone, such as those already instituted on current NASA 
missions, should be continued. Range of motion exercises may need to be added to existing exercise regimes. 
Complete elimination of sedatives and other pharmaceutical agents from the body will occur naturally shortly after 
waking, allowing for the return of normal wellbeing.  
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5. Impact on NASA’s Human Research Program (HRP) 
 
In order to consider the full potential impact of torpor towards supporting future human spaceflight, the medical team 
reviewed all of the NASA Human Research Program (HRP) Identified Spaceflight Risks. Each team member 
independently considered each risk and provided a score on its potential to positively or negatively impact each risk. 
Additionally, each member provided not only their personal rationale but also supporting clinical research whenever 
possible. Some of the risks that were identified are poorly understood and have not been evaluated by any large, formal 
studies at this time. This overall results from the research team indicated that torpor could positively benefit at least 
11 different HRP spaceflight risks, which are represented in Table 4. Note that for brevity, the risks determined to 
have minimal or no impact on HRP risks due to torpor were not included. 
 
Table 4. NASA HRP Risk Rankings based on SpaceWorks’ Team Qualitative Torpor Impact Assessment 
Torpor Impact 
Rankings 
HRP Risk 
ID #  NASA HRP Risk Title 
1 33 Risk of Spaceflight-Induced Intracranial Hypertension/Vision Alterations 
2 21 Risk of Inadequate Nutrition 
3 5 Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders 
4 26 Risk of Performance and Behavioral Health Decrements Due to Inadequate Cooperation, Coordination, Communication, and Psychosocial Adaptation within a Team 
5 28 Risk of Performance Decrements and Adverse Health Outcomes Resulting from Sleep Loss, Circadian Desynchronization, and Work Overload 
6 3 Risk of Acute (In-flight) and Late Central Nervous System Effects from Radiation Exposure 
7 16 Risk of Impaired Control of Spacecraft/Associated Systems and Decreased Mobility Due to Vestibular/Sensorimotor Alterations Associated with Spaceflight 
8 4 Risk of Acute Radiation Syndromes Due to Solar Particle Events (SPEs) 
9 13 Risk of Cardiovascular Disease and Other Degenerative Tissue Effects from Radiation Exposure 
10 27 Risk of Performance Decrement and Crew Illness Due to an Inadequate Food System 
11 17 Risk of Impaired Performance Due to Reduced Muscle Mass, Strength & Endurance 
 
 
While SpaceWorks is not proclaiming torpor as a solution to these risks, our team feels strongly that this technology 
may provide a roadmap for potential research and study to address these issues in the future. Details on some potential 
risk benefits will be provided. 
 
 
5.1. Short-term and Long-term Effects of Radiation Exposure and SPEs 
 
HRP Identified Spaceflight Risks #3, #4 and #13 all address the concerns of the detrimental effects of radiation 
exposure on astronauts during prolonged space missions. There are 23 significant studies on hibernation, hypothermia 
and radio-resistance ranging from 1961 – 2017 [140-162]. These studies included research on a variety of mammals 
(including mice, rats, hamsters, and ground squirrels) as well as cell and tissue samples collected from similar 
mammals and humans. In each case, the studies observed some radio-protective affect associated with hypothermia, 
with some studies showing significant increases in the mean survival time and the overall survival rates of the 
hypothermic groups. There are multiple theories of how hibernation provides radio-resistance, but given the limited 
number of studies none of them have been verified. Also, there has been renewed interest in hibernation and its 
radioprotective effects. For example, Isaac Bailey, Pharmacologist and Organic Chemist, University of Alaska 
Fairbanks, was recently awarded research funds from the Alaska Space Grant Program to study the impact of 
metabolic reduction on bone density loss and radioprotection (April 2017). 
 
Radiation and chemotherapy are an essential component of the treatment of cancer. Cancer patients can be exposed to 
high-doses of radiation during these treatments, but these levels are still limited by tissue toxicity, which limits the 
maximum radiation and chemotherapy dose that can be used on the tumor. When exceeded, tissue toxicity results in 
damage to other vital organs and serious side effects to the patient. Oncologists are currently exploring if hypothermia 
could allow patients to be treated with radiation and chemotherapy at doses that would not be acceptable in normal 
conditions because of organ dose limits. In addition, researchers are interested in determining if hypothermia could 
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prevent or mitigate the more serious complications caused by these treatments. These studies are also still in early 
stages and limited data currently exists. 
 
 
5.2. Spaceflight-Induced Intracranial Hypertension/Vision Alterations 
 
Multiple large studies have found that TH was effective at lowering intracranial pressure resulting from traumatic 
brain injury [163-171]. As a result, there is now support for the use of TH as a safe and effective treatment option for 
refractory intracranial hypertension [22]. The primary mechanism of action is that TH minimizes cerebral fluid shifts 
due to changes in central and peripheral blood pressure and blood electrolyte changes due to cellular death. This same 
mechanism of action is likely to minimize the microgravity induced effects of increased intracranial pressure on vision 
changes as well as vestibular/motosensory alterations. In addition, placing a crew in a torpor state may provide a more 
efficient engineering model to allow for induced gravity in the crew habitat, also mitigating microgravity affects. 
 
 
5.3. Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders, and the Risk 
of Performance and Behavioral Health Decrements 
 
As discussed above, little to no study data exists on the cognitive effects of TH. Given what we know about the mental 
state of hibernating animals, an astronaut in a state of torpor would likely cycle through episodes of mental 
wakefulness (without awareness), and non-REM sleep. Therefore, the only mental deficits they would experience 
would be those similar to sleep deprivation, with a short period of sleep recovery potentially all that is needed to 
transition from sleeping passenger to active explorer.   
 
Sleep disruption, monotony and boredom are the most frequent complaints of individuals in an integrated collaboration 
environment such as space flight, with the combination of monotonous work with requirements for high degrees of 
alertness and penalties for errors seen as especially stressful [131,132]. Given this fact, utilizing torpor would not only 
provide significant engineering benefits but would very likely reduce the amount of emotional and psychological 
stress, monotony, boredom, and sleep disruption experienced by crew members during a prolonged mission. When 
coupled with the reduction in the length and frequency of crew interaction and conflict, as well as greater opportunity 
for privacy and independence, is likely to significantly reduce the incidence of intrapersonal conflict and relationship-
based stress. 
 
 
5.4. Adverse Outcomes Due to Sleep Loss, Circadian Desynchronization, and Work 
Overload 
 
Studies on medication usage rates showed that 45% of all medications used by Space Shuttle crew members were 
sleep aids, and that 71% of all astronauts onboard the ISS have reported using sleep aids at least once during a mission 
[172,173]. Use of sleep onset medications not only affects the level of wakefulness and alertness of the crew members 
but can also have long-term medical complications including liver damage and withdrawal affects [174].  Prolonged 
sleep cycles of seven days and beyond could significantly reduce the use of sleep onset medication and eliminate 
astronaut work overload. The crew would spend a majority of the transit time during deep space missions in a torpor 
state. This will mitigate most of the emotional and psychological stress associated with crew interactions, isolation, 
lack of sleep and the physical discomforts of space travel. The result would be reduced incidences of depression, 
anxiety, sleep disruption and interpersonal conflicts during the portion of the mission where the crew has minimal 
mission tasks that engage their attention and promote teamwork.  
 
As discussed above, with what we know about the mental state of hibernating animals, an astronaut in a state of torpor 
would likely cycle through episodes of mental wakefulness (without awareness), and non-REM sleep. Therefore, 
astronauts do have the potential to experience some level of sleep deprivation while in torpor. However, the level of 
sleep disruption is not likely to exceed current levels experienced by crews on current missions, with a short period of 
sleep recovery potentially all that would be needed to transition from torpor to fully active.  
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5.5. Risk of Impaired Performance Due to Reduced Muscle Mass, Strength & Endurance 
 
Significant muscle atrophy can be observed in human muscles after only 5 days in space, but an overall time course 
and plateau for atrophy has not been established [175]. While generally not a concern during missions, these changes 
in the musculoskeletal system contribute significantly to the impaired function and risk of reloading injury experienced 
in the post-flight period [176]. As in bone density loss, humans on bed rest exhibit similar levels of muscle atrophy to 
those seen by astronauts in a zero-g environment. Bed rest studies show a notable level of muscle atrophy in as little 
as four days with significant increases continuing until two weeks, with larger losses noted in younger verses older 
patients [177].  
 
Once again, hibernating animals do not exhibit the same levels of muscle atrophy during inactive hibernation periods. 
Studies routinely show that there is relative stability of fiber type percentage and size, fiber size to body mass ratio, 
myosin heavy chain isoform content, shortening velocity, power output and elevated specific tension in hibernating 
animals between summer and winter months [178-180]. Torpor may provide similarly benefits to muscle atrophy 
prevention and the follow-on risk of reloading injury. 
 
Additionally, placing the crew in a torpor state may again provide a more efficient engineering model for inducing 
gravity in the crew habitat, mitigating microgravity affects. Outside of that, the reduced state of consciousness 
associated with torpor will allow for more prolonged and aggressive use of known preventative mechanisms, such as 
Neuromuscular Electrical Stimulation (NMES). While thoroughly studied and clinically proven to significantly impact 
muscle atrophy in both the hospital and microgravity environments, the repeated and prolonged use of NMES on large 
muscle groups is difficult to achieve due to the level of physical and mental discomfort it causes [181-184]. With crew 
members in a deep sleep like state, higher levels of muscle protection could be achieved with NMES by allowing for 
longer, more frequent, and more intense therapy sessions on large muscle groups. 
 
5.6. Risk of Inadequate Nutrition and Effects on Crew Performance and Crew Illness 
 
Inadequate nutrition has been a concern since the dawn of exploration. For NASA missions in particular, the NASA 
HRP Identified Spaceflight Risks #21 and #27 address concerns of inadequate nutrition and its effect on crew 
performance and risk of illness. Beyond the obvious concerns of malnutrition (fatigue, weight loss, muscle and bone 
density loss), poor nutritional intake is also directly associated with decreased immune function, impaired memory 
and cognitive function, and even decreased mental wellbeing [185-187]. Scientists have long known that rehydrated 
foods (such as those currently used on long-term space missions) lose nutritional value though the 
dehydration/preparatory process and during storage [188]. Enteral based nutrition formulas, such as those proposed 
for SpaceWorks’ torpor protocol, have a proven nutritional stability and store capability of two years as currently 
constituted (for unopened containers stored at room temperature) [63]. Given the ease of use and the prolonged 
bioavailability and storage life, nutritional supplementation during torpor should meet all recommended nutritional 
requirements and adequately protect from malnutrition and its associated detrimental effects.  
 
 
5.7. Adverse Risk of Bone Fracture and Spaceflight-induced Changes to Bone 
 
Spaceflight-induced changes to bone leading to early onset osteoporosis and the subsequent increased risk of both 
long bone fracture and intervertebral disc damage (NASA HRP Identified Spaceflight Risks #2, #11, and #15) have 
long been known as significant medical concerns associated with long-term space missions. Data collected from 
Skylab and Mir astronauts have shown bone density losses of nearly 8 percent in the calcaneus (heel bone) over 84 
days and 19 percent over 140s days [189]. It is estimated that a three-year Mars mission could result in a loss of bone 
density mineralization of 50 percent or more [190]. Bone density loss in humans on bed rest is surprisingly similar to 
those seen by astronauts in a zero-g environment. One study on the effects of 100 days of bed rest treatment for T8 
spine compression fractures revealed a 19% reduction in lumbar spine bone mineral density and a 6% reduction in 
total hip density [191]. 
 
While the overall torpor impact for these risk areas were generally not scored high by the team, it is worth noting that 
hibernating animals (even though they can be inactive for time periods equal to or longer than those of astronauts or 
bedridden patients), do not exhibit the same bone density losses discussed above. Studies involving arctic ground 
squirrels and bears showed: 1) Cortical bone geometrical properties (i.e., thickness, cross-sectional area, and moment 
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of inertia) at the midshaft of the femur were not different in animals sampled over the hibernation and active seasons; 
2) That while femoral ultimate stress tended to be lower in hibernators than in summer animals, bone toughness was 
not affected by hibernation, 3) And that the area of osteocyte lacunae was not different between active and hibernating 
animals [192,193]. In addition, there were no differences in bone structure, mineral content, or mechanical properties 
between fall and spring bears, and bone geometrical properties differed by less than 5% and bone mechanical 
properties differed by less than 10% [193]. These studies show that hibernating animals are able to preserve many 
bone properties during hibernation despite being physically inactive for up to 8 months. 
 
It is plausible that torpor may be able to provide similarly significant bone protection in unloaded environments (i.e. 
microgravity or bed-rest), resulting in a decreased risk of vertebral disc and large bone fracture or reloading injury. At 
a minimum, placing the crew in a torpor state appears to provide a more efficient engineering model for inducing 
gravity in the crew habitat, which can be used to mitigate these effects of microgravity. 
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6. Engineering Analysis and Modeling 
 
6.1. Mission Architecture Closure Model 
 
To support the planned mission-level architecture assessments, SpaceWorks integrated several proprietary, conceptual 
design tools into an Integrated Design Framework (IDF) using Phoenix Integration’s ModelCenter© software (see 
Figure 10). The input parameters for each tool were anchored to data gathered based on a NASA EMC Reference 
architecture. The IDF was then used to assess hundreds of thousands of architecture options in order to properly size 
and understand the impact of various technologies and/or system assumptions. 
 
 
Figure 10. Mission Architecture Integrated Design Framework (IDF) 
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Table 2 provides a listing of the engineering tools used to support the architecture modeling. Bullseye is an in-space, 
high-thrust trajectory simulation tool developed by SpaceWorks [194]. The software minimizes the mission energy 
requirements (i.e. C3 or DV) for a user-specified transit phase(s) and/or destination stay time, utilizing two-body 
patched conic approximations. The Bio-Simulator is an enhanced version of an initial, Excel-based model for 
optimizing the crew schedule using the sentinel protocol (see Section 6.1.2). REDTOP-Lite is a performance analysis 
routine for liquid rocket engines and is capable of sizing an engine to a required thrust level and predicting the specific 
impulse (Isp) and weight for the engine based on the selected cycle type (e.g. expander, staged-combustion) [195]. 
 
Table 5. Engineering Analysis and Design Tools 
Domain Tool Name Modeling Framework/Language 
Mission Variant Generator - Python 
Trajectory and Mission Design Bullseye Java 
Torpor Schedule Optimization Bio-Simulator C++ 
Rocket Engine Sizing REDTOP-Lite C++ 
Propulsive Stage Mass Properties StageSizer Excel 
Habitat Mass Properties HabSizer Excel 
Artificial Gravity System Sizing AG-Sizer Excel 
Crew Metabolism Custom Excel Spreadsheet Custom Excel Spreadsheet 
 
6.1.1. Parametric Propulsive Stage Sizing 
 
Reducing the mass of the habitat will enable reductions in propulsive stage mass, reduce the total number of stages, 
or/and reduce the engine count per stage for equivalent DV requirements. To evaluate the potential performance 
savings obtained with the use of torpor, SpaceWorks sized and estimated the mass of the stages using StageSizer, a 
parametric sizing tool for liquid propellant propulsive stages. StageSizer can perform a detailed analysis and sizing of 
approximately 15 different subsystems required for a launch system or in-space propulsive stage. This includes tank 
structures, interstage adapters, power generation, power management & distribution (PMAD), thrust structure, 
communications, thermal control, pressurization system, attitude control system (ACS), etc. 
 
StageSizer was initially anchored to a NASA EMC reference propulsive stage mass statement and dimensions; as 
detailed in Reference 198. Using this reference model as a point of departure, SpaceWorks was able to generate 
propulsive stage concepts for each new payload mass and mission opportunity by varying the key stage design 
parameters of maximum diameter, length, engine vacuum thrust level, and engine quantity.  
 
6.1.2. Bio-Simulator Tool 
 
SpaceWorks created a dynamic software tool to optimize the crew schedule by maximizing the total inactive/torpor 
period for the specified mission segment subject to a minimum number of active crew members, a maximum and 
minimum torpor cycle duration, minimum active period, the number of crew teams, mission duration, mission time to 
first induction cycle, etc. The schedule is optimized at the resolution of hours and can be performed for any number 
of crewmembers. Additionally, torpor-specific parameters such as the minimum and maximum core body temperature 
(e.g. 32 to 34 degrees C), rate of cooling (e.g. 2.0 degrees/hour), and rewarming rate (e.g. 0.5 degrees/hour) are used 
to generate crew metabolic profiles over time for the mission duration.  
 
The Bio-Simulator tool performs an exhaustive, full-factorial assessment by discretizing the design space and 
generating a crew schedule for each combination of design parameters. One scheduling complexity arises out of the 
need to phase the induction period for the crew members to permit generating scenarios where all crew members are 
not in synch to be active or inactive simultaneously. To handle this, the tool includes an induction offset parameter as 
an internal parameter that adds the additional degree of freedom necessary to meet the user-specified constraints. 
 
Table 6 provides the results from the Bio-Simulator for two reference mission scenarios. The first is for a crew size 
of 4 and the second is for a crew size of 8. For both cases, the minimum number of active crew members was required 
to be at least 1. For the 4-crew scenario, while the maximum permissible torpor duration was 14 days, the allowable 
duration was limited to 9 days given the design constraints and requirement to have at least one active member. The 
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8-crew scenario gives the crew a lot more schedule flexibility and the allowable torpor duration is permitted to reach 
the maximum value of 14 days. This results in an increase in the overall torpor utilization rate (i.e. total time in 
torpor/total mission time) from ~71% to ~82%. 
 
Table 6. Comparison of Torpor Sentinel Protocol Results for Crew Size of 4 versus 8 (from Bio-Simulator) 
Parameters 4 Crew Results 8 Crew Results 
Mission Duration 200 days 200 days 
Maximum Torpor Cycle Duration 14 days 14 days 
Initial Induction Delay 7 days 7 days 
Minimum Number Active Crew 1 1 
Maximum Number Inactive 3 7 
Minimum Number Active 1 1 
Total Crew Active Hours 5,520 6,984 
Total Transition Hours 261 389 
Total Crew Inactive Hours 13,419 31,027 
Ideal Torpor Cycle Duration / Active Period 9 days / 3 days 14 days / 2 days 
Initial Crew Offset 72 hours 48 hours 
Torpor Utilization % for Mission 70.85% 81.63% 
 
 
Figure 11 graphs the core body temperature over time for the first 30-days with a crew size of 4. For this scenario, the 
target core temperature during torpor was desired to be held at a constant 32-degrees C. During periods of activity, 
the core temperature for each member is at the nominal value of 37-degrees C. Note that there was an initial 7-day 
delay (or 168 hours) after the start of the mission before initiating any crew members into torpor. Per the specified 
constraint, it is also easy to see that there is always at least one crew member that is active. Figure 12 
 provides a similar view, but in this scenario the core temperature is oscillated between 32 and 34-degrees C. One of 
the reasons for doing this is to potentially minimize the wake time for additional crew members in the event of an 
emergency. The 2-degree delta may reduce the required rewarming time by 1-2 hours. 
 
 
Figure 11. Bio-Simulator Results: 4-Crew with Constant Core Temperature 
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Figure 12. Bio-Simulator Results: 4-Crew with Variable Core Temperature 
 
6.1.3. Modeling Crew Consumables and Metabolism 
 
Reducing the total mass of the required crew consumables is one of the primary advantages of the torpor-inducing 
habitat. SpaceWorks calculated changes in the total mass of crew consumables by calculating new totals as a function 
of crew biological profile, transit duration, and torpor metabolism reductions.   
 
The baseline crew model consists of four astronauts with uniform nutrition and hydration requirements. Individual 
basal metabolic rate (BMR) is calculated with a variant of the Harris-Benedict Equation modified by Mifflin.  Activity 
level effects are captured by multiplying the calculated BMR by an activity level multiplier. Table 7 lists the 
assumptions regarding reference crew physiology and nutrition. With these parameters, the total food intake rate for 
each crew member is approximately 1.95 kg/day. 
 
Inducing torpor reduces the mass of required crew consumables in two ways. First, astronauts in torpor can be 
sustained with liquid, enteral feeding instead of 'normal' solid food. Enteral nutrition supplements have a higher caloric 
density by design, are able to be stored more efficiently with less packaging waste materials, and the water content of 
the nutrients can be recaptured in a closed-loop life support system. As a result, simply switching from 'normal' solid 
food to a liquid enteral supplement leads to a large reduction in total crew consumables. Assumptions for the enteral 
nutrition model are given in  
Table 8. With enteral nutrition and a normal metabolism, the total food intake rate for each crew member is 0.762 
kg/day. 
 
 
Table 7. Reference Crew Member Physiological Assumptions for Sizing Case 
Name Value Units 
Gender Male - 
Weight 73.25 kg 
Height 75 in 
Age 40 years 
Carbohydrates % of Total Caloric 
Intake 
55 % 
Fat % of Total Caloric Intake 25 % 
Protein % of Total Caloric Intake 20 % 
Food Fluid Fraction 30 % 
Nutrition Dosage 26.0 g/day/kg-mass 
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Table 8. Torpor Crew Physiological Assumptions for Sizing Case 
Name Value Units 
Gender Male - 
Weight 73.25 kg 
Height 75 in 
Age 40 years 
Enteral Nutrition Dosage 8.663 g/day/kg-mass 
 
 
Torpor induction also reduces metabolic rate, which leads to an even lower daily nutritional requirement. The exact 
savings depends on the degree of metabolic reduction, which is a function of the core body temperature. 
 
For each mission, the total food mass required to sustain the crew is calculated for the parameters given in Table 7 
and  
Table 8. Mission-specific inputs include the active and torpor cycle durations and 'crew-days' from the Torpor Cycle 
Scheduler. Outputs from this analysis are the active, transition, and torpor nutrient rate (kg/person/day) and the total 
food mass required for the mission. 
 
 
6.1.4. Integrated Design Framework (IDF) 
 
To support rapid design space exploration and trade studies, SpaceWorks integrated all parametric design tools into 
an Integrated Design Framework (IDF).  The IDF automates the data flow and execution of each model in the 
following sequence of analyses: 
 
1. Define mission destination and departure year 
2. Determine the minimum characteristic energy (C3) trajectory and compute time of flight and ΔV requirements 
for each segment of the trajectory using Bullseye 
3. Optimize crew torpor schedule if evaluating a torpor-enabled mission using the Bio-Simulator 
4. Estimate nominal and contingency crew consumables mass based on the mission duration and nutrition type 
selected 
5. Parametrically estimate the habitat mass based on mission duration and total consumables mass 
6. Generate engine design for selected nominal thrust level (assuming high-performance expander cycle design 
using LOX/CH4 propellants) 
7. Size each stage in the transfer vehicle propulsive stack 
8. Sum total mass of all transfer stages required for both outbound and return segments 
 
 
6.2. Cost Modeling 
 
SpaceWorks estimated the overall architecture-level costs for the crew transit elements based on the published 
Evolvable Mars Campaign (EMC) documentation and results generated from the parametric models for both 
architecture configurations (EMC Reference Habitat and the SpaceWorks Torpor Habitat). The overall architecture 
level cost model includes recurring (production) and non-recurring (research, development, testing, and evaluation) 
costs for the in-space propulsive stages and transit habitat(s), as well as mission operations and launch costs. Mass 
inputs were used from the Habitat and Propulsive Stage sizing models, as well as component application inputs from 
the design team, and programmatic inputs consummate with NASA standard modeling approaches. A combination of 
parametric and analogous cost tools was used to model various components of the architecture-level costs. The primary 
industry cost tools utilized for this effort are shown in Table 9. Note that technology development costs for torpor 
were not included in the cost estimates. Consistent with all other subsystem development efforts and standard cost 
estimating practices, maturation costs up to TRL 6 are not accounted for. 
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Table 9. System Cost Modeling Tools 
Tool Name Developer Used For 
SEER-H Galorath, Inc. Recurring and Non-Recurring Costs 
PCEC NASA Recurring and Non-Recurring Costs 
MOCET Aerospace Corporation Operations Costs 
 
 
6.2.1. SEER-H Costing Tool 
 
SEER-H is a parametric cost-analysis tool developed and distributed for the last 20 years by Galorath, Inc. (see Figure	13) [199]. It is used in numerous industries, including aerospace and defense. The tool consists of internal knowledge 
bases with cost estimating relationships (CERs) that are applied to both organization and project-specific factors. 
Principal inputs include: 
 
• Mass 
• Application 
• Acquisition process 
• Complexity 
• Material properties 
• Heritage design percentage 
• Labor rates 
• Learning effects 
• Production standard 
• Platform category 
 
Outputs from SEER-H consist of subsystem development and production costs based on a user-input work breakdown 
structure. System level costs are disseminated into integration, assembly and checkout (IACO), system test operations 
(STO), system support equipment (SSE), system engineering and integration (SE&I), and program management (PM) 
costs.  
 
Figure 13. SEER-H Cost Estimation Tool Interface from Galorath, Inc. 
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6.2.2. PCEC Costing Tool 
 
The Project Cost Estimating Capability (PCEC) tool is a parametric cost-analysis tool produced and maintained by 
the NASA Engineering Cost Office at Marshall Spaceflight Center (see Figure	14) [200]. Building on the wide-spread 
acclaim of its predecessor, NAFCOM, PCEC integrates over 150 NASA and Air Force spaceflight hardware projects 
to provide CERs and cost modeling frameworks for establishing probabilistic cost estimates. PCEC allows for simple 
weight-based estimates, as well as complex, multi-input estimates. Tool outputs consist of subsystem design and 
development, as well as production costs.  
 
There are two primary cost estimating methodologies available within PCEC: 
 
• Multi-variable estimating is data driven, statistically based and allows users to document estimating 
assumptions rather than using complexity factors – supportable, repeatable, and verifiable. 
 
• Weight-based estimating is valuable early in the estimating process when an analyst may only have a WBS 
and mass statement – also useful if estimating hardware very analogous to a mission in the historical database 
 
For this analysis, weight-based estimating was used due to the early stage of the design concepts. Additionally, the 
relatively high-level master-equipment-list (MEL) available for the purposes of cost estimating was insufficient to 
properly assess complexity factors and specific assumptions.  
 
 
Figure 14. PCEC Parametric RDT&E and TFU Cost Estimation Tool Interface from NASA 
 
PCEC was used as an alternative estimating tool for habitat WBS items that were either too broad to be accurately 
estimated at the component level using SEER, or that had relatively small knowledge bases in SEER (i.e., exclusively 
human exploration-related WBS items). In each instance where PCEC was used, both the development and production 
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costs were modeled as a direct throughput cost in the overall SEER model. PCEC was used for the following WBS 
items: 
 
• Crew Visual Displays & Controls 
• Environmental Control & Life Support  
• Crew Accommodations 
• EVA Equipment 
• Airlock Equipment 
• Mechanisms & Other 
 
 
6.2.3. MOCET Costing Tool 
 
The Mission Operations Cost Estimating Tool (MOCET) is a model developed by the Aerospace Corporation in 
partnership with NASA’s Science Office for Mission Assessment (SOMA) [201]. As seen in Figure	15, MOCET 
provides a new capability to generate cost estimates for the operational portion of NASA science missions. The overall 
MOCET development effort drew upon nearly 50 individual earth orbiting and planetary science missions to develop 
CERs for mission operations.  
 
Figure 15. MOCET Mission Cost Estimation Tool Interface from NASA and Aerospace Corporation 
 
Within the tool, each segment of the mission is separated out into one of 18 different phases, each with a length of 
time (in months), as well as unique, phase-specific input factors. The resulting output is both a cost by phase, as well 
as a total mission cost. For each manned Mars mission in the EMC Reference Architecture, the following phase 
structure was used: 
 
Table 10. MOCET Mission Phases Used for Manned Mars Missions 
Phase Description MOCET Phase Type 
Mars Transfer Vehicle Assembly & Check-out Checkout 
Earth Departure/TIM Burn Cruise 
Entry into Mars 1-SOL Orbit Orbit Insertion 
Orbiting in Mars 1-SOL Orbit Orbital Operations 
Rendezvous with Pre-Position Hardware Orbital Operations 
Pre-Position Hardware Checkout Checkout 
Surface Operations (Dormant Habitat) Cruise 
Rendezvous with Habitat Orbital Operations 
Return Vehicle Checkout Checkout 
Mars Departure/TEI Burn Orbit Insertion 
Mars to Earth Flight Cruise 
Lunar Retrograde Orbit Insertion/DRLOI Burn Orbit Insertion 
Rendezvous Orbital Operations 
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The MOCET tool is primarily intended for use with NASA science missions, and not crewed exploration missions. 
Due to the lack of a suitable alternative for estimating mission operations costs, SpaceWorks elected to use the 
MOCET tool as a baseline, while augmenting the MOCET outputs with additional analogous cost estimates based on 
the 2013 ISS operations budget. To avoid over-proportioning ISS operations costs, SpaceWorks used only a subset of 
the operations budget that included only those cost centers expected to be incurred in a similar capacity during a 
manned Mars mission. Table	10 identifies the selected mission phases to be included. These costs were escalated to 
FY2018 dollars and scaled based on the expected mission duration. The additional human exploration-related 
expenses included in operations cost estimates are shown in Table	11. 
 
Table 11. MOCET Mission Cost Categories and Monthly Cost 
Cost Category Average Monthly Cost ($M, FY2013) 
Labor $ 328 
Operation & Maintenance of Equipment $ 238 
Advisory & Assistance Services $ 106 
Operations & Maintenance Services $ 102 
Other Services $ 94 
Other Purchases $ 44 
Suppliers & Materials $ 22 
Travel $ 12 
Land & Structures $ 8 
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7. Advanced Habitat Designs 
 
7.1. Habitat Design Assumptions 
 
7.1.1. General Assumptions 
 
The crew habitat is designed to support a complement of 4 during the transit phases of missions to Mars and/or the 
Martian moons of Phobos and Deimos. The habitat is sized for 1100 days of crewed duration during the Mars mission, 
plus additional uncrewed time at a lunar Distant Retrograde Orbit (LDRO) for outfitting and checkout. The transit 
habitat will be reused over several missions and is assumed to last for 15 years. 
 
The habitat is designed to fit within the 8.4 meter diameter shroud for Space Launch System (SLS) which corresponds 
to a 7.5 meter diameter usable envelope that limits the habitat diameter to less than 7.5 meters when stowed. This 
diameter maintains flexibility to use the 8.4 or 10 meter diameter SLS shrouds. The habitat length limit is set by the 
8.4 meter diameter shroud usable envelope when co-manifested with a hybrid propulsive stage (HPS) for LDRO 
insertion. The transit habitat is launched with the HPS, with the habitat on the top of the propulsion stage. These launch 
vehicles are packaged with adaptors such that neither payload carries the loads of the other.  
 
The habitat structure is sized to provide sufficient load bearing interfaces for integration with propulsion stages or 
other elements above or below the habitat in the launch-vehicle stack. A factor of safety of 2.0 on ultimate loads was 
selected to comply with JSC 65828 "Structural Design Requirements and Factors of Safety for Spaceflight Hardware". 
The habitat provides 3 docking mechanisms with hatches, which is driven by aggregation operations requiring 
simultaneous docking with the Gateway habitat, logistics delivery modules, and Orion crew vehicle.  
 
Micrometeoroid Orbital Debris (MMOD) protection is sized to be sufficient for the 15-year lifetime in a deep space 
environment. The transit habitat does not carry dedicated GCR and SPE protection beyond that provided by the habitat 
structure, internal subsystems, and consumables. Internal layout of consumables is therefore driven by the desire to 
maximize passive GCR and SPE protection.  
 
The habitat does not contain any power generation systems. Instead, it receives power generation located on the 
propulsive element(s) of the combined transfer vehicle stack. The habitat does include internal power management 
and distribution systems and batteries to provide 72-hours of power in emergency scenarios. 
 
The habitat internal atmosphere is a 101.3 kPa (14.7 psia), with 21% O2 nominal atmosphere. The habitat contains a 
fully closed-loop water recycling and oxygen generation life support systems, with a 30-day open-loop consumable 
backup for water, oxygen generation, and carbon dioxide removal. The habitat also carries logistics, spares, and 
maintenance for the full crew during the entire 1100-day mission duration.  
 
7.1.2. Life Support Systems 
 
The Environmental Control and Life Support System (ECLSS) for the habitat is its most important subsystem. Where 
possible, existing and near-term technologies used on the ISS were selected in the design of this system to minimize 
risk associated with development. The ECLSS for the torpor habitat uses a Water Processing System (WPS) to recycle 
water, and the Atmosphere Revitalization System (ARS) and Oxygen Generation System (OGS) to recycle oxygen. 
 
In the WPS, water is collected from the atmospheric humidity (driven by passenger breathing and sweat) using the 
Temperature and Humidity Control (THC) subsystem and collected from passenger urine in the Urine Processor 
Assembly; a vacuum distillation process is used to recover water from urine. All water collected is sent to a Water 
Processor for treatment.  
 
In the ARS, the first step of the oxygen recovery process is to remove the carbon dioxide from the cabin atmosphere 
using a Carbon Dioxide Removal Assembly (CDRA). The ARS also includes a Trace Contaminant Control Subsystem 
(TCCS) to filter particulates and remove volatile organic trace gases from the air. 
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Once collected the carbon dioxide is passed OPS, specifically to the Carbon Dioxide Reduction Assembly (CReA) 
for processing. The CReA uses a Sabatier reaction to convert carbon dioxide and hydrogen into methane and water. 
The water is sent on to the final step of this process, the Oxygen Generation Assembly (OGA). The OGA uses 
electrolysis to break the water into hydrogen and oxygen gas. The oxygen is fed back into the cabin atmosphere, while 
the hydrogen is sent back into the CReA to support the Sabatier reaction. 
 
The additional hydrogen required to maintain the CReA is recovered from its methane exhaust. Excess oxygen in the 
system, introduced from the food solids and recovered via the OGA, is reacted with the methane exhaust to produce 
carbon dioxide and water. The water is sent to the OGA for electrolysis, while the carbon dioxide and remaining 
methane are vented from the habitat. A small amount of hydrogen gas is included in the system outfitting to initiate 
this process. 
 
For torpor-enabled habitats, the required crew support systems and body interfaces are identified in Figure 16. When 
torpor is utilized, the maximum duration is nominally 14 days. The crew schedule, generated by the Bio-Simulator 
tool, is set such that there is always at least one active crew member. This yields active periods between cycles of 2-3 
days, depending on the total number of crew members. 
 
Figure 16. Torpor Pod and Crew System Implementation 
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7.2. NASA Reference EMC Habitat Design 
 
7.2.1. Habitat Design 
 
Summary metrics for the EMC Reference transit habitat are shown in Table 12. For a crew of four, the habitat provides 
25 m3 of habitable volume per person. 
 
Table 12. NASA EMC Reference Habitat Summary Metrics 
Metric Value 
Empty Mass 21.0 t 
Loaded Mass 45.5 t 
Length 7.5 m 
Diameter 7.2 m 
Habitable Volume 100 m3 
Pressurized Volume 300 m3 
Power Required 20 kW 
 
 
The NASA EMC Reference habitat geometry is shown in Figure 17 and Figure 18. The habitat is divided into two 
levels. The lower level serves as the crew living area and workspace. The upper level houses consumables and spares, 
as well as crew sleeping quarters. Life support subsystems are housed in the deck beneath the lower level. 
 
 
Figure 17. NASA EMC Reference Habitat Concept Views (4 Crew) 
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Figure 18. NASA EMC Reference Habitat Lower Level (left) and Upper Level (right) Overhead Views 
 
The lower level is divided into four quadrants as shown in Figure 18. The upper left quadrant contains crew exercise 
equipment, medical equipment, and storage for medical supplies. The upper right quadrant contains the toilet, shower, 
and storage for crew hygiene supplies. The lower right quadrant is the galley, which includes food rehydration and 
warming stations, a foldable table and chairs for mealtimes, and storage for habitat cleaning supplies. The lower left 
quadrant is the command station with interfaces and displays for the onboard computer systems.  
 
The upper level has four private crew quarters for sleeping and relaxation, one for each crewmember. The sleeping 
quarters are surrounded on all sides by ISS-style cargo transfer bags (CTBs) containing all of the life support system 
consumables: 1100 days of food; 30 days of emergency water, oxygen, and lithium hydroxide canisters; and 
contingency oxygen and nitrogen to re-pressurize the cabin in case of depressurization. Equipment spares are also 
carried in CTBs. 
 
The radiation protection provided by the consumables allows the crew quarters to also serve as a storm shelter during 
SPEs. Crew total GCR exposure is also reduced because the crew spends 7-8 hours a day resting in the protected 
sleeping quarters. 
 
The two levels are connected by a central hatch. Three of the four docking hatches are located in the lower level along 
the walls. The fourth docking hatch is location in the upper level in the center of the ceiling. 
 
A full mass breakdown statement for the NASA EMC Reference Habitat is shown in Table 13.  
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Table 13. NASA EMC Reference Habitat Mass Breakdown Statement 
Subsystem Mass (kg) Descriptions/Notes 
Structures 7,361 Pressure vessel, windows, hatches, internal walls & floors 
Docking & Launch Support 1,305 Docking and berthing mechanisms, launch support hardware 
MMOD Protection 680  
Power Distribution 1,231 Batteries, power distribution units, switches, converters, harness 
Electronics 450 Command and data handling, communications, crew displays and controls 
Thermal Management 1,811 Internal and external active TCS fluid loops, radiators, MLI 
Environmental Control 1,078 Atmosphere revitalization and oxygen generation 
Crew Habitation & Support 2,284 Water processing system, food preparation, waste collection, exercise equipment, medical equipment, crew hygiene 
EVA Support 1,134 Airlocks, suits, suit charging stations 
Maintenance & Repair 393 Robotic support equipment and charging stations 
Payload Provisions 3,251 Multipurpose workstation with payload manipulation and storage equipment 
Empty Mass 20,978  
Habitat Outfitting 4,258 Crew mission kits and stowed items, habitat ECS consumables 
Maintenance, Repair, & Spares 4,694 Equipment spares, tools 
Payloads & Research 2,023 Scientific research experiments 
Habitation Consumables 4,975 Water, oxygen, waste collection canisters, health care, hygiene 
Food Consumables 8,524 Dehydrated food 
Outfitting & Consumables 24,475 Pressure vessel, windows, hatches, internal walls & floors 
Total 45,452  
 
 
7.2.2. Cost Assessment – Single Production Unit 
 
For the NASA EMC Reference Habitat (with 4-Crew), the cost results shown in Table 14 reflect the cost of RDT&E, 
prototypes, and one production unit. This estimate does not reflect any margin or contractor fees, as this was calculated 
at the architecture-level.  
 
Table 14. NASA EMC Reference Habitat Cost by Element 
Work Element Development ($M,FY2018) 
Production – 1 Unit 
($M,FY2018) 
Total*** 
($M,FY2018) 
Body Structures $ 1,304 $ 149 $ 1,453 
Natural & Induced Environmental Protection  $ 29 $ 2 $ 31 
Power Systems $ 521 $ 133 $ 654 
Command & Data Handling Systems $ 84 $ 8 $ 92 
Guidance, Navigation, & Control Systems $ 26 $ 2 $ 28 
Communications & Tracking Systems $ 91 $ 37 $ 128 
Crew Displays & Controls $ 28 $ 5 $ 33 
Environmental Control Systems $ 319 $ 63 $ 381 
Crew/Habitation Support Systems $ 252 $ 46 $ 298 
Extravehicular Activity Support Systems $ 163 $ 22 $ 184 
Maintenance & Repair Systems $ 155 $ 26 $ 182 
Connection & Separation Systems $ 97 $ 15 $ 112 
Launch Support Equipment $ 36 $ 8 $ 44 
System Integration, Test, & Evaluation $ 901 $ 148 $ 1,049 
Total* $ 4,004 $ 664 $ 4,668  
* Cost differences between sum of elements and total are due to rounding 
** Margin and fee not included 
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7.2.3. Cost Assessment – Two Production Units 
 
For the NASA EMC Reference Habitat, the incremental cost of producing a subsequent unit was examined and the 
results are provided in Table 15. The additional production unit is necessary to allow a mission using the NASA EMC 
design to accommodate eight (8) crew members vs. the nominal four. For this analysis, it was assumed these habitats 
would not be produced in a single batch, but rather in sequential order allow for learning to take place. These estimates 
include production learning curve effects ranging from 85% to 93% depending on the component type/application. 
This estimate does not reflect margin or contractor fees, as this was calculated at the architecture-level.  
 
 
Table 15. Incremental Cost for Additional NASA EMC Reference Habitat 
Work Element First Unit ($M, FY2018) 
Additional Unit 
($M, FY2018) 
Total for Two*** 
($M, FY2018) 
Body Structures $ 149 $ 119 $ 268 
Natural & Induced Environmental 
Protection  
$ 2 $ 2 $ 4 
Power Systems $ 133 $ 108 $ 241 
Command & Data Handling Systems $ 8 $ 7 $ 15 
Guidance, Navigation, & Control Systems $ 2 $ 2 $ 4 
Communications & Tracking Systems $ 37 $ 33 $ 70 
Crew Displays & Controls $ 5 $ 4 $ 9 
Environmental Control Systems $ 63 $ 52 $ 115 
Crew/Habitation Support Systems $ 46 $ 43 $ 89 
Extravehicular Activity Support Systems $ 22 $ 19 $ 51 
Maintenance & Repair Systems $ 26 $ 23 $ 49 
Connection & Separation Systems $ 15 $ 12 $ 27 
Launch Support Equipment $ 8 $ 7 $ 15 
System Integration, Test, & Evaluation $ 148 $ 100 $ 248 
Total* $ 664 $541 $1,205 
* Cost differences between sum of elements and total are due to rounding 
** Margin and fee not included 
 
 
7.3. NASA EMC Habitat Concept Using Torpor 
 
7.3.1. Methodology 
 
The motivation for this design effort was to characterize the impact of implementing torpor into an existing transit 
habitat design. In the creation of this habitat design, only those systems directly impacted by the inclusion of the torpor 
concept of operations and supporting subsystems were changed. 
 
In this concept, the majority of the standard dehydrated space food is replaced with liquid enteral nutrition formula. 
The crew is also provided with two weeks of solid (normal) food stores for each period of transition into and out of 
torpor operations, or eight weeks’ worth in total. The replacement of solid food with liquid nutrition formula yields 
significant reduction in total food mass because of the mass-efficiency of the formula relative to solid food. The 
quantity of housekeeping and other habitat consumables was also reduced to capture the impact of reduced crew 
activity on habitat outfitting requirements. 
 
Because the crew spends the majority of the transit phase in torpor, the scientific payloads and payload provisions 
were removed. The on-duty crewmembers will spend the majority of their time tending to those crewmembers in 
torpor and maintaining spacecraft operations. Payload storage is still available for sample return to Earth. 
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7.3.2. Habitat Design 
 
Summary metrics for the NASA EMC habitat using torpor are shown in Table 16, along with the reduction in value 
from the reference habitat. 
Table 16. NASA EMC Habitat Using Torpor Summary Metrics 
Metric Value Reduction Percent Reduction 
Empty Mass 17.0 t 4.0 t 19% 
Loaded Mass 32.3 t 13.1 t 29% 
Length 7.5 m - - 
Diameter 7.2 m - - 
Habitable Volume 100 m3 - - 
Pressurized Volume 300 m3 - - 
Power Required 20 kW - - 
 
The geometry and configuration of the habitat are unchanged from the reference EMC habitat. It is assumed that the 
torpor support subsystems are integrated directly into the existing crew quarters. 
 
A full mass breakdown statement for the EMC Reference Habitat is shown in Table 17, along with the reduction in 
mass from the reference habitat. 
 
Table 17. NASA EMC Reference Habitat Mass Breakdown Statement 
Subsystem Mass (kg) Reduction (kg) 
Structures 7,361 0 
Docking & Launch Support 1,181 124 
MMOD Protection 680 0 
Power Distribution 1,231 0 
Electronics 450 0 
Thermal Management 1,811 0 
Environmental Control 1,078 0 
Crew Habitation & Support 1,688 595 
EVA Support 1,134 0 
Maintenance & Repair 393 0 
Payload Provisions 0 3,251 
Empty Mass 17,008 3,970 
Habitat Outfitting 4,102 156 
Maintenance, Repair, & Spares 4,379 315 
Payloads & Research 0 2,023 
Habitation Consumables 3,114 1,861 
Food Consumables 3,660 4,864 
Outfitting & Consumables 15,255 9,219 
Total 32,263 13,189 
 
 
7.4. SpaceWorks Torpor-Enabled Habitat Designs 
 
7.4.1. Methodology 
 
The motivation for this design was to fully characterize the impact of implementing torpor in a new habitat design, 
primarily by taking advantage of the reduced consumables and supplies storage volume, and to reduce the quantity of 
equipment spares required based on lower ECLSS demands during torpor period. 
 
As with the previous concept, the majority of the standard dehydrated space food is replaced with dehydrated enteral 
nutrition formula. The crew is provided with two weeks of solid food for each period of transition into and out of 
Advancing Torpor Inducing Transfer Habitat for Human Stasis to Mars  
NIAC Phase II Final Report 
SpaceWorks Enterprises, Inc. (SEI)  
 
48 
torpor operations, or eight weeks’ worth in total. As before, the replacement of solid food with nutrition formula yields 
significant reduction in total food mass because of the mass-efficiency of the formula relative to solid food. Compared 
to the reference habitat, the quantity of housekeeping and other habitat consumables was also reduced to capture the 
impact of reduced crew activity on habitat outfitting requirements. This reduced food and consumables mass translates 
to reduced consumables volume. 
 
Similarly, because the crew spends the majority of the transit phase in torpor, the scientific payloads and payload 
provisions are not included. The on-duty crewmembers will spend the majority of their time tending to those 
crewmembers in torpor and maintaining spacecraft operations. Payload storage is still available for sample return to 
Earth. 
 
A new habitat layout was conceived to take full advantage of the reduced consumables and supplies volumes. It was 
decided that, because only one crewmember is active for the majority of the mission, the habitable volume per 
crewmember can be reduced below 25 m3. This allowed for a significant reduction in overall habitat size. Subsystems, 
equipment, and accommodations were repackaged into the smaller volume. This allowed the pressure vessel, 
structures, and MMOD protection masses to be reduced based on the smaller habitat geometry. 
 
The reduced habitable volume can also be propagated into the sizing of the ECLSS systems. With smaller ECLSS 
systems, the power requirements of the habitat are also reduced, thus reducing the mass of the power distribution and 
thermal management systems.  
 
7.4.2. Habitat Design 
 
Summary metrics for the SpaceWorks torpor-enabled habitat are shown in Table 18, along with the reduction in value 
from the NASA EMC Reference habitat. 
 
Table 18. SpaceWorks Torpor-Enabled Habitat Summary Metrics 
Metric Value Reduction Percent Reduction 
Empty Mass 12.5 t 8.5 t 40% 
Loaded Mass 25.5 t 20.0 t 44% 
Length 6.5 m 1.0 m 13% 
Diameter 6.0 m 1.2 m 16% 
Habitable Volume 50 m3 50 m3 50% 
Pressurized Volume 180 m3 120 m3 40% 
Power Required 15 kW 5 kW 25% 
 
The SpaceWorks torpor-enabled habitat geometry is shown in Figure 19 and Figure 20. Similar to the EMC Reference 
design, the habitat is divided into two levels. The lower level serves as the crew living area and workspace. The upper 
level houses consumables and spares, as well as crew torpor modules. Life support subsystems are housed in the deck 
beneath the lower level. 
 
The lower level is divided into five areas as shown in Figure 20. The top area contains storage for medical supplies 
and habitat cleaning supplies. The upper left area is the command station with interfaces and displays for the onboard 
computer systems. The upper right area contains crew exercise equipment and medical equipment. The lower left area 
contains the shower and hygiene station. The lower right area contains the toilet and storage for crew hygiene supplies. 
The bottom area is the galley, which includes food rehydration and warming stations, and a foldable table and chairs 
for mealtimes.  
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Figure 19. SpaceWorks Torpor Habitat Concept Views (4 Crew) 
 
 
 
Figure 20. SpaceWorks Torpor Habitat Concept Lower Level Design (4 Crew) 
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The upper level, as shown in Figure 21, has four torpor modules containing all of the torpor support subsystems, one 
for each crewmember. The torpor modules are surrounded on all sides by ISS-style cargo transfer bags (CTBs) 
containing all of the life support system consumables: 60 days of food and 1100 days of enteral nutrition; 30 days of 
emergency water, oxygen, and lithium hydroxide canisters; and contingency oxygen and nitrogen to re-pressurize the 
cabin in case of depressurization. Equipment spares are also carried in CTBs. 
 
The radiation protection provided by the consumables allows this area to also serve as a storm shelter during SPEs. 
Crew total GCR exposure is significantly reduced because the crew spends the majority of the mission in torpor within 
this protected area. 
 
Figure 21. SpaceWorks Torpor Habitat Concept Upper Level Design (4 Crew) 
 
 
The two levels are connected by a central hatch. Three of the four docking hatches are located in the lower level along 
the walls. The fourth docking hatch is location in the upper level in the center of the ceiling. 
 
A full mass breakdown statement for the SpaceWorks torpor-enabled habitat is shown in Table 19, along with the 
reduction in mass from the reference habitat. 
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Table 19. SpaceWorks Torpor-Enabled Habitat Mass Breakdown Statement 
Subsystem Mass (kg) Reduction (kg) Description/Notes 
Structures 4,101 3,260 Pressure vessel, windows, hatches, internal walls & floors 
Docking & Launch Support 1,040 264 Docking and berthing mechanisms, launch support hardware 
MMOD Protection 474 206  
Power Distribution 923 308 Batteries, power distribution units, switches, converters, harness 
Electronics 450 - Command and data handling, communications, crew displays and controls 
Thermal Management 1,459 352 Internal and external active TCS fluid loops, radiators, MLI 
Environmental Control 896 182 Atmosphere revitalization and oxygen generation 
Crew Habitation & Support 1,650 633 
Torpor support subsystems, water processing 
system, food preparation, waste collection, 
exercise equipment, medical equipment, crew 
hygiene 
EVA Support 1,134 - Airlocks, suits, suit charging stations 
Maintenance & Repair 393 - Robotic support equipment and charging stations 
Payload Provisions - 3,251  
Empty Mass 12,522 8,455  
Habitat Outfitting 3,872 386 Crew mission kits and stowed items, habitat ECS consumables 
Maintenance, Repair, & Spares 2,386 2,308 Equipment spares, tools 
Payloads & Research - 2,023  
Habitation Consumables 3,114 1,861 Water, oxygen, waste collection canisters, health care, hygiene 
Food Consumables 3,660 4,864 Dehydrated food and enteral nutrition formula 
Outfitting & Consumables 13,033 11,442  
Total 25,555 19,897  
 
A graphic showing the mass reduction in the SpaceWorks torpor-enabled habitat compared to the NASA EMC 
reference habitat is shown in Figure 22. 
 
 
Figure 22. SpaceWorks Torpor Habitat Mass Savings and Subsystem Impact Distribution 
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7.4.3. Cost Assessment – Single Production Unit 
 
For the SpaceWorks Torpor Habitat (4-Crew System), the cost results in Table 20 reflect the cost of RDT&E, 
prototypes, and one production unit. This estimate does not reflect margin or contractor fees, as this was calculated at 
the architecture-level.  
Table 20. SpaceWorks Torpor Habitat Cost By Element (4 Crew) 
Work Element Development  ($M, FY2018) 
Production -1 Unit 
($M, FY2018) 
Total*** 
($M, FY2018) 
Body Structures $ 800 $ 88 $ 888 
Natural & Induced Environmental Protection  $ 21 $ 2 $ 23 
Power Systems $ 379 $ 95 $ 474 
Command & Data Handling Systems $ 84 $ 8 $ 92 
Guidance, Navigation, & Control Systems $ 26 $ 2 $ 28 
Communications & Tracking Systems $ 91 $ 37 $ 128 
Crew Displays & Controls $ 28 $ 5 $ 33 
Environmental Control Systems $ 288 $ 57 $ 345 
Crew/Habitation Support Systems $ 185 $ 28 $ 212 
Extravehicular Activity Support Systems $ 163 $ 22 $ 185 
Maintenance & Repair Systems $ 153 $ 26 $ 179 
Connection & Separation Systems $ 97 $ 15 $ 112 
Launch Support Equipment $ 23 $ 5 $ 28 
System Integration, Test, & Evaluation $ 629 $ 120 $ 749 
Total* $ 2,965  $ 511  $ 3,476  
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
 
7.4.4. Cost Assessment – Two Production Units 
 
The cost of producing an additional torpor habitat was examined and the results are provided in Table 21. The 
additional production unit is necessary to allow a mission architecture that can accommodate eight crew members vs. 
the nominal four. For this analysis it was assumed these habitats would not be produced in a single batch, but rather 
in sequential order allow for learning to take place. These estimates include production learning curve effects ranging 
from 85% to 93% depending on the component type/application. This estimate does not reflect margin or contractor 
fee, as this was calculated at the architecture-level. 
Table 21. Incremental Cost for Additional SpaceWorks Torpor Habitat 
Work Element First Unit ($M, FY2018) 
Additional Unit  
($M, FY2018) 
Total for Two 
($M,FY2018)** 
Body Structures $ 88 $ 71 $ 159 
Natural & Induced Environmental 
Protection  
$ 2 $ 1 $ 3 
Power Systems $ 95 $ 78 $ 173 
Command & Data Handling Systems $ 8 $ 7 $ 15 
Guidance, Navigation, & Control Systems $ 2 $ 2 $ 4 
Communications & Tracking Systems $ 37 $ 33 $ 70 
Crew Displays & Controls $ 5 $ 4 $ 9 
Environmental Control Systems $ 57 $ 48 $ 105 
Crew/Habitation Support Systems $ 28 $ 26 $ 54 
Extravehicular Activity Support Systems $ 22 $ 20 $ 41 
Maintenance & Repair Systems $ 26 $ 22 $ 48 
Connection & Separation Systems $ 15 $ 12 $ 27 
Launch Support Equipment $ 5 $ 4 $ 9 
System Integration, Test, & Evaluation $ 120 $ 81 $ 201 
Total* $ 511  $ 409 $ 918 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
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7.5. Cost Comparisons for System Designs 
 
The cost savings for the SpaceWorks Torpor Habitat are primarily driven by eight individual WBS items. The areas 
of greatest impact are provided in Table 22.  
 
Table 22. Torpor Habitat Primary Cost Saving Drivers 
Work Element 
EMC Reference 
Habitat Total Cost*** 
($M, FY2018) 
Torpor Habitat 
Total Cost*** 
($M, FY2018) 
Cost Delta 
Body Structures $ 1,453 $ 888 - 39% 
Natural & Induced Environmental 
Protection  
$ 31 $ 23 - 27% 
Power Systems $ 654 $ 474 - 28% 
Crew/Habitation Support Systems $ 298 $ 212 - 29% 
Launch Support Equipment $ 44 $ 28 - 37% 
System Integration, Test, & Evaluation $ 1,049 $ 749 - 29% 
* Cost differences between sum of elements and total are due to rounding 
** Margin and fee not included 
 
The over dollar-figure difference between the two systems is estimated to be approximately $1.2B, representing an 
approximately 26% cost reduction when using the SpaceWorks Torpor Habitat (4-Crew System) vs. the EMC 
Reference Habitat (4-Crew System). 
 
 
7.6. Alternate Eight-Crew Torpor Habitat System Design 
 
7.6.1. Methodology 
 
The motivation for this design study was create an alternate torpor-enabled habitat design to support a crew of 8 rather 
than a crew of 4 (or 8 via 2 identical habitats). For a crewed surface mission to Mars, a larger crew complement is 
desired compared to precursor Mars-vicinity missions. This design leverages the design elements of the 4-crew torpor-
enabled design, with necessary changes made in habitable volume, subsystems design, and consumables quantity to 
support the increased crew size. In this concept of operations, there will be two crew members on duty at all times, 
with the remainder of the crew being in torpor. It would be possible to alter the 4-crew member schedule such that 
there is still only 1 active crew member at any time, leaving 7 in the torpor state. However, while this would increase 
the overall effectiveness of torpor (higher inactive/active ratio), it would also increase the workload and burden on the 
active crew member. 
 
As with the 4-person concept, the majority of food consumables is provided as liquid enteral nutrition formula. The 
crew is provided with two weeks of solid food for each period of transition into and out of torpor operations, or sixteen 
weeks’ worth in total. The quantity of housekeeping and other habitat consumables is also doubled. 
 
A new habitat layout was conceived provided sufficient habitable and total volume for the increased crew size. 
Subsystems, equipment, and accommodations were repackaged into the new volume. The pressure vessel, structures, 
and MMOD protection masses were recalculated based on the new habitat geometry. 
 
The increased number of crew has a significant impact on the sizing of the ECLSS systems. With larger ECLSS 
systems, the power requirements of the habitat are also increased, thus increasing the mass of the power distribution 
and thermal management systems.  
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7.6.2. Habitat Design 
 
Summary metrics for the SpaceWorks 8-crew torpor-enabled habitat are shown in Table 23, along with comparative 
specifications from the 4-crew torpor habitat design. As anticipated, there is a design efficiency in that doubling the 
crew size does not double the habitat mass. The diameter of the habitat is still below the target limit established for 
incorporation within the smaller 8.4 meter diameter SLS payload fairing. 
 
Table 23. SpaceWorks Torpor-Enabled Habitat 8-Crew vs 4-Crew Summary Metrics 
Metric 8-Crew Design 4-Crew Design 
Empty Mass 19.5 t 12.5 t 
Loaded Mass 42.3 t 25.5 t 
Length 8.75 m 6.50 m 
Diameter 7.25 m 6.00 m 
Habitable Volume 100 m3 50 m3 
Pressurized Volume 360 m3 180 m3 
Power Required 30 kW 15 kW 
 
The SpaceWorks torpor-enabled habitat geometry is shown in Figure 23. The habitat is divided into three levels. The 
upper level houses consumables and spares, as well as crew torpor modules. The middle level serves as the primary 
crew living area and workspace. The lower level houses the hygiene areas and life support subsystems. 
 
Figure 23. Alternate SpaceWorks Torpor Habitat Concept Views (8 Crew) 
 
The mid-level deck is divided into three areas. The first area is the galley, which includes food rehydration and 
warming stations, and a foldable table and chairs for mealtimes. The second area contains crew exercise equipment 
and medical equipment. The third area is the command station with interfaces and displays for the onboard computer 
systems. 
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The lower level contains two hygiene stations, two toilets, and storage for housekeeping supplies. It also contains the 
majority of the habitat life support systems. 
 
The upper level has four torpor modules containing all of the torpor support subsystems, one for each crewmember. 
The torpor modules are surrounded on all sides by ISS-style cargo transfer bags (CTBs) containing all of the life 
support system consumables: 60 days of food and 1100 days of enteral nutrition; 30 days of emergency water, oxygen, 
and lithium hydroxide canisters; and contingency oxygen and nitrogen to re-pressurize the cabin in case of 
depressurization. Equipment spares are also carried in CTBs. 
 
The radiation protection provided by the consumables allows this area to also serve as a storm shelter during SPEs. 
Crew total GCR exposure is significantly reduced because the crew spends the majority of the mission in torpor within 
this protected area. 
 
The three levels are connected by a central hatch. Three of the four docking hatches are located in the middle level 
along the walls. The fourth docking hatch is location in the upper level in the center of the ceiling. 
 
A full mass breakdown statement for the SpaceWorks 8-crew torpor-enabled habitat is shown in Table 24, compared 
against the mass of the 4-crew habitat design. 
 
Table 24. SpaceWorks 8-Crew vs 4-Crew Torpor-Enabled Habitat Mass Breakdown Statement 
Subsystem 8-crew Design (kg) 4-crew Design (kg) 
Structures 6,683 4,101 
Docking & Launch Support 1,258 1,040 
MMOD Protection 760 474 
Power Distribution 1,846 923 
Electronics 526 450 
Thermal Management 2,514 1,459 
Environmental Control 1,798 896 
Crew Habitation & Support 2,586 1,650 
EVA Support 1,134 1,134 
Maintenance & Repair 393 393 
Payload Provisions 0 - 
Empty Mass 19,500 12,522 
Habitat Outfitting 5,867 3,872 
Maintenance, Repair, & Spares 3,416 2,386 
Payloads & Research 0 - 
Habitation Consumables 6,153 3,114 
Food Consumables 7,320 3,660 
Outfitting & Consumables 22,757 13,033 
Total 42,257 25,555 
 
 
 
7.7.  Cost Comparisons for 8-Crew Torpor Habitat System Design 
 
It is worth examining and comparing the cost results of developing a single 8-crew habitat design compared to 
producing two smaller 4-crew habitats. The RDT&E and production costs estimates indicated a total cost of ~$3B 
when using 2 smaller habitats of ~$4B for a single, larger habitat. The smaller habitat designs benefits from a lower 
initial development cost and learning rate improvements for the 2nd habitat. The ECLSS experienced the largest cost 
increase due to the complexity of this system and increased size. Not that while the 2-habitat option benefits on the 
basis of cost, its mass is ~20% larger than the single 8-crew habitat design. This will result in larger propulsion stages 
for the 2-habitat solution that may ultimately offset the initial cost savings that were obtained for the habitats alone. 
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Table 25. SpaceWorks Torpor Habitats Cost Comparison 
Work Element 
2x4-Crew Torpor Habitat  
Total Cost ** 
 ($M, FY2018) 
8-Crew Torpor 
Habitat ** 
Total Cost  
($M, FY2018) 
Cost 
Difference 
Body Structures $ 959 $ 1,328 38% 
Natural & Induced Environmental 
Protection  
$ 24 $ 34 42% 
Power Systems $ 553 $ 659 19% 
Environmental Control Systems $ 394 $ 628 60% 
Crew/Habitation Support Systems $ 238 $ 313 31% 
Launch Support Equipment $ 32 $ 41 28% 
System Integration, Test, & Evaluation $ 831 $ 1,025 23% 
Total* $ 3,031 $ 4,029 $ 998 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included  
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8. Mars Exploration Mission Analysis 
 
8.1. Introduction 
 
As indicated in the previous sections and analysis results, incorporating torpor into the in-space transportation system 
will significantly reduce the mass of the crew habitat and provide both physical and psychological benefits to the crew. 
These benefits directly impact the full Mars Mission architecture by reducing propulsive stage mass and quantity, 
reducing the number of SLS launches required, and by providing health benefits to the crew such as reduced radiation 
damage (potentially) and psychological strain. The following sections outline a series of architecture trades that 
quantify the mission-level improvements enabled by the torpor concept. 
 
 
8.2. NASA EMC Mars Architecture Overview 
 
8.2.1. Overview 
 
During the Phase I Effort, SpaceWorks selected the NASA DRM 5.0 (circa. 2009) mission and architecture as a point 
of departure [1]. Since that time, NASA has invested significant effort into a new series of Mars mission studies 
referred to collectively as the Evolvable Mars Campaign (EMC). This collection of architecture and technology 
studies is intended to guide the agency’s efforts to sustainably extend human presence from Low-Earth Orbit (LEO) 
into deep space. 
 
There are several important distinctions between the various EMC scenarios and the older DRM 5.0 architecture. First, 
the EMC scenarios lay out a campaign of several missions that leverage existing investments to progressively prove-
out systems and reduce the effective overhead for each individual mission. Next, the EMC incorporates proposals 
from private industry to supplement government assets. Finally, the EMC assumes the operation of a 'lunar gateway' 
which will serve as the primary base of operations for aggregation of mission assets, on-orbit assembly, and system 
checkout. To appropriately capture these ambitious capabilities and trade-offs, the authors have selected the EMC's 
"Mars vicinity and Phobos followed by mission to Mars' surface" scenario as the baseline architecture for performing 
architecture-level assessments. Specific architecture details and requirements for this scenario are described in the 
next section. 
 
8.2.2. The “EMC Baseline” Mission Architecture 
 
SpaceWorks selected a specific subset of the various NASA-published EMC studies to use a reference point of 
departure for use in specific architecture performance comparisons. For the purposes of this study, the EMC Baseline 
refers to a campaign that includes a single manned mission to Phobos in 2033, followed by two subsequent missions 
to the surface of Mars in 2039 and 2043. All missions are supported by robotic precursor and supply missions and 
assume the reuse of a single habitat module and several re-used propulsive stages. In this architecture, robotic missions 
use high efficiency Solar Electric Propulsion (SEP) for minimum launch cost while manned missions used advanced 
Methane Cryogenic Propulsive Stages (MCPS) to minimize time of flight and radiation exposure. EMC studies and 
reports from 2016-2017 form the baseline point of departure from which to evaluate the torpor crew transport vehicle. 
References [196] and [197] are the primary sources of all EMC baseline design parameters and reference values. 
 
The EMC Baseline Architecture makes the following assumptions: 
 
• Humans will travel to the Mars System by mid-2030s. 
• The International Space Station (ISS) will operate through at least 2024 – until a regular cadence of Space 
Launch System (SLS)/Orion missions to cis-lunar space is established. The Mars-class life support and 
related habitation systems will be tested first on ISS. 
• The SLS Block 2 launch vehicle will be available (4 x RS-25 engines on Core + Exploration Upper Stage 
(EUS) + Evolved Boosters + 8.4 m or 10 m fairing) for Mars missions. 
• The Orion spacecraft will be available. 
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• The SLS/Orion launch rate of one per year is sustainable in the Proving Ground Phase 1 and will increase to 
one cargo and one crew launch per year in preparation for the Mars mission system validation. 
• In-space propulsion technology will utilize solar electric propulsion systems; augmented with chemical 
systems when necessary to reduce trip times. 
• Mars vehicle checkout and aggregation will be conducted in cis-lunar space to leverage infrastructure 
established during Proving Ground missions in the 2020s. 
• Crew vehicle and transportation systems will be reused for sustainability and potential cost advantages when 
reasonable. 
 
8.2.3. Baseline Concept of Operations 
 
Each of the three missions will have unique profiles and trajectories, but the overall concept of operations for each 
mission, shown for the Phobos mission in Figure 24, remains very similar. The overall in-space crew transportation 
architecture is designed to be the same for each of the three missions in order to reduce risk and development costs. 
 
 
Figure 24. Representative Mars Campaign Mission CONOPS for Phobos Mission 
 
During pre-supply transit, the Crew Transportation Vehicle (CTV) goes through assembly and checkout in a Distant 
Lunar Retrograde Orbit (DLRO) near a future Deep Space Gateway (DSG). Following successful pre-deployment and 
CTV checkout, the crew launches on a dedicated launch vehicle to a lunar-distance, highly elliptical orbit (LDHEO) 
to rendezvous with the CTV. After successful rendezvous, the CTV performs a Trans-Mars Injection (TMI) maneuver 
and departs for Mars. Using chemical propulsion, the total mission time from TMI to Earth Orbit Injection (EOI) is 
approximately 1100 days for each of the three crewed mission opportunities in 2033, 2039 and 2043. This cadence 
allows for alternating crew and pre-supply mission departures. According to reference [197], the total change in 
velocity (ΔV) for each individual mission ranges from 2,800 m/s to 3,400 m/s. 
 
Upon arrival at Mars, the CTV performs a Mars Orbit Injection (MOI) burn to enter a 1-Sol parking orbit at Mars. 
Next, depending on the mission, the crew descends to the surface of either Phobos or Mars to rendezvous with pre-
Advancing Torpor Inducing Transfer Habitat for Human Stasis to Mars  
NIAC Phase II Final Report 
SpaceWorks Enterprises, Inc. (SEI)  
 
59 
deployed assets and being their surface mission phase. Upon completing their mission, the crew returns to the CTV 
and departs for Earth via a Trans-Earth Injection (TMI) burn. Finally, the CTV arrives in Earth's vicinity and performs 
the EOI burn to capture back into LDHEO where astronauts transfer to a reentry vehicle and return home to Earth. 
Both the EOI propulsive stage and the crew habitat return to LDRO for inspection and reuse. 
 
8.2.1. Reference Crew Habitat Design 
 
See Section 7.2.1 for a full description of the crew habitat design for the EMC Baseline architecture. 
 
8.2.2. Reference Crew Transport Propulsive Stage 
 
As detailed in reference [198], the selected EMC architecture assumes a modular crew transit system (CTS) to 
maximize 'reuse of elements and commonly applied technologies'. Each CTS ‘stack’ consists of the crew habitat, two 
propulsive stages, integration structure, and large solar arrays for power generation. Using a modular stack allows for 
the effective payload mass at each propulsive maneuver to minimized, while still enabling reuse of both the habitat 
and some of the propulsive stage elements. 
 
NASA has investigated several different primary propulsion systems under the auspices of the EMC study including 
high-power Solar Electric Propulsion (SEP), Nuclear Thermal Propulsion (NTP), and a Methane Cryogenic 
Propulsion Stage (MCPS). As note previously, a liquid oxygen - liquid methane propulsion is viewed as a key, 
enabling technology because it is compatible with future envisioned in-situ propellant production capabilities, and 
because it can be leveraged for multiple vehicles including the Mars Descent Vehicle (MDV), the Mars Ascent Vehicle 
(MAV), and the CTS. Due to low TRL and the inability to share propulsive elements with both the MDV and MAV, 
the NTP option was not considered for the present study. SpaceWorks ultimately selected the MCPS option for use in 
crew transportation architecture sizing because it enables high-thrust, interplanetary trajectories that significantly 
reduce the in-space travel time and radiation exposure levels for the crew (compared to the low-thrust SEP variant). 
 
The baseline MCPS is a self-contained propulsive stage with independent propellant storage, power generation and 
management, communications, reaction control thrusters, and main propulsion. Figure 25 provides a notional image 
of the MCPS. 
 
 
Figure 25. Notional MCPS Propulsive Stage 
 
The baseline MCPS is designed for modularity and resiliency under several driving requirements. First, the MCPS is 
designed for production in quantity. Sharing the propulsive stage design over multiple missions reduces the total 
number of propulsion system design programs and leads to reduced program cost and risk. To further embrace these 
optimizations, a single, modular engine design is used to power all EMC propulsive stages including the interplanetary 
CTV, the MDV and the MAV. The baseline MCPS is assumed to contain three of these modular engines with a thrust 
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level of 22,500-lbf each. For propellant, this main propulsive system relies on two in-line, aluminum tanks with a 
diameter of 4 meters.   
 
Each MCPS must support independent, and in some cases autonomous operation, to enable remote rendezvous and 
docking maneuvers. As a result, the MCPS is a fully self-contained unit with power, thermal, communications, and 
attitude control systems. The baseline point of departure design for the MCPS requires 4.4kW at peak load and draws 
this power from a pair of deployed ATK Ultraflex solar arrays. Each array has a diameter of 4.4 meters and a mass of 
46.8 kg. General thermal control is accomplished using an ammonia coolant loop with deployable radiators.  
Cryogenic propellant thermal management is accomplished by a single 90k reverse turbo-Brayton cryocooler. The 
reference mass of the MCPS is 45,320-kg [197] . 
 
 
8.3. Parametric Mission Design Approach 
 
To ensure appropriate comparisons, SpaceWorks sized each baseline mission and torpor analog using the same 
assumptions, constraints, and system closure model. As detailed in Section 6.1, all domain-level analysis tools were 
integrated into the IDF to enable rapid design optimizations and trade studies.  SpaceWorks used the IDF to evaluate 
hundreds of thousands of design variants for each mission type. This optimization was accomplished by using the IDF 
to run a full-factorial design of experiments with the parameters given in Table 26. Note that the values chosen for 
this effort (and variables of interest) could easily be further expanded - at the expense of increased analysis time. 
Additionally, the time of flight and propulsive ΔV estimates that were generated for each architecture is held constant 
across all variants for the full factorial assessment. 
 
Table 26. Phobos Mission DOE Parameters 
Parameter Values Units 
Outbound Stage Count 1, 2, 3 # 
Return Stage Count 1, 2, 3 # 
Engine Design Thrust 20.0, 22,5, 25.0 Klbf 
MCPS Stage Diameter 9.0, 10.0, 11.0, 12.0, or 13.0 feet 
Outbound Stage #1 Engine Count 1, 2, 3, or 4 # 
Outbound Stage #2 Engine Count 1, 2, 3, or 4 # 
Return Stage #1 Engine Count 1, 2, 3, or 4 # 
Return Stage #2 Engine Count 1, 2, 3, or 4 # 
 
This design space exploration process was used to determine a minimum mass architecture designs for each of the 
study cases, subject to launch mass and initial thrust-to-weight constraints. Figure 26 captures the results of this 
process by plotting the total mass of the return CTS stack versus the total mass of the outbound CTS stack. Design 
points generally segmented themselves into groups for each combination of outbound and return stage count. Results 
for lower stage counts (i.e. 1 out, 1 return) coalesced in the bottom left while higher stage counts (i.e. 3 out, 3 return) 
were represented in the upper right corner. The total mission mass color scale and primary metric of interest for each 
variant is the sum of the respective crew habitat, outbound propulsive stages, and return propulsive stages.  
 
Two primary constraints impacted the number of feasible cases considerably. First, the total launch mass of an 
individual stage is limited to 45 metric tons to ensure that it can be launched to DLRO by an SLS Block 2 vehicle. 
Second, the initial thrust-to-weight for each propulsive stack is required to be at least 0.3 to maintain the ‘near 
instantaneous ΔV assumption’ required for the trajectory model. For cases were the specified constraints are not met 
or violated, the architecture becomes denoted in gray. Note that while these values represent the nominal constraints, 
alternative relaxed constraints are discussed in later sections.  
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Figure 26. Mission Mass Results using NASA EMC Habitat for 4-Crew Mission to Phobos (40,000 Cases) 
 
In all evaluated cases, the minimum total mass case corresponded to the case with the fewest total number of propulsive 
stages, engines, and the lowest total thrust that still met all constraints. 
 
 
8.4. Mars Phobos-Deimos Missions with Torpor and 4-Crew Members 
 
8.4.1. Re-Optimized Reference Mission Design 
 
Campaign Mission #1 of the EMC Baseline is a manned expedition to Mars’ orbit and the surface of Phobos with four 
crew members. The reference mission departs for Mars in 2033 and returns in 2035 with an outbound time of flight 
of 230 days and a return time of flight of 198 days. 
 
To ensure a consistent comparison, SpaceWorks re-sized the reference mission to minimize the total mission mass 
and the total number of propulsive stages. First, SpaceWorks re-optimized the outbound and return trajectories to 
minimize mission total C3. These trajectories assume a total of four, approximately 300-second duration burns with 
one each at TMI, MOI, TEI, and EOI. The parking orbits at Earth and Mars are described in Table 27. In the reference 
mission, the crew departs from High-Earth Orbit (HEO), travels to a ‘1-sol parking orbit’ at Mars, then returns to 
HEO.  Specific periapsis and apoapsis altitudes are derived from the NASA DRM 5.0 report. 
 
Table 27. Assumed Terminal Orbits for Transfers Between Earth and Mars 
Orbit Periapsis Altitude (km) Apoapsis Altitude (km) 
HEO 400.0 326,400 
Mars 1-Sol 250.0 33,793 
 
The trajectories were optimized via a full-factorial search for all dates in the year 2033 and for time of flights ranging 
from 150 to 275 days.  The new optimized trajectories for the 2033 opportunity are described in Table 28.   
 
 
High Mass 
Low Mass 
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Table 28. Minimum C3 Trajectories for 2033 Mission to Mars Orbit 
Parameter Outbound Trajectory Return Trajectory 
Departure Date 4/16/2033 5/6/2035 
Arrival Date 11/2/2033 11/22/2035 
ΔV1 (km/s) 0.53 1.06 
ΔV2 (km/s) 1.25 0.53 
Time of Flight (days) 200  200  
Total C3 (km2/s2) 20.078  17.947 
 
 
Using these new optimal trajectories, SpaceWorks used the IDF in concert with the design space exploration process 
described in Section 8.3 to establish a new ‘Reference Optimized’ architecture. The new propulsive stage designs are 
described in Table 29. This architecture analysis, conducted using SpaceWorks methods and analysis tools, will 
provide a fairer point of comparison when weighing against torpor-enabled architectures. Note that the search yielded 
a solution with one fewer propulsive stage by sizing the return propulsive stage to accomplish both the TEI and EOI 
burns. The re-optimized EMC mission for a crew of four departing in 2033 has a total crew transportation mass of 
145.7t. All stages utilize a combination of common LOX/CH4 engines, each with a vacuum thrust of 20,000-lbf. 
 
Table 29. Mass-Optimized EMC Baseline Mission with 4-Crew Departing in 2033 
Parameter Outbound Trajectory Return Trajectory 
Propulsive State Burns MOI TMI TEI-EOI 
Inert Mass (t) 7.13 7.27 8.44 
Usable Propellants (t) 24.16 18.01 35.41 
Payload(s) (t) 45.27 MOI Stage 43.72 
Gross Weight (t) 76.57 101.85 87.57 
Stage Length (feet) 33.4 29.7 40.4 
Stage Diameter (feet) 10.0 10.0 10.0 
Number Engines 3 4 3 
Engine Vacuum Thrust, each (Klbf) 20 20 20 
 
 
8.4.2. SpaceWorks Torpor-Enabled Mission Design 
 
For the same trajectories and mission duration, replacing the EMC Reference habitat with the SpaceWorks Torpor 
habitat leads to a 62.3-ton (42.7%) mass reduction for the crew transportation system. This mass reduction is achieved 
by using a less massive habitat (25.5t vs. 45.5t), reducing crew consumables and total propellant loads. These impacts 
enable a vehicle design that can meet all design constraints while utilizing one less propulsive stage. Figure 27 shows 
the allocation and magnitude of mass reductions for the major components. Note that the outbound stage #2 (or 
‘OutStg2’) mass reduction, along with the outbound stage #1 (or ‘OutStg1’) mass increase are the result of dropping 
the second, outbound propulsive stage in favor of a single larger stage. 
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Figure 27. Impact of Torpor on Overall Mission Mass to Phobos Relative to Optimized NASA EMC Baseline 
 
 
Optimal propulsive staging for the Phobos mission using the SpaceWorks Torpor habitat is given in Table 30. Note 
that the mass savings derived from the SpaceWorks Torpor habitat led to a reduction in the total number of propulsive 
stages by combing the MOI and TMI burns into in a single stage.  
 
Table 30. Mass-Optimized SpaceWorks Torpor Mission Departing in 2033 (4 Crew Members) 
Parameter Outbound Trajectory Return Trajectory 
Propulsive Stage Burns MOI-TMI TEI-EOI 
Inert Mass (t) 6.73 6.26 
Usable Propellants (t) 26.95 23.12 
Payload(s) (t) 28.22 27.79 
Gross Weight (t) 61.90 57.18 
Stage Length (feet) 38.2 35.3 
Stage Diameter (feet) 9 9 
Number Engines 2 2 
Engine Vacuum Thrust, each (Klbf) 20 20 
 
 
SpaceWorks Torpor-enabled mission architectures can offer significant crew health improvements and over a 40% 
reduction to 83.4t in the total mass of the crew system. In addition, the total number of LOX/CH4 engines to be 
produced drops from 10 to 4, and the total number of SLS launches required drops from 7 to 5. The effects of these 
changes on campaign cost are detailed in Section 9. 
 
 
8.5. Mars Surface Landing Missions with Torpor and 8-Crew Members 
 
8.5.1. Study Motivation 
 
NASA’s Evolvable Mars Campaign (EMC) studies emphasize the efficiency and achievements that can be made by 
developing a series of missions that feature “incremental investments in capabilities to enable a cadence of 
incrementally more complex missions” [2,196,196,197]. Pursuant to this goal, SpaceWorks has investigated a follow-
on to the 2033 Phobos mission that features 8 crew members to showcase the mission-enabling mass savings 
achievable with a torpor-enabled crew system. Other than the number of crew, this mission follows the same NASA 
EMC assumptions and ground rules laid out in Section 8.2. Robotic pre-supply missions depart for Mars in 2035 and 
2037. Following successful pre-supply checkout, the crew embarks on a Conjunction-class mission in 2039. After an 
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extended stay on the surface of Mars, the crew returns to Earth in 2041. SpaceWorks generated a minimum 
characteristic energy trajectory using the Bullseye trajectory tool assuming four ~300-second propulsive burns with 
the destination orbits and burn locations the same as the 2033 mission. Parameters for the optimal trajectory are 
presented in Table 31. 
 
Table 31. Minimum C3 Trajectories for 2039 Mission to Mars 
Parameter Outbound Trajectory Return Trajectory 
Departure Date 10/08/2039 08/13/2041 
Arrival Date 06/09/2040 05/15/2042 
ΔV1 (km/s) 1.05 1.08  
ΔV2 (km/s) 1.00 0.59 
Time of Flight (days) 245  275  
Total C3 (km2/s2) 48.731  17.947 
 
 
The Martian surface stay time is 430 days and the total mission time from Earth-orbit departure to Earth-orbit return 
is 950 days. Although the in-space transportation time is longer for this mission than the 2033 mission, the total 
expected mission duration is the same. With these new trajectories as inputs, SpaceWorks used the IDF to explore 
alternative architecture designs via a full-factorial DOE with the independent variables described in Table 26. 
 
8.5.2. NASA EMC Baseline with 8 Crew 
 
To size a reference 8 crew mission with the baseline NASA EMC stages, SpaceWorks developed a CTS model that 
houses 8 crew members by stacking two independent EMC Baseline habitats. All 4-crew missions outlined in Section 
8.4 can be completed with four or less propulsive stages while still meeting the mass and thrust-to-weight constraints 
of 45 tons and 0.3 respectively. For the 8-crew mission however, the total crew habitat mass increased by a sufficient 
amount that it was no longer possible to use a single propulsive stage for each ΔV burn while still meeting these 
constraints. As a result, the IDF full-factorial search also included variants where either the first or second burn was 
split between two stages. After performing the full-factorial search with up to three propulsive stages in either 
direction, however, there were still no variants of the propulsion stage architecture that could transport eight crew 
members to Mars using the EMC baseline habitats. 
 
To find feasible designs, the constraints on the EMC Baseline case’s propulsive stages would have to be relaxed to a 
maximum 50-ton launch mass and an initial thrust-to-weight minimum of 0.24. Even with these relaxed constraints, 
Figure 28 shows that only a small set of cases, all with three stages in either direction, are feasible. As before, 
architecture scenarios that could not meet the constraints are identified in grey. 
 
The minimum mass EMC Baseline variant with 8 crew has a total CTS mass of 332 tons. This design requires 9 total 
propulsive stages (3 out and 3 return) and 24 engines to support both outbound and return transits. Table 32 provides 
the propulsive stage details. 
 
It should be mentioned that it would be possible to simply send two completely independent crew “trains”, each with 
a single habitat sized for a crew of four. Based on the preceding results, this would yield a value of 291.4 t for our 
primary metric of ‘total mission mass’. Notably there are both performance (e.g. safety, reliability, redundancy, etc.) 
and non-performance factors (e.g. crew interaction, complexity, emergency options, etc.) worth considering for 
placing the 8 crew members together during the mission. Assuming a feasible architecture design can be obtained in 
either case, it is not immediately obvious which approach is better. However, this examination was beyond the scope 
of this effort. 
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Figure 28. Results for 8-Crew Mission to Phobos using EMC Reference Habitat 
 
Table 32. Propulsive Stage Sizing for Minimum Mass, 8-Crew EMC Baseline Mission 
 Outbound Return 
Propulsive Burn MOI TMI-2 TMI-1 EOI TEI-2 TEI-1 
Percent of Burn 100% 50% 50% 100% 50% 50% 
Inert Mass (t) 10.36 10.42 12.52 8.37 9.36 11.26 
Usable Propellants (t) 37.09 28.25 35.91 23.06 23.30 29.52 
Payload(s) (t) 92.58 140.03 178.70 88.73 120.16 152.83 
Gross Weight (t) 140.03 178.70 227.14 120.16 152.83 193.61 
Stage Length (feet) 34.8 32.7 34.5 31.9 31.9 32.9 
Stage Diameter (feet) 13.0 13.0 13.0 13.0 13.0 13.0 
Number Engines 3 4 5 3 4 5 
Engine Vacuum Thrust, 
each (Klbf) 25 25 25 25 25 25 
 
 
8.5.3. SpaceWorks Torpor Architecture with 8 Crew 
 
SpaceWorks also examined a torpor-enabled, 8-crew mission to Mars that supports 8 crew by stacking two 
independent SpaceWorks Torpor habitats together, as detailed in Section 7.4. The IDF was used to run a full factorial 
design sweep with the original constraints on maximum launch weight (45t) and minimum thrust-to-weight (0.3) 
applied. Unlike the EMC baseline, the SpaceWorks Torpor architecture can still meet these original constraints when 
sized for a crew of 8. The results of this design space sweep with the original constraints are shown in Figure 29. 
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Figure 29. Results of Torpor for 8-Crew Mission to Phobos with Original Constraints 
 
When the relaxed constraints on maximum launch weight (50t) and minimum thrust-to-weight (0.24) are applied, the 
SpaceWorks Torpor mission architecture makes it possible to send 8 crew with only two propulsive stages in either 
direction. The feasible cases under the relaxed constraints are shown in Figure 30. 
 
 
 
Figure 30. Results for Torpor 8-Crew Mission to Phobos with Relaxed Constraints 
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Under the relaxed constraints, the optimal architecture requires a total of four propulsive stages, 14 LOX/CH4 engines, 
and has a total mass of 187.4 metric tons. See Table 33 for propulsive stage mass details. 
 
Table 33. Propulsion Stage Sizing for Minimum Mass, 8-Crew SpaceWorks Torpor Architecture 
 Outbound Return 
Propulsive Stage Burns MOI TMI EOI TEI 
Inert Mass (t) 7.22 9.97 6.05 9.06 
Usable Propellants (t) 21.40 37.18 13.44 30.93 
Payload(s) (t) 52.17 80.79 50.53 70.01 
Gross Weight (t) 80.79 127.93 70.01 109.99 
Stage Length (feet) 30.6 38.4 28.4 35.2 
Stage Diameter (feet) 11.0 11.0 11.0 11.0 
Number Engines 3 4 3 4 
Engine Vacuum Thrust, each (Klbf) 22.5 22.5 22.5 22.5 
 
For the same trajectories and mission duration, the SpaceWorks Torpor habitat leads to a 144.6-ton (43.6%) mass 
reduction for the crew transit system. This mass reduction is achieved due to the less massive habitat that ultimately 
enables elimination of two entire propulsive stages. Figure 31 shows the allocation and magnitude of mass reductions 
for major components. Note that both the Outbound Stage #3 and Return Stage #3 mass savings are realized by 
eliminating those stages from the vehicle. 
 
 
Figure 31. Impact of Torpor on Mission Mass 
 
 
8.5.4. SpaceWorks Torpor-enabled Mission with 8-Crew Habitat 
 
Further mass reductions can be realized by combining the two 4-crew SpaceWorks Torpor habitats into a single 8-
crew habitat. This approach greatly increases the packing efficiency of the habitat and reduces the mass of the habitat 
by nearly 9 tons, as detailed in Section 7.6. SpaceWorks again characterized the design space for this variant by 
running a full-factorial search with the IDF. This search showed that even under the original propulsive stage 
constraints on max launch weight (45t) and minimum thrust-to-weight (0.3), a unified, 8-crew habitat further reduces 
the total CTS mass to 151.82 tons; a reduction of over 35 tons (18.9%). Furthermore, the 8-crew habitat enables a 
mission architecture that requires one fewer propulsive stage than the SpaceWorks Torpor mission with 2x4-crew 
habitats, and 3 fewer propulsive stages than the EMC Baseline case. Propulsive Stage details for the torpor-enabled 
architecture with an 8-crew habitat are given in Table 34. 
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Table 34. Propulsive Stage Sizing Results for Minimum Mass, Single 8-Crew SpaceWorks Torpor Habitat 
Architecture 
Parameter Outbound Trajectory Return Trajectory 
Propulsive State Burns MOI TMI TEI-EOI 
Inert Mass (t) 6.15 8.54 8.74 
Usable Propellants (t) 17.82 31.06 36.20 
Payload(s) (t) 43.31 67.28 41.67 
Gross Weight (t) 67.28 106.89 86.80 
Stage Length (feet) 29.5 37.7 40.9 
Stage Diameter (feet) 10.0 10.0 10.0 
Number Engines 2 3 3 
Engine Vacuum Thrust, each (Klbf) 25 25 25 
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9. Mars Architecture Campaign Cost 
 
A human Mars campaign is often estimated to cost in the hundreds of billions of dollars, with the least expensive 
options still ranging in the tens of billions of dollars. Despite recent increases in NASA’s human exploration budget, 
minimizing overall mission architecture costs are critical. Assessing the affordability of a torpor-enabled architecture 
is critical in validating that this technology could be successfully integrated into the agency’s Evolvable Mars 
Campaign (EMC). To determine the economic impacts of a torpor-enable design, the non-recurring (NRE) 
development and recurring production costs were estimated for the EMC Baseline architecture, as well as for torpor-
crewed mission architectures.  
 
When evaluating Mars architecture campaign costs, definitions surrounding what elements should be included vary 
widely. Architecture studies may cover everything from SLS/Orion, to the Lunar-orbiting Gateway, to astronaut deep 
space habitat training. For the purposes of this analysis, SpaceWorks focused on a specific subset of activities within 
the overall EMC for comparison and that are of most relevance when assessing the impact of torpor enabled systems. 
An exact description of what elements are and are not included in this analysis is shown below in Table 35 
 
Table 35. Mars Architecture Campaign Cost Analysis Scope 
Work Element Element Included Launch Included 
ISS Utilization - - 
Commercial Crew - - 
Commercial Cargo  - - 
SLS/Orion/Crew Rendezvous  - - 
Lunar Orbiting Gateway  - - 
Crew Training  - - 
Crew Transportation  - O 
Crew Supplies - O 
Deep Space Habitat  O O 
In-space Propulsive Stages  O O 
Habitat/Propulsive Stage Assembly O - 
Spacecraft/Habitat Operations O - 
Mars Surface Habitat  - - 
Mars Surface Operations  - - 
 
The above included activities have been roughly categorized as the “in-space transportation” phase of the campaign. 
This phase nominally begins at the assembly of the crew habitats with the propulsive stages, includes the duration of 
the astronaut phase leading up to the departure of the crew for the Martian (or Martian moon) surface, and the entirety 
of the return journey, ending at the rendezvous point in lunar orbit. Additionally, included is the “dormant habitat” 
operations while the crew is on the surface. The overall Mars architecture cost analysis considered a three-part 
exploration campaign consisting of a 4-person mission to Phobos/Deimos, and two 8-person missions to the Martian 
surface. This analysis considered a nominal surface stay duration for each mission of approximately 400 days.  
 
A combination of parametric cost tools results, publicly available cost estimates, and internal cost sources were used 
to produce the crew mission architecture estimates. The estimates assume the program is conducted as a customary 
government acquisition program via contracting to a traditional aerospace prime contractor. All system technologies 
are or were assumed to be at technology readiness level (TRL) 6 or greater, thus technology maturation costs for 
anything below TRL 6 were not included in the cost results. Industry standard programmatic wraps reflective of a 
standard government program were applied to base costs, as necessary.  
 
Based on traditional cost estimating definitions, the crewed mission architecture design, development, test and 
evaluation (DDT&E) costs include the development, testing, and integration of each of the relevant subsystems for all 
architecture elements, and the effort to integrate the subsystems together for each element. The production costs 
include the acquisition, manufacturing, and integration of all subsystems, as well as system level integration. Modest 
learning curves were applied when calculating the total production costs of multiple identical elements. For the 
purposes of the architecture-level cost analysis, a 10% vendor fee was applied to the habitat and propulsive stages, as 
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well as a 20% margin was applied to all cost centers. A detailed description of all cost tools and methodologies used 
for this effort can be found in Section 6.2 Cost Modeling.  
 
 
9.1. NASA Reference EMC Baseline Architecture Cost 
 
SpaceWorks’ independent cost assessment for an approximately 10-year, multi-mission Mars campaign using the 
NASA EMC Baseline architecture indicates an in-space transportation cost of approximately $41B, broken out across 
four categories: Launch, Habitat, Propulsive Stage, and Operations. 
Figure 32. NASA EMC Baseline Architecture Cost Breakdown (FY2018) 
 
9.1.1. NASA EMC Baseline Architecture Launch Cost 
 
SpaceWorks assumed an SLS per-launch cost of $500M for this analysis, with a total of 21 launches being required 
across all three missions. This results in the launch costs being the second most significant cost driver for the in-space 
transportation phase, encompassing nearly $13B (~31%) of the entire architecture-level cost. A breakdown of launches 
can be found below in Table 36. 
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Table 36. NASA EMC Baseline Architecture Required Heavy Lift Launches 
Mission Cargo/Propulsive Stage Launches Habitat Launches Crew Launches Total 
Phobos/Deimos Mission 4 1 1 6 
Mars Surface Mission #1 6 1 1 8 
Mars Surface Mission #2 6 0* 1 7 
Total 16 2 3 21 
* Prior mission habitats are recovered to DLRO and reused 
 
 
9.1.2. NASA EMC Baseline Architecture Habitat Cost 
 
While the crew habitat is the single most expensive hardware element, it is the smallest cost driver for the in-space 
transportation phase due to the lower quantity. It is also an important driver of other individual cost centers. Based on 
the independent cost assessment for the NASA EMC Baseline Habitat design (see Section 7.2), habitat costs at the 
architecture level (including margin) are estimated to be approximately $7B (17%). This estimate includes Research, 
Development, Testing, & Evaluation (RDT&E), as well as production costs for two NASA EMC Baseline Habitats 
(4-Crew System). In this configuration, SpaceWorks assumed that the initial habitat produced for the Phobos/Deimos 
mission would be re-used for the subsequent missions and that only one additional habitat would need to be produced 
for the two Mars surface missions. Table 37 details the architecture-level breakdown of habitat costs for the NASA 
EMC Baseline architecture. 
 
Table 37. NASA EMC Baseline Architecture Habitat Costs 
Work Element RDT&E Cost** ($M, FY2018) 
First Production Unit 
($M, FY2018) 
Second Unit 
($M, FY2018) 
Total*** 
($M, FY2018) 
Habitat $ 4,004 $ 664 $541 $ 5,209 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
 
 
9.1.3. NASA EMC Baseline Architecture Propulsive Stage Cost 
 
Propulsive stage costs for the NASA EMC Baseline are estimated to be approximately $9B (21%) at the architecture 
level (including margin). This estimate includes Research, Development, Testing & Evaluation (RDT&E), as well as 
production costs for each propulsive stage. Based on inputs from the engineer design team, each propulsive stage was 
assumed to be different enough that it would require its own development effort, which drive the Propulsive Stage 
costs up significantly. For each of the propulsive stages used for the Phobos/Deimos mission, a production quantity 
of one was used, while propulsive stages for the Mars surface missions used a quantity of two (to reflect two missions) 
– it was assumed these stages would not be produced in batches, and thus learning curve effects consummate with 
industry standard rates were used. The final Return Stage (Return Stage #3) is the exception to this rule, as it was 
assumed this stage could be reused for the second mission after returning to Earth, and a production quantity of one 
was used.  
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Table 38. NASA EMC Baseline Architecture Propulsive Stage Costs 
Work Element RDT&E Cost ($M, FY2018) 
Production Cost 
($M, FY2018) 
Total*** 
($M, FY2018) 
Phobos/Deimos Outbound Stage #1 $ 574 $ 66 $ 640 
Phobos/Deimos Outbound Stage #2 $ 463 $ 59 $ 522 
Phobos/Deimos Return Stage #1 $ 485 $ 61 $ 545 
Mars Surface Outbound Stage #1 $ 789 $ 160 $ 1,042 
Mars Surface Outbound Stage #2 $ 597 $ 138 $ 788 
Mars Surface Outbound Stage #3 $ 572 $ 125 $ 756 
Mars Surface Return Stage #1 $ 626 $ 151 $ 826 
Mars Surface Return Stage #2 $ 561 $ 133 $ 741 
Mars Surface Return Stage #3 $ 521 $ 66 $ 688 
Total* $ 5,188  $ 959  $ 6,547  
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
 
 
9.1.4. NASA EMC Baseline Architecture Operations Cost 
 
Mission operations costs for the NASA EMC Baseline architecture are the largest cost driver for the overall 
architecture and are estimated to be nearly $13B (including margin) over the entire campaign. This estimate is based 
on the cost of spacecraft operations, scientific payload operations, and human exploration-related operations over the 
10-year campaign. As outlined in Section 6.2.3, operations costs were estimated using the MOCET tool produced by 
the Aerospace Corporation and augmented with analogous figures from NASA 2013 ISS operations budget. 
SpaceWorks recognizes this cost approach leaves room for improvement, but believe it provides a reasonable baseline 
for exploring the tradeoffs between the EMC Baseline and SpaceWorks Torpor architectures at the present design-
fidelity.  
 
Table 39. NASA EMC Baseline Architecture Operations Costs 
Work Element Total Cost ($M, FY2018) *** 
Phobos/Deimos Operations $ 3,659  
Mars Surface Mission #1 Operations $ 4,614  
Mars Surface Mission #2 Operations $ 4,614  
Total $ 10,739 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
 
 
9.2. SpaceWorks Torpor Baseline Architecture Cost 
 
A similar cost assessment was conducted for the minimum-mass SpaceWorks Torpor architecture identified in Table 
30 and Table 33. The results indicate an in-space transportation cost of approximately $26B, broken out across four 
categories as: Launch, Habitat, Propulsive Stage, and Operations. Figure 35 provides the relative cost contributions 
for each of these categories. 
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Figure 33. SpaceWorks Torpor-Optimized Architecture Cost Breakdown (FY2018) 
 
9.2.1. SpaceWorks Torpor Architecture Launch Cost 
 
Launch is the second most significant cost driver for the in-space transportation phase, encompassing $9B (~29%) of 
the entire architecture-level cost. SpaceWorks assumed an SLS per-launch cost of $500M for this analysis, with a total 
of 15 launches being required across all three missions. A breakdown of launches can be found below in Table 40. 
Relative to the optimized, non-torpor NASA EMC campaign requiring 21 launches, a net savings of $3B is already 
achieved using torpor. 
 
Table 40. SpaceWorks Torpor Architecture Required Heavy Lift Launches 
Mission Cargo/Propulsive Stage Launches 
Habitat 
Launches 
Crew 
Launches Total 
Phobos/Deimos Mission 2 1 1 4 
Mars Surface Mission #1 4 1 1 6 
Mars Surface Mission #2 4 0 1 5 
Total 10 2 3 15 
 
 
9.2.2. SpaceWorks Torpor Architecture Habitat Cost 
 
The habitat is the smallest cost driver for the in-space transportation phase but is an important driver of the other 
individual cost centers. Based on the cost assessment for the SpaceWorks Torpor Habitat design (see Section 0), 
habitat costs at the architecture level are estimated to be approximately $5B (17%). This estimate includes Research, 
Development, Testing, & Evaluation (RDT&E), as well as production costs for two SpaceWorks Torpor Habitats (4-
Crew System). In this configuration, SpaceWorks assumed that the initial habitat produced for the Phobos/Deimos 
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mission would be re-used for the subsequent missions and that only one additional habitat would need to be produced 
for the two Mars surface missions. Table 41 details the architecture-level breakdown of habitat costs for the NASA 
EMC Baseline architecture. 
 
Table 41. SpaceWorks Torpor Architecture Habitat Costs 
Work Element RDT&E Cost  ($M, FY2018) 
First Production Unit 
($M, FY2018) 
Second Unit 
($M, FY2018) 
Total*** 
($M, FY2018) 
Habitat $ 2,965 $ 511 $ 409 $ 3,885 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
 
 
9.2.3. SpaceWorks Torpor Architecture Propulsive Stage Cost 
 
Propulsive stage costs for the SpaceWorks Torpor architecture are estimated to be approximately $5B (16%) at the 
architecture level (including margin). This estimate includes Research, Development, Testing & Evaluation 
(RDT&E), as well as production costs for each propulsive stage. Based on inputs from the engineer design team, each 
propulsive stage was assumed to be different enough that it would require its own development effort, which drive the 
Propulsive Stage costs up significantly. For each of the propulsive stages used for the Phobos/Deimos mission, a 
production quantity of one was used, while propulsive stages for the Mars surface missions used a quantity of two (to 
reflect two missions) – it was assumed these stages would not be produced in batches, and thus learning curve effects 
consummate with industry standard rates were used. The final Return Stage (Return Stage #2) is the exception to this 
rule, as it was assumed this stage could be reused for the second mission after returning to Earth, and a production 
quantity of one was used.  
 
 
Table 42. SpaceWorks Torpor Architecture Propulsive Stage Costs 
Work Element RDT&E Cost ($M, FY2018) 
Production Cost 
($M, FY2018) 
Total*** 
($M, FY2018) 
Phobos/Deimos Out Stage 1 $ 485 $ 53 $ 538 
Phobos/Deimos Return Stage 1 $ 409 $ 128 $ 537 
Mars Surface Out Stage 1 $ 583 $ 128 $ 711 
Mars Surface Out Stage 2 $ 468 $ 108 $ 576 
Mars Surface Return Stage 1 $ 517 $ 122 $ 638 
Mars Surface Return Stage 2 $ 433 $ 58 $ 491 
Total* $ 2,894 $ 596 $ 3,490 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
 
 
9.2.4. SpaceWorks Torpor Architecture Operations Cost 
 
Mission operations costs for the NASA EMC Baseline architecture are the second largest cost driver for the overall 
architecture and are estimated to be nearly $12B (39%) over the entire campaign (including margin). This estimate is 
based on the cost of spacecraft operations, scientific payload operations, and human exploration-related operations. 
As outlined in Section 6.2.3, operations costs were estimated using the MOCET tool produced by the Aerospace 
Corporation and augmented with analogous figures from NASA 2013 ISS operations budget. This analysis did not 
specifically account for any inflation or deflation factors to account for differences in operations management for a 
crew under the impact of torpor, as there is no current basis for quantifying these impacts. Cost differences were based 
on already established CERs set out in the MOCET tool. Further exploration into the operations impact of torpor could 
yield substantial changes in the operations cost modeling of the SpaceWorks Torpor architecture operations costs. 
SpaceWorks recognizes this costing approach leaves room for improvement, but believes it provides a reasonable 
baseline for exploring the tradeoffs between the architectures at the present design-fidelity.  
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Table 43. SpaceWorks Torpor Architecture Operations Costs 
Work Element Total Cost ($M, FY2018)*** 
Phobos/Deimos Operations $ 2,780 
Mars Surface Mission #1 Operations $ 3,552 
Mars Surface Mission #2 Operations $ 3,552 
Total $ 9,884 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee not included 
 
 
9.3. SpaceWorks Torpor vs. NASA EMC Baseline Architecture Cost Comparison 
 
The SpaceWorks Torpor architecture demonstrates a significantly lower cost than the NASA EMC Baseline 
architecture, yielding a total savings in excess of $10B. Cost savings of the torpor-enabled campaign were driven 
heavily by a lower overall habitat size, which in turn significantly reduced the number of required launches and 
propulsive stages. Operations costs were less impacted by the reduced habitat size; however, the mission operations 
impact of torpor have not yet been fully explored and future potential savings may be unveiled as additional research 
progresses. 
 
This analysis suggests that the SpaceWorks Torpor architecture is not only cost competitive with the NASA EMC 
Baseline architecture, but actually significantly cheaper. Overall, the SpaceWorks Torpor-enabled architecture is 
estimated to reduce the in-space transportation phase of an EMC architecture by approximately 24%.  
 
Table 44. SpaceWorks Torpor Architecture Costs vs. EMC Baseline Architecture Costs 
Work Element 
EMC Baseline Architecture 
Cost 
($M, FY2018)*** 
SpaceWorks Torpor Architecture 
Cost 
($M, FY2018)*** 
Cost Delta 
Launch $ 12,600  $ 9,000  29% 
Habitat $ 6,863  $ 5,126  25% 
Propulsive Stages $ 8,114  $ 4,607 43% 
Operations $ 12,886  $ 11,860  8% 
Total $ 40,462  $ 30,593  24% 
* Cost differences between sum of elements and total are due to rounding, ** Margin and fee included 
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10. Exploration Missions Beyond Mars 
 
10.1. Introduction 
 
To further examine the potential of torpor, SpaceWorks performed the systems analysis for a future human mission 
beyond Mars to the main asteroid belt, with a goal of visiting Ceres. From a brief literature search and review, there 
were very few published architecture designs for human missions to Ceres. However, Ceres is one of the more 
interesting and compelling destinations beyond Mars orbit. 
 
As it is highly unlikely that a mission to Ceres would occur prior to any human mission to Mars, mission opportunities 
were evaluated in 2040+ timeframe and nominal scenario selected. A crew complement of three (3) was assumed to 
be the minimum number acceptable that would not compromise any science goals and/or safety of the crew.  
 
 
10.2. Destination: Ceres 
 
Ceres is the largest object in the asteroid belt, comprising approximately 1/3 of the total mass of all asteroid belt 
objects. Due to its synodic period with the Earth of 1.28 years compared to 2.14 years for Mars, mission opportunities 
are much more frequent. However, the required mission propulsive DVs are much more demanding relative to Mars. 
Table 45 provides some orbital parameters and features for Ceres. 
 
Table 45. Specifications for Asteroid Belt Object Ceres 
Parameter Value 
Distance from Sun 2.55 – 2.98 AU 
Orbital Period 4.6 years 
Mean Radius 474 km 
Orbital Inclination (ecliptic) 10.6 degrees 
Escape Velocity 0.51 km/s 
Surface Gravity 0.03 Gs 
 
 
Figure 34 provides the envision CONOPS for the Ceres mission. An initial pre-deployment of various assets to vicinity 
and surface of Ceres is assumed.  A short-stay surface habitat, exploration vehicle, and return propulsive stages are 
all sent in advance of the crew. The current architecture is also predicated and enabled with ISRU to produce hydrogen 
from frozen, subsurface ice at Ceres and provide the return fuel for the NTR stages. 
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Figure 34. CONOPS for Human Mission to Ceres 
 
 
10.3. Architecture Analysis 
  
To establish the mission propulsive requirements, Bullseye was used for the in-space trajectory analysis. It was 
decided that the transit time should be constrained to be less than 300 days, with a minimum surface stay time of at 
least 60 days. The optimal DVs for this scenario is shown in Table 46, along with the corresponding crew time of 
flight in Table 47. Note that some small DV savings could be achieved with longer transit times and/or shorter surface 
stay times. 
Table 46. Propulsive DV Requirements for Ceres Mission 
Propulsive Maneuver Delta-V (km/s) 
Trans-Ceres Insertion (from LDRO) 3.7 
Ceres Rendezvous Insertion 7.2 
Trans-Earth/Lunar Insertion 10.2 
DLRO Insertion 3.2 
Total Mission DV 24.3 
 
Table 47. Crew Time of Flight for Ceres Mission 
Mission Phase Time of Flight (days) 
Outbound (from DLRO) 300 
Ceres Vicinity 60 
Return (to DLRO) 300 
Total Crew Mission Duration 660 
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Due to significant reduction in solar flux as the crew moves beyond Mars coupled with the demanding mission DVs 
required, it was decided that the stages will all use hydrogen-fueled Nuclear Thermal Rocket (NTR) for propulsion 
instead of attempting to use traditional chemical propellants or SEP. The NTRs were assumed to have a vacuum Isp 
of a ~900 seconds and a vacuum thrust level of 25,000-lbf (per engine). 
 
SpaceWorks then used the torpor habitat sizing model to establish a new design with capabilities to support a mission 
to Ceres. For this mission and design, a crew complement of 3 was assumed. The fully outfitted SpaceWorks Torpor 
habitat mass was estimated at 18.5 tons for the 660-day mission duration. Table 48 provides some additional 
specifications for the habitat.  
 
Table 48. Ceres Mission Crew Habitat Specifications 
Metric Value 
Crew Complement 3 
Empty Mass 12.3 t 
Loaded Mass 18.5 t 
Habitable Volume 40 m3 
Pressurized Volume 140 m3 
Power Required 12 kW 
Total Consumables (nutrition, water, atm. Gas, medical, etc.) 2.5 t 
Nominal Consumables Outfitting 360 days 
Length 6.0 meters 
Diameter 5.5 meters 
 
 
10.4. Mission Analysis Results 
 
Since this was a very preliminary effort and examination, an extensive architecture search using the IDF was not 
conducted for this part of the study. A local optimization was conducted assuming 3 outbound NTR propulsive stages 
and 2 return NTR propulsive stages. Due to the use of hydrogen fuel, large propellant tanks were going to be required. 
Therefore, the stage diameters were all set at the maximum value permitted within an SLS fairing (~7.3 meters) and 
their lengths were allowed to vary to achieve the necessary DV.  
 
The results of the stage sizing are provided in Table 49. While the gross weight of the stack for the return phase was 
almost 500t, note that it is assumed that ISRU from Ceres will be used to provide the ~300t of fuel. An assessment of 
the practicality and logistics for this has not been conducted at this time. 
 
While the mission analysis generally did not encounter any issues achieving the necessary DVs, the resultant length 
of the stages exceeding 50-meters was excessive and will be problematic as the system is currently envisioned. 
Alternate design solutions that involve increasing the number of stages or reusing the tank(s) of a future heavy-lift 
launch system, or manufacturing of the tanks in orbit are all possible remedies. 
 
Table 49. Ceres Mission Propulsive Stage Sizing Results 
 Outbound Return 
Propulsive Maneuver COI TCI EOI TEI-1 TEI-1 
Inert Mass (t) 30.43 80.1 15.22 60.45 96.48 
Usable Propellants (t) 40.04 146.8 14.39 102.2 191.73 
Payload(s) (t) 17.84 COI Stack 17.84 EOI Stack TEI-1 Stack 
Gross Weight (t) 88.31 315.12 47.45 210.1 498.3 
Stage Length (m) 20.4 57.0 11.3 42.4 66.5 
Stage Diameter (m) 7.3 7.3 7.3 7.3 7.3 
Number NTR Engines 2 4 1 3 4 
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11. Trade Studies 
 
11.1. Parasitic Radiation Shielding 
 
In space there are two predominant types of harmful radiation: Solar Particle Events (SPE) and Galactic Cosmic Rays 
(GCR). While SPE can be very dangerous and harmful to the crew, it is relatively easy to shield against compared to 
GCR radiation. The effectiveness of two materials, aluminum and polyethylene for radiation shielding is shown in 
Figure 35.  
 
 
Figure 35. Radiation Shielding for Two Different Material Options and Varying Thickness 
 
To examine the potential to reduce the crew’s radiation exposure, both the EMC Reference habitat and SpaceWorks 
Torpor habitat were examined using two different approaches to apply and integrate parasitic radiation shielding 
materials. For the EMC habitat, the first scenario considered covering the exterior structure completely. The second 
scenario examined the EMC habitat with only the crew quarters region of the habitat covered. For the SpaceWorks 
Torpor habitat, a full coverage scenario was examined in addition to only placing shielding around the crew torpor 
modules/pods.  
 
The radiation effects for this analysis were only considered for the space segment of the mission, with 600 total days 
in space. During this time, a crew member is expected to spend 67% of that time in torpor. This last metric matters 
when additional shielding is considered on the torpor pods. 
 
In order to understand how the mass of shielding affected the radiation dosage, different shielding schemes needed to 
be considered. The two materials used were aluminum, to represent the structure, and polyethylene to represent the 
consumables on board. The three different benchmark cases used for each were 5-cm of aluminum with 5-cm of 
polyethylene; 5-cm of aluminum with 10-cm of polyethylene; and 5-cm of aluminum with 15-cm of polyethylene. 
From this an empirical formula was developed to determine the thickness required in order to achieve the desired 
radiation dosage (or reduction). 
 
As specific radiation exposure requirements for a Mars mission have not been identified yet, the reduction range of 
interest was varied from 20% to 30%. Additional mission radiation dosage reductions are achievable but undesirable 
due to diminishing returns on radiation protection. This is partially due to the general ineffectiveness of shielding 
against GCR radiation. Figure 36 presents the results of the radiation study.  
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Figure 36. Shielding Mass Impact vs. Radiation Exposure Reduction for Various Implementation Concepts 
 
The two most demanding mass requirements resulted for both scenarios of the EMC Reference habitat. This is 
primarily due to the larger size of the habitat, though the surface area of the habitat module and the torpor modules is 
roughly comparable. The second lightest option is the torpor habitat fully shielded. This habitat has a smaller surface 
area than the EMC design, resulting in less mass for the same percentage of radiation reduction. 
 
The most interesting option however is applying additional radiation protection over the torpor modules/pod areas 
only. Since crew members spend a significant portion of their time in torpor and the significantly lower surface area 
to cover means that there is a much lower mass penalty associated with reducing their radiation exposure. Additionally, 
not only was this shielding approach the lowest mass, but the actual magnitude of the mass penalty is the only one 
likely to be acceptable from a mission sizing/performance perspective.  
 
While the benefits of torpor are typically demonstrated in terms of mass reductions for the entire system via reduced 
habitat and propulsion stage size(s), an alternate approach is to reinvest those savings back into the habitat in order to 
improve overall safety (e.g. added redundancy) and/or improve crew health (e.g. reduce radiation exposure). 
 
 
11.2. Reduced Mars Transit Duration 
 
The duration of the interplanetary crew transfer mission phase is an important factor to be considered when managing 
environmental and psychological risks to the crew. Any reduction in the total amount of time that the crew spends 
drifting through interplanetary space can result in huge dividends through reduced radiation exposure, reduced bone 
and muscle loss, and less cumulative psychological strain. Reductions in transit time can also increase the amount of 
productive surface time for a given mission. 
 
For all of these reasons, mission designers generally try to minimize the total amount of time the crew spends in transit. 
This is part of the rationale for using lower performing (but high thrust) chemical propulsion systems. While solar-
electric propulsion can offer lower overall system mass through higher performance, the resultant transit times increase 
significantly due to the lower thrust levels. This is generally detrimental to the crew health in a number of ways.  
 
As demonstrated previously, using a torpor-enabled architecture offers significant advantages over a traditional system 
in the domains of crew health, total system mass, and total mission cost. However, some of these advantages can be 
traded for alternative advantages by increasing the mass and thrust of the propulsive stages to reduce the duration of 
the in-space transit time.   
 
To evaluate this approach, SpaceWorks generated a short-duration transit trajectory for the 2033 Phobos mission and 
then re-evaluated the optimal system design using the process outlined in Section 8.3. To size the short duration 
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trajectory, SpaceWorks maintained the same terminal orbits and 4-burn structure as the original mission but fixed the 
transit duration to be 150 days for both outbound and return flight. Under these constraints, the new minimum-mass 
trajectories are described in Table 50.   
 
Table 50. Mission C3 Trajectories for “Fast” 2033 Crewed Mission to Mars Vicinity 
Parameter Outbound Trajectory Return Trajectory 
Departure Date 4/26/2033 6/20/2035 
Arrival Date 9/23/2033 11/17/2035 
ΔV1 0.686 km/s 1.528 km/s 
ΔV2  1.928 km/s 0.635 km/s 
Transit Time of Flight 150 days 150 days 
Total C3  32.06 km2/s2 25.82 km2/s2) 
 
 
Achieving the 150-day transit trajectory requires the propulsive stages to provide 42% more DV (+1.406 km/s).  
SpaceWorks explored this new trade space using the IDF for the fast transit mission approach and, as expected, the 
total mass of the system is increased significantly.  
 
Figure 37 includes the results of the new, 150-day transit (upper right) and previous slower transit time cases of 200 
days. 
 
 
Figure 37. Impacts on Total System Mass for SpaceWorks Torpor Habitat with 150-day Transits (upper 
right) versus 200-day Transits to Phobos in 2033 (bottom left) 
 
Reducing the interplanetary transit time leads to significant increases in total system mass and requires an additional 
propulsive stage when compared to the mass-optimal solution for the baseline 200 day transit. Summary results are 
provided in Table 51. 
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Table 51. Comparison of CTS for the Nominal and Short-Duration Mission 
Parameter Baseline 200 Day Transit Short 150 Day Transit Delta 
Total System Mass 83.42 t 117.71 t + 34.29 t 
Total Propulsive Stages 2 3 + 1 
Total # Engines 4 8 + 4 
Total ΔV 3.37 km/s 4.78 km/s + 1.41 km/s 
One-Way Time of Flight 200 days 150 days - 50 days 
Total Mission Duration 950 days 935 days - 15 days 
 
 
This short-duration mission architecture shows the most promise when compared to the EMC Baseline architecture.  
Even while providing 40% more DV, the short-duration SpaceWorks Torpor architecture still weighs 28 tons less than 
the EMC Reference case. This study shows that the SpaceWorks Torpor-enabled habitat can enable crewed Mars 
mission with less time in space, less risk to the crew from transit hazards, and still deliver mass savings compared to 
the non-torpor EMC Reference case. 
 
 
11.3. Artificial-Gravity Concepts 
 
11.3.1. Motivation 
 
Placing the crew in an inactive, hibernation state achieves many engineering advantages for deep space missions. With 
the crew in hibernation, the total pressurized volume required for habitation and living quarters is significantly 
reduced. In addition, many ancillary crew accommodations (e.g. food galley, cooking and eating supplies, exercise 
equipment, entertainment, etc.) can be eliminated. Additionally, a person in torpor has reduced metabolic rates, and 
therefore requires less consumable food, water, and oxygen. 
 
Having the crew inactive and stationary during the mission also provides additional and significant flexibility to the 
habitat design that can help solve or mitigate a number of the health issues stemming from long-duration spaceflight. 
One approach to eliminating these risks is by rotating the habitat element to induce an acceleration field inside the 
crew cabin, thus simulating gravity. This concept of artificial gravity is not new - spinning habitats have been 
considered from the earliest days of human space exploration and have been featured heavily in both engineering 
studies and works of science fiction. For an active crew, this often means creating a habitat in which the crew can 
“stand up” in the induced gravity field. Such a habitat must be large enough to not impart a significant acceleration 
gradient across a crew member, otherwise the crew can become disoriented or suffer other ill health effects. With a 
stationary crew, however, the crew can be “lying down” in the induced gravity field, significantly reducing the size 
requirements of the habitat and avoiding issues with gravity gradients. 
 
11.3.2. Designs 
 
SpaceWorks has evaluated two alternative concepts for inducing artificial gravity onboard a Mars Crew Transportation 
System (CTS). Both concepts feature a modular design with multiple propulsive stages arranged along a truss structure 
and connected to a pair of rotating habitats. However, the habitat truss structure and axis of rotation varies between 
the two concepts. 
 
The first concept (AG1) places the habitats at opposite ends of a long truss with a central docking node at the center. 
The entire truss rotates about the central docking node where it is attached to the propulsive stage assembly. This 
concept is shown in Figure 38 and the masses required for each of the AG system components is given in Table 52. 
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Figure 38. Notional AG1 “Traditional” Concept Configuration for Torpor and Non-Torpor Habitats 
 
Table 52. AG1 Component Masses and Descriptions 
Component Mass [t] Length [m] Diameter [m] 
Rotating Truss 12.0 60.0 2.0 
Central Docking Node 11.6 - 4.2 
Cupola 1.8 - 3.0 
CMGs 5.0 - - 
Total 30.4   
 
 
Compared to a non-AG CTS design, the AG1 requires an additional 30.4 tons of hardware, plus the additional 
propellant mass required to rotate the system and that depends on the total mass moment of inertia. 
 
The second concept (AG2) leverages the crew’s stationary state in torpor to dramatically reduce the radius of rotation. 
AG2, shown in Figure 39, shrinks the distance to the habitat from the central docking node, and places the axis of 
rotation along the center axis of each habitat. The habitats rotate in opposite direction to balance the imparted rotational 
moments. 
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Figure 39. Notional AG2 Configuration 
 
The reduction in truss length reduces the total mass of the AG system hardware for AG2 to 21.4 tons. See Table 53 
for details. 
 
Table 53. AG2 Component Mass Estimates and Descriptions 
Component Mass [t] Length [m] Diameter [m] 
Rotating Truss 3.0 15.0 2.0 
Central Docking Node 11.6 - 4.2 
Cupola/CMGs 5.8 - 3.0 
Total 21.4   
 
 
11.3.3.  Impact on Crew Transportation Architecture 
 
Each of these artificial gravity concepts offer crew-health benefits at the cost of additional mass. To characterize the 
optimal configuration for each AG concept, SpaceWorks evaluated over 40,000 alternative designs. This study uses 
the same ground rules and assumptions laid out for 8-crew missions to Mars in Section 8.5. All mission ΔV estimates 
are based on the same mass-optimal trajectory that departs during the 2039 opportunity.  
 
Table 54 enumerates the parameter values that were explored in the design space sweep. 
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Table 54. Full-Factorial Trade Space Parameters for Artificially Induced Gravity Configurations 
Parameter Values Units 
Outbound Stage Count 1, 2, 3 # 
Return Stage Count 1, 2, 3 # 
Engine Design Thrust 20.0, 22,5, 25.0 Klbf 
Propulsion Stage Diameter 9.0, 10.0, 11.0, 12.0, or 13.0 feet 
Outbound Stage #1 Engine Count 1, 2, 3, or 4 # 
Outbound Stage #2 Engine Count 1, 2, 3, or 4 # 
Return Stage #1 Engine Count 1, 2, 3, or 4 # 
Return Stage #2 Engine Count 1, 2, 3, or 4 # 
 
 
First, SpaceWorks characterized the impact of the AG1 concept on the crew transportation system (CTS) for an 8-
crew mission to Mars departing in 2039. All crew, environmental, and propulsion assumptions for this study match 
the assumptions given in Sections 8.2 and 8.5. Table 55 provides the propulsive ΔVs, assuming four ~300 second 
burns at TMI, MOI, TEI and EOI, with a departure in 2039. 
 
Table 55. Minimum C3 Trajectories for 2039 Mission to Mars 
Parameter Outbound Trajectory Return Trajectory 
Departure Date 10/08/2039 08/13/2041 
Arrival Date 06/09/2040 05/15/2042 
ΔV1 1.05 km/s 1.079 km/s 
ΔV2 1.00 km/s 0.593 km/s 
Time of Flight 245 days 275 days 
Total C3 48.731 km2/s2 17.947 km2/s2 
 
 
To appropriately characterize the feasible results from the design space exploration, SpaceWorks applied constraints 
on the total wet mass and initial thrust-to-weight (T/W) of each propulsive stage. The total wet mass was constrained 
to 50 tons, the SLS Block II launch capacity to DRO, and the stage initial T/W was constrained to 0.24. Under these 
constraints, AG1 with the SpaceWorks Torpor habitat is feasible with a total of six propulsive stages. However, sizing 
the AG1 CTS with the EMC Reference habitat yields no viable variants under these constraints. For the sake of 
comparison, these constraints were relaxed to a maximum propulsive stage mass of 65 tones (30% increase of SLS 
Blk-2 capabilities) and a minimum stage initial T/W of 0.18. Under the relaxed constraints, the AG1 system with EMC 
Reference habitats requires a total of 6 propulsive stages, each with a wet mass between 45 and 65 tons. 
 
The results of the design space sweep for this configuration is shown in Figure 40. Note that each of the nine groupings 
of points represents a different quantity of outbound and return propulsive stages. Points colored in gray represent 
infeasible points based on the specific maximum stage mass and minimum stage initial T/W. 
 
Under the relaxed constraints, the minimum CTS mass for the AG1 concept with the EMC Reference habitat is 450.47 
tons. A basic mass breakdown and comparison is given in Table 56. 
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Figure 40. Total Mission Mass Sizing Results for AG1 Configuration and 2 EMC Reference Habitat for 
Mission to Mars Surface in 2039 (8 Crew)  
 
Subsequently sizing the AG1 concept with the SpaceWorks Torpor habitat for 8 crew members yields far more options 
due to the reduced torpor habitat mass of ~44%. This mass reduction leads to reduced propellant requirements, smaller 
propulsive stage sizes, and enables numerous options for minimum mass systems that have one less propulsive stage, 
as shown in Figure 41. 
 
 
Figure 41. Total Mission Mass Sizing Results for AG1 Configuration and 2 SpaceWorks Torpor Habitats for 
Mission to Mars Surface in 2039 (8 Crew) 
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Finally, SpaceWorks performed the same design space sweep described in Table 54 to characterize and compare the 
AG2 concept relative to the AG1 concept. Note that the AG2 concept design using a small radius of rotation is only 
feasible with the SpaceWorks Torpor habitat and inactive crew members. 
 
The AG2 concept reduces the mass of the AG hardware systems from 30.4 tons to 20.4 tons (a 9t savings), and 
significantly reduces the propellant mass necessary to provide the same level of artificial gravity. These mass savings 
are passed downstream to the propellant and inert masses of the propulsive stages to enable the lowest total system 
mass of any of the AG concepts. All evaluated configurations from the design space sweep are displayed in Figure 
42. The total system mass for the best AG2 configuration was 251.78 tons and consisted of 2 outbound stages and 2 
return stages. 
 
 
Figure 42. Total Mission Mass Sizing Results for AG2 Configuration and 2 SpaceWorks Torpor Habitats for 
Mission to Mars Surface in 2039 (8 Crew) 
 
11.3.4. Summary 
 
The addition of an artificial gravity system to a Mars mission architecture results in a significant increase in total 
system mass but may be required if numerous human spaceflight challenges cannot be solved through other means. 
Compared to the non-AG systems with 8 crew and the EMC Reference habitat, inclusion of the AG1 system led to a 
35% increase in total system mass and was unable to meet the original constraints on maximum propulsive stage mass 
and minimum propulsive stage T/W. Under the original constraints, the torpor-enabled habitat becomes a required 
and enabling technology to fly a Mars mission with the AG1 system. Furthermore, the torpor-enabled habitat leads to 
even greater mass savings by enabling the AG2 concept. The minimum system mass and mass breakdown for each of 
the three cases studied in this section are given in Table 56. 
 
While the architecture costs were not estimated for this initial examination, it is anticipated that one of the most 
significant mission cost reductions will be due to reductions in the number of propulsion stages. While the lower 
system mass is beneficial, the elimination of actual hardware elements and engines from the architecture as well as 
in-space automated rendezvous and docking (AR&D) maneuvers are expected to be more impactful.  
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Table 56. Mass Breakdown for the Minimum-Mass Solutions of Each AG Concept Case 
Component AG1 with EMC Reference Habitat 
AG1 with Torpor 
Habitat 
AG2 with Torpor 
Habitat 
Habitat Mass (x2) 92.58 t 52.17 t 51.17 t 
AG System Total Mass 37.0 t 33.7 t 21.8 t 
Total Crew System Mass 450.48 t 299.9 t 251.8 t 
Number of Propulsive Stages 6 5 4 
Number of Engines 25 18 12 
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12. Developmental Roadmap 
 
12.1. Technology Development Roadmap 
 
The team developed a high-level timeline and roadmap of the activities, studies, and research efforts necessary to 
mature and advance the torpor technology and concept from both a medical and engineering perspective. This roadmap 
is designed and coordinated to support human exploration missions to deep space starting in the 2030s timeframe, 
consistent with the mission architecture analysis. 
 
The roadmap identifies 14 key research and development activities. Activities are identified as being either: Primary, 
Secondary, or Tertiary. Primary activities are critical to development and implementation of the technology. 
Secondary activities are generally capability enhancements to the system and/or technology. Tertiary activities are 
primarily contingency off-ramps for the baseline approach.  
 
 
Element Timeframe/ Duration Type 
Preceeding 
Elements Title Description 
1.0   PRIMARY - 
EVALUATION AND 
ADMINISTRATION OF 
ADENOSINE A1AR AGONISTS 
 IN HUMANS  
 
1.1 Jan-2019 Sub-Element - Expanded Large Animal Study 
Porcine evaluations to confirm 
physiological response to 
administration of A1AR agonists 
1.1.1 3 months Activity - Large Animal Study for Torpor Induction 
Short/minimal duration evaluations 
examining induction process and 
response using A1AR agonists 
1.1.2 3 months Activity 1.1.1 Large Animal Study for Torpor Maintenance 
Longer duration evaluations examining 
the induction process followed by brief 
maintenance periods to assess 
sustained torpor when using A1AR 
agonists 
1.1.3 6 months Activity 1.1.2 Large Animal Study for Prolonged Torpor  
Extended duration evaluations refining 
the induction process followed by long 
maintenance periods 
1.1.4 12 months Activity 1.1.3 Large Animal Study with Repeat Torpor Cycles 
Studies to evaluate impact of multiple, 
repeat extended duration torpor cycles 
1.2 Jan-2021 Sub-Element 1.1 Limited Human Trials for Torpor Induction 
Testing on 4-6 healthy, human 
volunteers using CHA/8-SPT and 
spontaneous rewarming. Mix of men 
and women, with nominal ages in mid-
20s and mid-40s. Cooling will be via 
cold saline injection and application of 
external gel pads. Nutrition will not be 
provided. 
1.2.1 3 months Activity - Feasibility of Torpor Induction in Healthy Humans 
Achieve core body target temperatures 
after administration of torpor induction 
medication, starting at 35degC, 
34degC, 33degC, 32degC 
1.2.2 6 months Activity 1.2.1 Safety of Torpor Induction in Healthy Humans 
Assess any side effects due to 
chemical induction of torpor, including 
limited airway patency, adequacy of 
spontaneous ventilation, shivering, and 
hemodynamic stability 
1.2.3 6 months Activity 1.2.2 Optimal Weight-Based Dosage for Safe Induction of Torpor  
Evaluate various doses of torpor 
induction medication to reach target 
temperature with minimal side effects 
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1.2.4 3 months Activity 1.2.3 Tolerability of Induction without Sedation 
Evaluate volunteer physical and mental 
response to induction without use of 
sedatives. Examine cold sensitivity 
based on cooling rate to target core 
temperature and target temperature. 
1.3 Jul-2022 Sub-Element 1.2, 1.1.2 Limited Human Trials for Torpor Maintenance 
Testing on 4-6 healthy, human 
volunteers using CHA/8-SPT and 
controlled rewarming. Target 
maintenance period will be 24-hours. 
Mix of men and women, with nominal 
ages in mid-20s and mid-40s. Use of 
sedation during induction will be 
dependent on outcomes from 1.2.4 
activity. All cooling will be via cold 
saline injection and application of 
external gel pads. Nutrition will not be 
provided. 
1.3.1 6 months Activity - Feasibility of Torpor Maintenance in Healthy Humans 
Maintain target temperature after 
induction and achieving target 
temperature 
1.3.2 6 months Activity 1.3.1 Safety of Torpor Maintenance in Healthy Humans 
Assess any side effects during 
chemical maintenance of torpor, 
including limited airway patency, 
adequacy of spontaneous ventilation, 
shivering, and hemodynamic stability 
1.3.3 3 months Activity 1.3.2 Optimal Weight-Based Dosage for Safe Maintenance of Torpor 
Evaluate various doses of torpor 
induction medication to maintain target 
temperature with minimal side effects. 
1.3.4 3 months Activity 1.3.2 Tolerability of Maintenance without Sedation 
Evaluate volunteer's physical and 
mental response to torpor maintenance 
without use of sedatives. Induction 
period may or may not use sedation 
pending outcome of 1.2.4. 
2.0   PRIMARY   HUMAN TRIALS  FOR SPACE TORPOR  
2.1 Jan-2024 Sub-Element 1.3 Expanded Human Torpor Trials Study 
Significantly expand number of human 
volunteers.  All will use continuous 
infusion of CHA/8-SPT and controlled 
rewarming. Target maintenance 
periods will range from 72-336 hours. 
Mix of men and women, with nominal 
ages in 20s and 50s, and of various 
body mass. Cooling during induction 
will be via cold saline injection and 
ambient air during maintenance. 
Enteral feeding will be supplied using 
via gastrointestinal tube. 
2.1.1 3 months Activity - Feasibility and Safety with 3-Days Torpor for Healthy Humans 
Conduct torpor induction and 
maintenance evaluations with 3-day 
maintenance periods for all volunteers. 
2.1.2 2.5 years Activity - 
Characterization of Metabolic 
Rate Reductions and 
Consumables Demand during 
Torpor 
Measure impact of torpor on metabolic 
rate reductions via oxygen demand, 
CO2 production testing, etc. Assess 
caloric demands to provide and 
maintain adequate nutrition with 
extended duration torpor periods. 
2.1.3 6 months Activity 2.1.1 Feasibility and Safety with 7 Days Torpor for Healthy Humans 
Conduct torpor induction and 
maintenance evaluations with 7-day 
maintenance periods for all volunteers. 
2.1.4 12 months Activity 2.1.2 
Feasibility and Safety with 2 
Weeks Torpor for Healthy 
Humans 
Conduct torpor induction and 
maintenance evaluations with 14-day 
maintenance periods on subjects 
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exhibiting greatest tolerance during 
induction, health/stability during 
maintenance, and fastest recovery. 
2.1.5 12 months Activity 2.1.3 Feasibility and Safety of Repeat Torpor Cycles in Humans 
Conduct torpor induction and 
maintenance evaluations with repeat 
torpor cycles. Initial evaluation would 
focus on 3-day torpor cycles with a 7-
day recovery period. This would be 
expanded to 14-day torpor cycles with 
a 14-day recovery period. Maximum 
number of repeat cycles would be 
dependent on physiologic, mental and 
emotional tolerance of volunteers. 
2.2 Oct-2026 Sub-Element 2.1 Conduct In-Space Evaluations of Torpor  
2.2.1 6 months Activity - LEO ISS Environment Torpor Test of Human Induction 
Repeat of previous protocols from 1.3 
and 2.0 in a LEO gravity free 
environment. These will be Human-
tended procedures, with minimal 
automation 
2.2.2 6 months Activity 2.2.1 
LEO ISS Environment Torpor 
Test of Human 
Induction/Maintenance 
Repeat of previous protocols from 1.3 
and 2.0 in a LEO gravity free 
environment. These will be Human-
tended procedures, with minimal 
automation 
2.2.3 6 months Activity 2.2.2 
Examining the Optimal Dosage 
for In-space 
Application/Administration of 
Torpor 
Repeat of previous protocols from 1.3 
and 2.0 in a LEO gravity free 
environment. These will be Human-
tended procedures, with minimal 
automation 
2.2.4 6 months Activity - Body Thermal Management System Testing 
Evaluation of current terrestrial torpor 
thermal management systems 
intended for use during prolonged 
torpor cycles in a gravity free 
environment. Any noted engineering 
changes required for proper function 
would be noted and equipment 
modifications performed at this time. 
2.2.5 12 months Activity - Evaluation of Automated Torpor Support Systems 
Evaluation of current terrestrial torpor 
automated support systems intended 
for use during prolonged torpor cycles 
in a gravity free environment. Any 
noted engineering changes required 
for proper function would be noted and 
equipment modifications performed at 
this time. 
3.0   PRIMARY   SPACE TORPOR  MISSION APPLICATION  
3.1 Oct-2028 Sub-Element 2.2.2, 2.2.4, 2.2.5 
In-Space Cis-Lunar Mission 
Trials Using Human Torpor   
3.1.1 1 year Activity - Deep Space Mission Protocols for Torpor 
Verification and test simulated “deep 
space” mission protocols under 
nominal conditions 
3.1.2 1 year Activity 3.1.1 Use of Torpor During Emergency Conditions in Deep Space 
Evaluate and test emergency response 
protocols in simulated “deep space” 
conditions 
3.1.3 1 year Activity 3.1.3 Torpor-Enabled Cis-Lunar Checkout Flight 
Conduct extended mission in cis-lunar 
space or Gateway using torpor with 
multiple cycles. 
30-90 day mission with total crew 
complement of 4; 2 crew members 
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undergoing torpor cycles during 
mission 
3.2 2032-2035 Sub-Element 3.1 Enabling the First Human Mars-Vicinity Space Missions 
Mission to Mars moons 
Phobos/Deimos, with crew 
complement of 4. Up to two weeks of 
torpor and repeat cycles during transit 
phases, with minimum of 1 active 
caretaker. 
      
3.3 2036-2040 Sub-Element 3.1 Enabling the First Human Mars-Landing Space Missions 
Mission to Mars surface, with crew 
complement of 4. Up to two weeks of 
torpor and repeat cycles during transit 
phases, with minimum of 1 active 
caretaker. Utilizing NMES and/or 
artificial gravity for muscle atrophy and 
bone loss. 
4.0   SECONDARY   
RADIOPROTECTIVE EFFECTS 
FOR HUMAN TORPOR WITH 
METABOLIC SUPPRESSION 
 
4.1 Jan-2019 Sub-Element - 
Identification of Mechanisms for 
Human Radioprotective Effects 
During Torpor 
Develop theories on possible 
mechanisms for radioprotective effects 
in humans 
      
4.2 Jan-2023 Sub-Element 4.1 Animal Evaluations for Radiation Shielding Mechanisms   
4.2.1 3 years Activity - 
Exposure Evaluation of 
Hibernating vs. Non-Hibernating 
Species at NASA Space 
Radiation Lab (NSRL), 
Brookhaven 
Examine radiation exposure impacts 
between hibernating and non-
hibernating species 
4.2.2 3 years Activity 4.2.1 
Exposure Evaluation for Large 
Animals at NASA Space 
Radiation Lab (NSRL), 
Brookhaven 
Conduct porcine study to assess any 
potential mechanisms that reduce 
radiation exposure impacts 
4.3 Jan-2030 Sub-Element 3.1.3, 4.2 
Evaluation of Humans During 
Cis-Lunar Space Missions 
Utilizing Long-Duration Torpor 
Obtain baseline radiation exposure 
levels between torpor and non-torpor 
crew members 
4.3.1 1 year Activity  
Crew monitoring during mission, 
with non-torpor control group vs. 
torpor test group 
 
4.4 2032-2035 Sub-Element 3.1, 4.3 
Evaluation of Human Radiation 
Exposure Impacts During Deep 
Space Missions 
Compare radiation exposure levels for 
crew with shielded torpor pods vs. 
unshielded 
4.4.1 4 years Activity  Crew monitoring during mission  
5.0   SECONDARY   
MUSCLE ATROPHY IMPACTS 
WITH METABOLIC 
SUPPRESSION  
DURING HUMAN TORPOR 
 
5.1 Jan-2020 Sub-Element 1.1.3 
Quantifying Muscle Atrophy 
Rates in Non-Hibernating 
Animals with Metabolic 
Suppression 
Large animal model testing using post 
torpor muscle strength testing and 
needle biopsy of muscular tissues to 
identify impacts of torpor on gravity 
based muscle atrophy  
      
5.2 Oct-2024 Sub-Element 5.1, 2.1.2 
Quantifying Muscle Atrophy 
Rates in Humans Undergoing 
Metabolic Suppression 
Large human model testing using post 
torpor muscle strength testing and 
needle biopsy of muscular tissues to 
identify impacts of torpor on gravity-
based muscle atrophy  
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5.3 Oct-2025 Sub-Element 5.2 Terrestrial NMES Effectiveness Studies 
Large human model testing using 
patient populations at risk for muscle 
atrophy (i.e. coma, paralysis, elderly) 
to evaluate the effectiveness of whole-
body NMES for muscle atrophy 
prevention. Study will utilize post 
therapy muscle strength testing and 
needle biopsy of muscular tissue to 
identify impacts after extended and 
extensive use of NMES on muscle 
atrophy  
      
5.4 Oct-2028 Sub-Element 2.2.2, 5.3 Space-Based NMES Effectiveness Studies 
Human model testing using ISS/LEO 
based crew members to evaluate the 
effectiveness of NMES for muscle 
atrophy prevention. Study will utilize 
post therapy muscle strength testing 
and needle biopsy of muscular tissue 
to identify impact of NMES on gravity-
based muscle atrophy  
6.0   SECONDARY   
BONE DEMINERALIZATION 
IMPACTS  
WITH METABOLIC 
SUPPRESSION  
DURING HUMAN TORPOR 
 
6.1 Jan-2020 Sub-Element 1.1.3 
Quantifying Bone 
Demineralization Rates in Non-
Hibernating Animals with 
Metabolic Suppression 
Large animal model testing using post 
torpor DEXA scans and core biopsies 
of bone tissue to identify impact of 
torpor on gravity-based bone 
demineralization 
      
6.2 Oct-2024 Sub-Element 5.1, 2.1.2 
Quantifying Bone 
Demineralization Rates in 
Humans with Metabolic 
Suppression 
Large human model testing using post-
torpor DEXA scans and core biopsies 
of bone tissue to identify impact of 
torpor on non-use bone 
demineralization 
      
6.3 Oct-2027 Sub-Element 2.2.2, 6.2 Space-Based Bone Demineralization Studies 
Human model testing using ISS/LEO 
based crew members to evaluate the 
effectiveness torpor for the prevention 
of bone demineralization. Study will 
utilize post-torpor DEXA scans and 
core biopsies of bone tissue to identify 
impact of torpor on gravity-based bone 
demineralization 
7.0   SECONDARY   
INCREASED INTRACRANIAL 
PRESSURE (ICP) IMPACTS  
DURING METABOLIC 
SUPPRESSION AND COOLING 
 
7.1 Oct-2025 Sub-Element 2.1.3 
Terrestrial Head Tilt Studies 
During Application of Torpor in 
Healthy Humans 
Large human model testing using 
Head Tilt Studies during torpor cycles 
to identify the impact of torpor Space 
Adaptation Syndrome and potential 
gravity induced increased ICP. 
      
7.2 Oct-2027 Sub-Element 7.1, 2.2.2 
Space-Based Measurements of 
Astronaut Cranial Pressure 
During Torpor 
Human model testing using ISS/LEO 
based crew members to evaluate the 
short-term impact of torpor Space 
Adaptation Syndrome and potential 
gravity induced increased ICP. 
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7.3 Oct-2030 Sub-Element 2.2.2, 3.1.2 Assessment of VIIP Impact During Extended Space Mission 
Human model testing using ISS/LEO 
based crew members to evaluate the 
long-term impact of torpor Space 
Adaptation Syndrome and potential 
gravity induced increased ICP. 
8.0   TERTIARY   
HUMAN TORPOR  
PHENOTYPE 
CHARACTERIZATION FOR 
OPTIMAL APPLICATION OF 
METABOLIC SUPPRESSION 
 
8.1 Oct-2026 Sub-Element 2.1 
Conduct human studies to 
establish optimal 
application/administration of 
torpor as well as any unique 
human tolerance/adaptations 
based on phenotype (height, 
gender, metabolism, etc.) 
Conduct torpor induction and 
maintenance evaluations with repeat 
torpor cycles. Focus of this study 
would be to validate any data collected 
from 2.1.4 that would indicate unique 
physiologic (i.e. weight, height, race, 
gender) or genetic tolerance of torpor 
by certain crew members 
9.0   PRIMARY   HUMAN TORPOR COGNITIVE AND PERFORMANCE STUDIES   
9.1 Oct-2026 Sub-Element 2.1 Mental Capabilities 
Conduct torpor induction and 
maintenance evaluations with repeat 
torpor cycles with pre-cycle and post-
cycle cognitive function, memory and 
psychological evaluation scores. 
      
9.2 Oct-2026 Sub-Element 2.1 Physical Capabilities 
Conduct torpor induction and 
maintenance evaluations with repeat 
torpor cycles with pre-cycle and post-
cycle physical performance and 
dexterity evaluations. 
10.0   PRIMARY   
FEEDING AND HYDRATION 
SYSTEMS FOR EXTENDED 
TORPOR MAINTENANCE 
PERIODS 
 
10.1 Jul-2023 Sub-Element - 
Design of Automated Control 
Systems for Monitoring, 
Measuring, Delivery, and Waste 
Management of Enteral Nutrition 
and Hydrating Fluids 
Adjustments to systems based on 
findings from 2.2.4 and 2.2.5 
      
10.2 Jul-2025 Sub-Element 10.1 
Short-Duration Testing of ACS-
MMDWM Nutrition/Hydration via 
PEG Tube in Healthy Humans 
Undergoing Torpor 
Conduct torpor induction and 
maintenance evaluations with repeat 
torpor cycles to evaluate the 
effectiveness and potential short-term 
side effects and complications of PEG 
enteral feeding and waste collection. 
      
10.3 Jul-2027 Sub-Element 10.2 
Long-Duration Testing of ACS-
MMDWM Nutrition/Hydration via 
PEG Tube in Healthy Humans 
Undergoing Torpor 
Conduct torpor induction and 
maintenance evaluations with repeat 
torpor cycles to evaluate the 
effectiveness and potential long-term 
side effects and complications of PEG 
enteral feeding and waste collection. 
11.0   PRIMARY   
AUTOMATED THERMAL 
CONTROL SYSTEM 
DEVELOPMENT 
 
11.1 Oct-2021 Sub-Element - 
Space-Qualified Sensor 
Development for Core 
Temperature Monitoring 
Primarily terrestrial evaluations. 
Develop and test medical devices for 
use in space environment for 
monitoring temperature of core and 
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extremities. Devices must be suitable 
for long-term use, reliable, highly 
accurate, and non-invasive. 
      
11.2 Oct-2022 Sub-Element 11.1 Cooling Management and Effectiveness Studies 
Look at various approaches and 
techniques for highly-controlled 
decrease in body and core 
temperature. Including ambient air 
cooling, periodic application of gel 
pads, esophageal cooling devices 
(ECD), trans-nasal cooling systems, 
etc. 
      
11.3 Oct-2023 Sub-Element 11.1 Warming Management and Effectiveness Studies 
Look at various approaches and 
techniques for highly-controlled 
increase in body and core temperature. 
Including ambient air rewarming, 
thermal blankets, heat pads, etc. 
12.0   TERTIARY   
OFF-RAMP :  
ARTIFICIALLY-INDUCING 
GRAVITY 
 
12.1 Jan-2025 Sub-Element 5.3, 6.2 
Mitigation of Bone Loss and 
Muscle Atrophy Using Artificial 
Gravity via Small Radii Rotational 
Systems 
Large human model testing while in 
induced torpor state using ground 
centrifuge testing to identify feasibility 
of torpor and the physiologic tolerance 
of humans to small radii rotation. 
12.1 18 months Activity  
Ground Centrifuge Testing in 
Torpor State (examine RPM and 
radius impacts, assess crew 
comfort, operations impact - 
safety) 
 
12.2 18 months Activity 12.1 Full-scale Ground Prototype Development  
12.3 2 years Activity 12.2 Unmanned, In-Space System Testing  
13.0   PRIMARY   
TORPOR MODULE 
ENGINEERING ANALYSIS & 
DESIGN  
 
13.1 Jan-2017 Sub-Element - Concept Design Review (CoDR) Completed in NIAC Phase-2 Study 
      
13.2 Jan-2019 Sub-Element 13.1 System Requirements Assessment (leading to SRR) 
Establish functional requirements, with 
threshold and objective goals 
      
13.3 Jul-2019 Sub-Element 13.2 Construct full-scale system mockup 
Establish functional layout and design 
for demonstration purposes 
       
13.4 Jul-2020 Sub-Element 13.2, 13.3 Subsystem RDT&E  
      
13.5 Jan-2026 Sub-Element 13.4 Ground Prototyping and Integrated Demonstration  
         
13.6 Jan-2027 Sub-Element 13.5 Flight-Qualified Prototype Development  
14.0   PRIMARY   
SYSTEM ENGINEERING  
FOR SPACE HABITAT  
DESIGN AND DEVELOPMENT 
 
14.1 Jan-2017 Sub-Element - Concept Design Review (CoDR) 
Design update will be pending 
outcome on effectiveness of torpor in 
mitigating microgravity effects on 
bone/muscle in 6.0 and 12.0. 
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14.1.1 2 years Activity  Completed in NIAC Phase-2 Study  
14.2 Jan-2019 Sub-Element 14.1 System Requirement Review (SRR) 
Establish functional requirements, with 
threshold and objective goals 
      
14.3 Jan-2020 Sub-Element 14.2, 13.4, 13.3 
Preliminary Design Development 
(leading to PDR) Detailed design of critical subsystems 
      
14.4 Jan-2022 Sub-Element 14.3, 13.5 System RDT&E Phase (leading to CDR)  
      
14.5 Jan-2026 Sub-Element 14.4 Full-Scale Ground Prototype  
      
14.5 Jan-2027 Sub-Element 14.5, 13.5 Production of Space-Qualified Block-1 Unit  
      
14.6 Jan-2029 Sub-Element 14.5, 3.1.2 Cis-Lunar Flight Demonstrations  
      
14.7 Oct-2031 Sub-Element 14.6 Production of Deep Space Habitat Block-2 Unit  
15.0   TERTIARY   
OFF-RAMP :  
NUTRITION AND FEEDING VIA 
TPN 
 
15.1 Jan-2026 Sub-Element 10.2 
Design of Automated Control 
Systems for Monitoring, 
Measuring, Delivery, and Waste 
Management of Total Parenteral 
Nutrition and Hydrating Fluids 
 
      
15.2 Jul-2027 Sub-Element 15.1 
Human Testing of ACS-MMDWM 
Nutrition/Hydration via PEG Tube 
in Healthy Humans Undergoing 
Torpor 
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12.2. Technology Maturation Challenges 
 
The team identified a number of key challenges and obstacles that must be solved and/or overcome in order to see this 
capability come to fruition. While not an exhaustive list, some notable items will be discussed briefly. 
 
12.2.1. Receipt of FDA Drug Approvals 
 
The proposed A1AR agonist, CHA, and antagonist, 8-SPT, used as an alternative, improved means to induce a low 
metabolic state in humans has not actually been tested in humans to date. FDA approval will be necessary before trials 
and further evaluation of the CHA/8-SPT compounds can begin on humans. 
 
While there have been numerous successful evaluations of these drugs on small animals, and limited studies on large 
animals, at least one large animal study involving numerous additional subjects (and a successful outcome) will likely 
be required before proceeding to human trials. 
 
12.2.2. Minimizing Sedation Levels 
 
With current clinical applications in critical care scenarios, heavy sedation is used to minimize movement, suppress 
the shivering reflex during cooling, reduce pain, and provide for the overall comfort of the patient. For a healthy crew, 
the primary concerns are to suppress the shivering reflex and provide for overall comfort. However, receiving high 
sedation levels over long periods of time will significantly increase the recovery period after a torpor cycle, possibly 
require the need to intubate the crew member, and is likely to have detrimental health effects.  
 
The ability and need to minimize the sedation levels is of the upmost importance. The use of A1AR agonists may 
suppress the shivering reflex and therefore significantly reduce the necessary sedation levels. A light sedative such as 
dexmedetomidine is a promising candidate for use during torpor. This non-opioid drug can sedate without the 
respiratory depression often encountered with many sedatives (e.g. Propofol, fentanyl, diazepam) and can even permit 
communication with the crew member in a semi aroused state. However, the impacts of long-term use of 
dexmedetomidine have not been evaluated and thus it is not currently recommended for use in clinical settings beyond 
short periods. 
 
12.2.3. Torpor Testing in the Spaceflight Environment 
 
Once successful terrestrial-based torpor testing has occurred and advanced sufficiently, testing will need to be 
conducted in the space environment. Initially, this is likely to be performed on a platform such as the International 
Space Station (ISS) or a future cis-lunar Gateway.  
 
However, there is a very risk-adverse culture towards spaceflight when it comes to humans and potentially high-risk 
experiments. To date, there has never been any surgery or even a sedated astronaut in space. Excluding spaceflight-
related deaths, all injuries have been relatively minor. This will pose challenges to testing. Particularly when it comes 
to fully exploring the limits and characterizing the capabilities of torpor. In addition to evaluating nominal operating 
conditions, scenarios that involve testing of emergency conditions will need to be conducted. These will include 
hardware system failures, rates that infection can spreads, rapid rewarming, etc. 
 
12.2.4. Evaluation of Potential Radioprotective Effects 
 
One of the more interesting and potentially significant impacts of torpor may reside in its ability to mitigate and reduce 
the damaging effects of space radiation. There is a growing body of evidence to support this as a possibility and to 
establish a plausible medical theory. While numerous extensive experiments and tests could be conducted at the 
cellular level, with organs, on small animals, etc., the testing of radiation exposure impacts on humans is highly 
problematic. 
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While new test facilities are being developed, the general approach for torpor development as it pertains to humans is 
to not presume any benefits and to conduct testing and collect data between torpor and non-torpor crew members over 
the natural course of spaceflight missions. Over time, any benefits that are identified and measured will be further 
leveraged to increase system performance, improve crew health, etc.  
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13. Summary and Recommendations 
 
This effort resulted in significant refinements to the envisioned approach for implementing the torpor concept for 
applications in space. The team methodically worked through the various challenges that were identified for the 
concept and made a number of changes to mitigate any potential issues. As such, we believe a sounder and more 
practical path forward for the development of ‘space torpor’ has been established. 
 
From a medical perspective, a number of findings and changes to the original concept were made. Specifically, 
 
• The sentinel protocol proved a reasonable and viable approach for implementing the torpor concept. The total 
crew time spent in torpor during the transit segment of a Mars mission was generally 70-80%, based on 
results from the Bio-Simulator tool. The team still envisions ultimately being able to support torpor durations 
for the crew (and passengers) that last the entirety of the transit phase, this capability will take time to achieve. 
In the near-term, achieving torpor cycles of 14-21 days can still have a significant positive impact to the 
mission design, sizing of architecture elements, and overall crew health. 
 
• The transition from crew nutrition and hydration provided via TPN to a liquid enteral solution approach 
supplied via a PEG tube resulted in eliminating a number of potential medical complications and permits the 
crew to consume normal (solid) food via oral intake when available and desired. 
 
• The use of cooled ambient air in the habitat as a means of achieving body thermal control (versus a trans 
nasal catheter device) eliminates a hardware medical system as well as the slightly uncomfortable 
implementation process for the crew of placing a cannula into their nostrils 
 
• Dexmedetomidine was identified as an excellent candidate for providing the necessary light sedation 
necessary for the crew during torpor induction. 
 
Specific results of the habitat design work performed yielded the following: 
 
• For the 4-crew habitat system designs, a mass savings of 56% was achieved. These gains were achieved 
through modifications of a more conservative system, that began with a very detailed NASA EMC reference 
design 
 
• For the 8-crew habitat system design, a 20% mass savings was realized, however had associated cost penalty 
of 25% cost increase (or $998M) compared to simply producing two of the 4-crew habitats concepts 
 
Specific results of the architecture design work performed yielded the following: 
 
• SpaceWorks conducted extensive exploration of the design space for numerous exploration missions and 
examined tens of thousands of architecture designs. In all cases, a torpor-enabled architecture continued to 
show significant mass savings compared to a traditional, non-torpor architecture design, even after permitting 
each architecture to be optimized. 
 
• Cost savings of approximately $10B were realized for the crew transit system over a 10-year Mars 
exploration campaign comprising 3 human missions to Mars and/or its vicinity. While not likely to be a large 
percentage reduction in the total mission costs once surface elements, ascent/descent stage, etc. are accounted 
for, the return on investment is very likely to exceed 10x and possibly be 100x.  
 
• Various scenarios were investigated to quantify alternate applications of the mass savings that can be 
achieved with torpor. It was demonstrated how the crew’s radiation exposure levels could be reduced up to 
30% with only a small mass penalty from the application of parasitic shielding. This was in comparison to 
mass increases on the non-torpor habitat that would yield an infeasible architecture design. 
 
Advancing Torpor Inducing Transfer Habitat for Human Stasis to Mars  
NIAC Phase II Final Report 
SpaceWorks Enterprises, Inc. (SEI)  
 
100 
• It was determined that the transit time to Mars could be easily reduced by 25%, from 200 days to 150 days, 
in order to minimize the crew’s time in space as well as exposure to the harmful effects of radiation and 
extended periods of microgravity. 
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Appendix B: Organization 
 
SpaceWorks Enterprises, Inc. (SEI) is an aerospace engineering concept design and systems analysis firm focusing on 
next-generation space transportation systems, future technologies, human and robotic exploration of space, and 
emerging space markets and applications. SpaceWorks’ advanced concept design and development work helps our 
customers envision the impact of future technologies, understand the feasibility of proposed space missions, and make 
strategic decisions regarding future markets. 
 
The experienced team uses the latest multidisciplinary design techniques and analysis methods to combine a range of 
technical and economic assessments into an integrated capability. In-house capabilities include performance 
assessment, aerodynamic analysis, propulsion systems analysis, mission design, cost assessment, reliability and safety 
analysis, reusable launch vehicle operations simulation, business case assessment, artwork, and custom computer 
animation and renders. Design work can be performed probabilistically or deterministically, depending on customer 
needs and requirements. 
 
Corporate customers include NASA, the U.S. Air Force, DARPA, traditional aerospace primes and emerging space 
entrepreneurs and their companies. Since our founding in 2000, SpaceWorks has served a variety of customers on 
space projects and contracts ranging from large to small, and from long to short duration. Our capabilities include 
single-discipline support for a client’s design team to complete end-to-end space concept analysis that includes 
performance, weight estimates, cost, and technology sensitivities. 
 
SpaceWorks engineers are also engaged in advanced research and outreach activities on topics that resonate with the 
world community. Our internal research projects include mission studies of concepts that might be used to deflect 
potentially dangerous asteroids, applications of space-based solar power for strategic energy independence, and 
promotion of market-driven space development activities such as space tourism and space resource utilization. 
 
In 2004, SpaceWorks received the NASA Group Achievement Award for the ATLAS Advanced Technology 
Lifecycle Analysis System management decision-support modeling tool as well as the NASA TGIR Turning Goals 
into Realities Award for Outstanding Contributions to the NGLT Systems Analysis Project Team (Mission Risk 
Analysis). SpaceWorks has also received the Orbital Sciences Corporation (OSC) Team Appreciation Award and is a 
recipient of the Inc. 500/5000 Award where it was listed as one of the fastest growing businesses in the United States. 
 
SpaceWorks is a privately held S-corporation based in Atlanta, GA. SpaceWorks is also a corporate partner in the 
Georgia Space Grant Consortium. 
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Appendix C: Study Team Members 
 
DR. JOHN E. BRADFORD, NIAC FELLOW 
 
John E. Bradford is President and Chief Operating Officer (COO) of SpaceWorks Enterprises in Atlanta, Georgia. 
SpaceWorks is an aerospace engineering concept design and systems analysis firm focusing on next-generation space 
transportation systems, future technologies, human and robotic exploration of space, and emerging space markets and 
applications. SpaceWorks’ advanced concept design and development work helps our customers envision the impact 
of future technologies, understand the feasibility of proposed space missions, and make strategic decisions regarding 
future markets. 
  
Dr. Bradford's expertise is in systems integration, multidisciplinary optimization, and the design and assessment of 
future space systems. Prior to joining SpaceWorks, Dr. Bradford worked at both NASA Marshall Space Flight Center 
(MSFC) in Huntsville, AL and Aerojet in Sacramento, CA. His specific area of interest is in computational analysis 
and design of future systems using collaborative, automated engineering frameworks. Dr. Bradford has developed 
both disciplinary analysis tools as well as end-to-end concept simulation models spanning performance assessment 
through life-cycle cost. 
 
Dr. Bradford received his Doctorate and Master's Degree in Aerospace Engineering from the Georgia Institute of 
Technology. At Georgia Tech, he was the recipient of a NASA Graduate Student Researchers Program (GSRP) 
Fellowship. He also holds a Bachelor of Science degree in Aerospace Engineering and a Minor in Computer 
Programming from North Carolina State University. He is a Senior Member of the American Institute of Aeronautics 
and Astronautics (AIAA), a NASA Academy (NAAA) alumnus, on the Steering Committee and a judge for NASA's 
RASC-AL student design competition, an alumni member of the AIAA High Speed Air-Breathing Propulsion 
Technical Committee, and regularly a guest speaker at science fiction conventions. 
 
MR. MARK SCHAFFER, SENIOR PROJECT ENGINEER 
 
Mark Schaffer is a Senior Aerospace Engineer in the Engineering division of SpaceWorks Enterprises, Inc. (SEI). Mr. 
Schaffer's disciplinary focuses include conceptual design of space access and space exploration architectures, 
performance and closure analysis of architecture elements, trajectory determination for Earth-to-orbit and deep space 
missions, and technology impact evaluation. 
 
Mr. Schaffer is member of SpaceWorks’ Advanced Concepts Group and is the company lead for human space 
exploration. In this role, he led a study sponsored by ULA to investigate cryogenic propulsive stages for human 
missions to the Moon, asteroids, and Mars. He has supported NASA lunar architecture studies for crew habitation and 
surface infrastructure design, and performed the habitat designs for a SpaceWorks study of manned Mars missions. In 
addition, Mr. Schaffer served as the team leader and lead engineer for SEI's Foresight proposal, a concept for a radio 
tagging mission to the asteroid Apophis. This proposal won first prize in the 2007-2008 Planetary Society Apophis 
Mission Design Competition. 
 
Mr. Schaffer also supports SpaceWorks’ space launch systems and hypersonic flight focus areas. He recently 
participated in the joint NASA-DARPA Horizontal Launch Study as a member of the analysis team, focusing on meta-
model development and integration for closure and performance metrics models, and technology impact evaluation 
on the concept vehicles. He also led a study through the Joint Systems Study to investigate the impact of technologies 
on NASA's TBCC launch system. 
 
Mr. Schaffer received his Bachelor of Science degree in Aerospace Engineering from the University of Illinois at 
Urbana-Champaign in 2006. 
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MR. BENJAMIN MERREL, AEROSPACE ENGINEER 
 
Mr. Benjamin Merrel is an Aerospace Engineer at SpaceWorks Enterprises, Inc. (SEI). Mr. Merrel serves as a member 
of SpaceWork’s Advanced Concepts Group with an emphasis on hypersonic vehicle design, analysis, and tool 
development. Prior to joining SpaceWorks, Mr. Merrel interned with the computational fluid dynamics (CFD) groups 
at both Northrop Grumman and Sage Physics. 
 
Mr. Merrel received his B.S. in Aeronautical and Astronautical Engineering from Purdue University. During his 
undergraduate tenure, he focused on conceptual design of hypersonic systems as an undergraduate researcher with 
Michael J. Grant and the Rapid Design of Systems Laboratory (RDSL). His advanced coursework included trajectory 
optimization, non-equilibrium aerodynamics, and U.S. technology policy. Additionally, Mr. Merrel led a student effort 
to become the first university team to design and test an orbital launch capability for small satellites. 
 
MR. CALEB WILLIAMS, LEAD ECONOMIC ANALYST 
 
Mr. Caleb Williams is the primary analyst for the SpaceWorks Commercial business unit where he specializes in 
helping government and commercial clients navigate the new space market landscape. Mr. Williams disciplinary 
focuses include parametric cost assessment, operations research, market forecasting, competitive intelligence, and 
corporate strategy. He routinely supports independent cost evaluations for various commercial and government 
customers, ranging from hypersonic vehicles to NASA flagship-mission proposals. Recent projects include a multi-
year effort to model the cost impacts of additively manufactured, modular rocket engines for AFRL, the evaluation of 
a $3B+ LEO satellite-broadband constellation bid for a major aerospace prime, and an investigation into corporate 
motivations behind vertical integration activity in the small satellite sector. 
 
Mr. Williams is the lead author for the SpaceWorks Nano/Microsatellite Market Forecast, an annual publication read 
by 2,500+ professionals each year and his commentary on the commercial space market has been widely featured by 
media outlets such as WIRED, SpaceNews, Kiplinger, NBC News, Constellations by Kratos, and many others.  
 
In addition to his professional work, Mr. Williams serves as the Associate Conference Chair for the Symposium on 
Space Innovations in Atlanta, and previously served as the Principal Investigator for the Solar Crafting project in 
NASA’s 3D Printed Habitat Design Challenge. 
 
DR. DOUGLAS TALK, MEDICAL TEAM LIASON 
 
Douglas W. Talk completed medical school at Eastern Virginia Medical School in Norfolk Virginia and performed 
his residency at the Naval Medical Center Portsmouth in Virginia. Dr. Talk holds a Master’s in Public Health and 
Epidemiology from Eastern Virginia Medical School. Dr. Talk is a native of North Carolina who earned his bachelor’s 
degrees in Biology and Biochemistry at North Carolina State University. He continues to be stationed at Naval Medical 
Center Portsmouth. He has headed several research studies and presented at both the Armed Forces District and 
American College of Obstetrics and Gynecology national meetings. 
 
During his four years on service as an OB/GYN resident and Chief resident his duties have included the care of both 
non-emergent and emergent obstetrics and gynecology patients. Dr. Talk has both clinical, surgical and intensive care 
unit privileges and works regularly with the Critical Care, Neonatology and Oncology departments in the treatment 
of cancer patients, obstetrical trauma and maternal/neonatal resuscitation, and acute medical care. Routine duties 
include diagnostic testing and evaluation of patients, medical and surgical management of illness and ICU care 
(including sedation, hypothermic therapy and nutritional recovery with TPN).   
 
Dr. Talk has an extensive military background. He attended the Naval Nuclear Power Training Program and served 
as both a nuclear chemist and nuclear plant technician aboard the USS Cavalla (SSN 684). After obtaining his 
bachelors’ degrees he served on board the USS Wadsworth (FFG 9) and USS Curts (FFG 38) acting as the Auxiliary 
Officer and Navigational Officer as well as performing duties as Officer of the Deck and Combat Information Center 
Officer.  Dr. Talk has also served as the Congressional Liaison Officer for the United States Fleet Forces Command 
Public Affairs Office. During his service he has earned multiple honors including the Navy Achievement Medal twice, 
the Navy Commendation Medal, several Admirals’ Letters of Accommodation, and was award the OB/GYN Intern 
of the year and later the Teaching Resident of the year at Naval Medical Center Portsmouth. 
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DR. KELLY DREW, MEMBER MEDICAL TEAM 
 
Kelly Drew is a Professor of Chemistry and Biochemistry with a research appointment in the Institute of Arctic 
Biology of the University of Alaska Fairbanks. She has studied hibernation for over 20 years. She received her Ph.D. 
in neuropharmacology at Albany Medical School with post-doctoral research in neuropharmacology at the Karolinska 
Institute. Her laboratory discovered that adenosine A1 receptor stimulation drives the onset of hibernation according 
to a seasonal, higher order process that regulates sensitivity to purinergic signaling. These mechanisms are now being 
studied in non-hibernating species as novel therapies for stroke and cardiac arrest and potentially for human 
hibernation. Dr. Drew was one of two Americans to be invited by a group of Scientists working with the European 
Space Agency on aspects of human hibernation. She was invited to join this group because of her expertise in the 
pharmacology of hibernation.  She has published 60 peer-reviewed papers and been funded since 2000 by NIH, NSF, 
DOD and DARPA. 
 
DR. ALEJANDRO RABINSTEIN, MEMBER MEDICAL TEAM 
 
Alejandro Rabinstein is a highly trained Neurocritical Care specialist with over 20 years of experience in the medical 
field. He has a deep interest in the therapeutic uses of induced hypothermia. He has pursued research on therapeutic 
hypothermia after cardiac arrest in the clinical setting and is involved in the design of experimental studies for the 
development of novel techniques to induce hypothermia. In 2008, Dr. Rabinstein received the Teacher of the Year 
Award for the Department of Neurology from the Mayo Fellows’ Association. He continues to work with the Mayo 
Clinic as a Professor of Clinical Neurology, the Medical Director of the Neuroscience ICU, and serves as the Director 
of the Fellowship Program in Neurocritical Care.  
 
An accomplished writer, Dr. Rabinstein’s expertise is well known and sought after in the medical community. He has 
authored or co-authored six books, 23 editorials, and has had more than 250 peer-reviewed articles published. He has 
also contributed to websites and written reviews of various letters, books, and periodicals. Dr. Rabinstein is an active 
member of numerous groups and societies, including the American Academy of Neurology and the Neurocritical Care 
Society.  
 
Dr. Rabinstein earned his medical degree in 1993 from Universidad Nacional de Cordoba in Argentina. He continued 
his studies in both Argentina and the United States becoming first a Resident in Internal Medicine, followed by a 
Resident in Neurology, and finally rounding off his studies by acquiring Fellowship status in Critical Care Neurology 
from the Mayo Clinic in 2002.  
 
As a Neurocritical Care Specialist with training in Internal Medicine, Critical Care and Neurology, Dr. Rabinstein is 
deeply interested in therapeutic uses of induced hypothermia. With his training, he is well prepared to study the 
physiological changes encountered when hypothermia is induced and to understand the neuroprotective mechanisms 
of this intervention. He has pursued research on therapeutic hypothermia after cardiac arrest in the clinical setting and 
is involved in the design of experimental studies for the development of novel techniques to induce hypothermia. 
 
DR. MATTHEW KUMAR, MEMBER MEDICAL TEAM 
 
Mathew Kumar brings over 25 years of experience in every aspect of therapeutic hypothermia (TH), from protecting 
the vital organs during cardiopulmonary bypass to deep hypothermic circulatory arrest for the surgical correction of 
arteriovenous malformations of the brain. After several years in clinical practice, he returned to basic research with a 
solid understanding of the utility and limitations of hypothermia in the current patient care environment and a clear 
understanding of what is necessary to safely extend the viable duration of therapeutic hypothermia beyond 1 or 2 
weeks. The Mayo Clinic has an over 100-year history of fostering scientific research and medical innovations. The 
institution is committed to providing time, materials, and the personnel necessary for investigators to succeed. Its 
research laboratories, hospitals, and graduate schools provide the intellectual environment and resources required to 
accomplish the goals of the proposed study. 
 
DR. LEROY CHIAO, MEMBER MEDICAL TEAM 
 
Leroy Chiao is a former NASA astronaut and International Space Station commander. He works in business and 
consulting. Chiao also holds appointments at Rice University and the Baylor College of Medicine and is the special 
advisor for human spaceflight to the Space Foundation. He has worked extensively in both government and 
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commercial space programs and has held leadership positions in commercial ventures and NASA. Chiao has extensive 
experience as a NASA Astronaut and prior to that, as a Research Engineer. Dr. Chiao is a fellow of the Explorers 
Club, and a member of the International Academy of Astronautics and the Committee of 100. Chiao also serves in 
various capacities to further space education. 
 
Dr. Chiao left NASA in 2005 following a fifteen-year career with the agency. A veteran of four space missions, Dr. 
Chiao most recently served as Commander and NASA Science Officer of Expedition 10 aboard the International 
Space Station. He has logged over 229 days in space - over 36 hours of which were spent in Extra-Vehicular Activity 
(EVA, or spacewalks). From June–September 2009, he served as a member of the White House appointed Review of 
U.S. Human Spaceflight Plans Committee, and currently serves on the NASA Advisory Council. 
 
Dr. Chiao studied Chemical Engineering, earning a Bachelor of Science degree from the University of California at 
Berkeley in 1983. He continued his studies at the University of California at Santa Barbara, earning his Master of 
Science and Doctor of Philosophy degrees in 1985 and 1987. Prior to joining NASA in 1990, he worked as a Research 
Engineer at Hexcel Corp. and then at the Lawrence Livermore National Lab. 
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